Original Article
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
N Engl J Med 2003; 348:518-527February 6, 2003
- Abstract
Background
Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but the risk associated with the various HPV types has not been adequately assessed.
Methods
We pooled data from 11 case–control studies from nine countries involving 1918 women with histologically confirmed squamous-cell cervical cancer and 1928 control women. A common protocol and questionnaire were used. Information on risk factors was obtained by personal interviews, and cervical cells were collected for detection of HPV DNA and typing in a central laboratory by polymerase-chain-reaction–based assays (with MY09/MY11 and GP5+/6+ primers).
Results
HPV DNA was detected in 1739 of the 1918 patients with cervical cancer (90.7 percent) and in 259 of the 1928 control women (13.4 percent). With the GP5+/6+ primer, HPV DNA was detected in 96.6 percent of the patients and 15.6 percent of the controls. The most common HPV types in patients, in descending order of frequency, were types 16, 18, 45, 31, 33, 52, 58, and 35. Among control women, types 16, 18, 45, 31, 6, 58, 35, and 33 were the most common. For studies using the GP5+/6+ primer, the pooled odds ratio for cervical cancer associated with the presence of any HPV was 158.2 (95 percent confidence interval, 113.4 to 220.6). The odds ratios were over 45 for the most common and least common HPV types. Fifteen HPV types were classified as high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82); 3 were classified as probable high-risk types (26, 53, and 66); and 12 were classified as low-risk types (6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108). There was good agreement between our epidemiologic classification and the classification based on phylogenetic grouping.
Conclusions
In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82 should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic.
Media in This Article
Table 1
Human Papillomavirus (HPV) Types in 1739 Patients with Squamous-Cell Cervical Cancer and in 259 Control Women Infected with Single or Multiple Types.Table 2
Prevalence of Human Papillomavirus (HPV) Types in Patients with Squamous-Cell Cervical Cancer and Control Women Infected with Single or Multiple Types, According to Age.Article Activity
- Article
Cervical cancer is the second most common cancer in women worldwide, and it is the principal cancer of women in most developing countries, where 80 percent of cases occur.1 Molecular epidemiologic evidence clearly indicates that certain types of human papillomavirus (HPV) are the principal cause of invasive cervical cancer2-4 and cervical intraepithelial neoplasia.5,6 More than 80 HPV types have been identified, and about 40 can infect the genital tract.7
Genital HPV types have been subdivided into low-risk types, which are found mainly in genital warts, and high-risk types, which are frequently associated with invasive cervical cancer. There is, however, no consensus concerning the categorization of many HPV types with low prevalence according to risk. Moreover, the number of putative high-risk types varies from 13 to 19, and only 11 HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, and 58) are consistently classified as entailing high risk.8-11 For these reasons, clear-cut criteria for classifying HPV types into low-risk and high-risk groups are needed. These criteria should be based on molecular epidemiologic studies that provide risk estimates and on functional evidence of the oncogenic potential of the various HPV types. A classification of HPV types based on their phylogenetic relationship has been proposed,12 but it has not been tested epidemiologically.
In 1995, the International Agency for Research on Cancer (IARC) concluded that four case–control studies yielded sufficient evidence to classify HPV types 16 and 18 as human carcinogens, but the evidence was limited or inadequate for other types.13 Since then, we have completed seven additional case–control studies in other populations, using similar protocols and HPV DNA–detection assays. We report here the pooled data from the 11 studies. These results form the basis for an epidemiologic classification of HPV types associated with cervical cancer, which can be compared with the phylogenetic classification. This information is essential for planning prevention by HPV vaccines and for screening programs based on HPV testing.
Methods
Study Design
From 1985 to 1997, we conducted 11 studies in nine countries with a broad range of rates of incidence of cervical cancer. Nine studies dealt only with invasive cervical cancer, and two also dealt with in situ cervical cancer. The subjects were drawn from high-risk populations in Africa (Morocco14 and Mali15) and South America (Colombia,2,16 Brazil,17 Paraguay,18 and Peru19); intermediate-risk populations in Asia (Thailand20 and the Philippines21); and low-risk populations in Spain.2,16 The methods of selection of patients and controls are described in the original study reports. Briefly, the patients were women with newly diagnosed, histologically confirmed invasive or in situ squamous-cell cervical cancer who had not received treatment. The control groups were population-based in the studies of invasive cervical cancer in Spain and Colombia and hospital-based or clinic-based in the other studies. They were frequency-matched to patients according to age (in five-year intervals) in all studies. The original histologic slides from which the diagnosis was made were reviewed by expert pathologists. All protocols were approved by the IARC and local ethics committees. Oral consent was obtained from the subjects in the Spanish and Colombian studies (which were initiated in 1985), consistent with the standard at the time. In the remaining studies, which were initiated later, written informed consent was obtained.
Collection of Data and Specimens
The women were interviewed at the hospital by trained interviewers using a standardized questionnaire to elicit information on risk factors for cervical cancer. After the interview, all women underwent a pelvic examination performed by a gynecologist or nurse, and two cervical scrapings were collected for cytologic study and detection of HPV DNA. A tumor-biopsy specimen was taken from most patients and kept frozen.
Detection, Typing, and Phylogenetic Grouping of HPV DNA
Detection of HPV DNA in cervical scrapings (exfoliated cells) and biopsy specimens was performed blindly in central laboratories with use of polymerase-chain-reaction (PCR)–based assays. Detailed protocols for these assays have been described. The relatively insensitive version of PCR primers for the L1 gene, MY09/MY11, was used in the Colombian and Spanish studies.22 The GP5+/6+ general primer system was used in the remaining studies.23 To detect the specific HPV types, oligohybridization methods were used for HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 54, and 56. A second round was performed for HPV types 6, 11, 26, 34, 40, 42, 43, 44, 53, 58, 59, and 68. A third round was performed for HPV types 57, 61, 66, 70, 72, 73, 81 (CP8304), 82 (W13B/MM4 subtype and IS39 subtype), 83, and CP6108. Specimens that were positive on assays with the GP5+/6+ system but that did not hybridize with any of these 33 probes were coded as HPV type X. Amplification of a fragment of the β-globin gene was used to assess the quality of the target DNA.
For specimens from patients found to be negative for β-globin and HPV DNA or positive for HPV X, DNA was extracted from the cell pellets and retested as described above. For detection of HPV in biopsy specimens, the sandwich method was used to check the histologic evidence of cancer, and an additional HPV-type–specific PCR was performed, with use of an E7 primer, for 14 HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) that were formerly designated as oncogenic types.4 These procedures were also used for reamplification of all control specimens classified as HPV X and a randomly selected subgroup of 32 specimens found to be positive for β-globin and negative for HPV DNA. After reamplification, 32 specimens from patients that were originally negative for HPV DNA were reclassified as positive for HPV DNA, but none of the specimens from control women were found to be positive for HPV DNA.
For patients, the combined prevalence of HPV DNA in exfoliated cells and in biopsy specimens is reported, whereas for control subjects, the prevalence of HPV DNA was determined only in exfoliated cells. Comparisons between patients and controls in which only the results from exfoliated cells were used produced virtually identical results.
For phylogenetic grouping of HPV types into low-risk or high-risk groups, we used the phylogenetic tree of 106 papillomavirus types based on an informative region within the L1 gene.24 The 12 HPV types that had been classified phylogenetically as high risk on the basis of sequence alignment,12 together with the types that are related to those 12 types, were classified as phylogenetically high risk in this study. Accordingly, among the 33 HPV types that were specifically tested, types 16, 31, 33, 35, 52, and 58 (all belonging to group A9); 18, 39, 45, 59, 68, and 70 (group A7); 26, 51, and 82 (group A5); and 53, 56, and 66 (group A6) were phylogenetically classified as high-risk HPV types. In contrast, types 6, 11, and 44 (group A10); 34 and 73 (group A11); 40 and 43 (group A8); 42 (group A1); 61, 72, 81, 83, 84, and CP6108 (group A3); and 57 (group A4) were classified as low-risk HPV types.
Statistical Analysis
To assess the risk of cervical cancer associated with HPV types, odds ratios and 95 percent confidence intervals were estimated by unconditional logistic regression.25 Odds ratios were adjusted for age as a categorical covariate (under 40, 40 to 49, 50 to 59, and over 59 years). Because of the small number of subjects from Mali, two categories were used (≤45 and >45 years). Odds ratios for individual HPV types were estimated by categorizing, as a single variable, each type or category of types. Subjects with HPV DNA–negative results were used as the reference category.
We defined as high-risk HPV types those associated, as single infections, with an odds ratio for cervical cancer of at least 5.0 and a lower 95 percent confidence limit of at least 3.0, as well as those that were detected in some of the patients but in none of the controls. We defined as low-risk HPV types those with an odds ratio for cervical cancer of at least 1.0 and a lower 95 percent confidence limit of less than 3.0, as well as those that were detected in some of the controls but in none of the patients. To test for a trend according to age in the prevalence of a specific HPV type among patients, the Mantel–Haenszel linear trend test was used. The Mantel–Haenszel test was used to test for homogeneity. All P values are two-sided.
Results
Study Subjects
A total of 2506 women with cervical cancer and 2491 control women were interviewed. Of the patients, 2365 (94.4 percent) had squamous-cell carcinoma and 141 (5.6 percent) had adenocarcinoma or adenosquamous carcinoma. A total of 1990 of the 2365 women with squamous-cell carcinoma (84.1 percent) and 2126 of the 2491 control women (85.3 percent) provided cervical specimens for HPV DNA testing.
Seventy-two of the 1990 specimens from patients (3.6 percent) and 198 of the 2126 control specimens (9.3 percent) tested for HPV DNA were negative for both β-globin and HPV and were excluded from the analysis, leaving 1918 patients and 1928 controls with specimens adequately tested for HPV DNA.
Specific Prevalence of HPV Types
A total of 1739 patients (90.7 percent) were positive for HPV DNA. Of these, 91.9 percent were infected with a single HPV type, and 8.1 percent were infected with multiple types. Among control women, 259 (13.4 percent) were positive for HPV DNA; of these, 86.1 percent were infected by a single HPV type, and 13.9 percent were infected by multiple types (Table 1Table 1
Human Papillomavirus (HPV) Types in 1739 Patients with Squamous-Cell Cervical Cancer and in 259 Control Women Infected with Single or Multiple Types.). In the studies in which the GP5+/6+ primers were used, the prevalence of HPV DNA was 96.6 percent in patients and 15.6 percent in controls. HPV types 16, 18, 45, 31, 33, 52, 58, and 35 (in descending order of frequency) were the eight most common types in patients, including infections with both single and multiple HPV types. HPV types 16, 18, 45, 31, 6, 58, 35, and 33 were the eight most common types in controls. The proportion of uncharacterized HPV types (HPV type X) was higher in controls (20.8 percent) than in patients (6.4 percent) (Table 1). HPV types 34, 57, and 83 were not found in any specimens from patients or controls.HPV type 16 was the most common type in all countries, with an overall prevalence of 58.9 percent, ranging from 43.9 percent in the Philippines to 72.4 percent in Morocco. HPV type 18 was the second most common type, with an overall prevalence of 15.0 percent (lowest in Spain [3.7 percent] and Colombia [4.4 percent] and highest in the Philippines [27.9 percent]). The third most common type, HPV type 45 (5.9 percent), had a very low prevalence in Spain and Colombia (0.8 percent and 0.6 percent, respectively), and its highest prevalence was in the Philippines (15.7 percent). HPV types 31 and 35 were more common in Latin America than in the other study areas. The prevalence of HPV type 52 was highest in Peru (8.6 percent). Some of the differences in type-specific prevalence observed between Spain and Colombia and the other countries could be related, at least in part, to differences in the sensitivities of the PCR assays used.
To explore the possibility of trends in the prevalence of HPV over time, the patients and controls were stratified into three groups according to age (Table 2Table 2
Prevalence of Human Papillomavirus (HPV) Types in Patients with Squamous-Cell Cervical Cancer and Control Women Infected with Single or Multiple Types, According to Age.). No statistically significant differences according to age in the distribution of HPV types (as single or multiple infections) were observed among the control women. Among the patients, the prevalence of HPV type 16 decreased significantly with age. Increases in prevalence with age were observed for types 39, 52, and 58.Risk Associated with HPV
The prevalence of HPV DNA among patients and controls and the corresponding odds ratios, adjusted for age, are presented in Table 3Table 3
Risk of Squamous-Cell Cervical Cancer Associated with the Presence of Human Papillomavirus (HPV) DNA. according to country. In the studies in which the GP5+/6+ system was used, the pooled odds ratio for cervical cancer associated with the presence of any HPV type was 158.2. When the MY09/MY11 primers were used, the pooled odds ratios were 63.4 and 19.1 in Spain and Colombia, respectively. The overall estimates of the odds ratio did not vary significantly according to age group. Adjustment for age slightly increased the odds ratios.The adjusted odds ratios for the various HPV types are shown in Table 4Table 4
Risk of Squamous-Cell Cervical Cancer According to Human Papillomavirus (HPV) Type.. Data on patients and controls in Spain and Colombia have been excluded, because they were tested with a less sensitive PCR assay. For HPV types 16, 18, 31, 33, 35, 45, 51, 52, 56, 58, 59, 68, and 73, the odds ratios were over 45 and the lower confidence limits were all higher than 4.0. They were therefore classified as high-risk types.HPV types 39 and 82 were also classified as high-risk types, because they were detected in some patients but in none of the 1928 controls. Because types 26, 53, and 66 were detected in only one to three patients, these types were classified as probable high-risk types (Table 1).
HPV types 40, 42, 43, 44, 54, 61, 70, 72, and CP6108 were not detected in patients and were considered low-risk types. Types 6, 11, and 81 were each detected in only 1 of the 1598 patients positive for single HPV types, and were therefore also classified as low-risk types (Table 1). Although the odds ratios for types 6 and 11 were 4.3 and 11.2, respectively, the lower limits of their confidence intervals were 0.5 and 1.0, respectively, further supporting their classification in the low-risk group.
The odds ratio for infection with multiple HPV types was not significantly different from that for infection with a single type (odds ratio for cervical cancer associated with multiple as compared with single infection, 0.7; 95 percent confidence interval, 0.4 to 1.0).
When our epidemiologic classification was compared with the phylogenetic grouping (Table 5Table 5
Phylogenetic and Epidemiologic Classification of HPV Types.), a discrepancy was observed only for two types: HPV type 70, which was classified as a high-risk type phylogenetically but as a low-risk type by our epidemiologic study; and HPV type 73, which was classified as a low-risk type phylogenetically but a high-risk type epidemiologically.No significant interactions were detected between HPV type and other known risk factors, such as high parity, long-term use of oral contraceptives, smoking, and age at first sexual intercourse (data not shown).
Discussion
Our pooled analysis of 11 case–control studies provides robust estimates of the risk of squamous-cell carcinoma of the cervix linked to 30 HPV types. Our best estimate of the pooled odds ratio for squamous-cell cervical carcinoma associated with HPV DNA positivity is 158.2 (Table 3). The association with the less common types is of a strength similar to the association found with HPV types 16 and 18.
Retesting of all patients who were negative for HPV DNA, but of only a small proportion of controls who were negative for HPV DNA, as well as the use of biopsy specimens from some of the patients, could have led to overestimation of the true odds ratios associated with HPV infection. However, we believe that any potential bias is likely to be small and would not substantially modify our results. In our validation studies in Peru, 19 of the 29 patients originally classified as negative for HPV DNA were reclassified as positive after retesting with E7 primers, whereas none of the controls were reclassified as positive.19 Similarly, in another study carried out in Thailand, the Philippines, and Spain, the prevalence of HPV DNA in exfoliated cells was very close to that in cervical-biopsy specimens from women without cervical cancer who were undergoing hysterectomy.26
Our epidemiologic classification, based on HPV-type–specific odds ratios and HPV prevalence among patients and controls, identified 15 HPV types as high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82). Three types (26, 53, and 66) should be considered probable high-risk types, since they were detected in only one to three patients and in none of the controls. Twelve types (6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108) were categorized as low-risk types, and three types (34, 57, and 83) were detected in none of the samples and were therefore considered to be associated with undetermined risk. According to the results of our study, five types that others have classified as low-risk types10,27 or as types associated with undetermined risk (26, 53, 66, 73, and 82) should now be added to the list of high-risk or probable high-risk types. The commercially available Hybrid Capture II (Digene) high-risk HPV test includes all of the types we have classified as high-risk types except types 26, 53, 66, 73, and 82.10 Our results indicate that this assay would have missed 18 of 1598 infections in patients (1.1 percent) and 1 of 223 in controls (0.4 percent).
We confirmed the low-risk status of six types widely regarded as such (types 6, 11, 40, 42, 43, and 44) and added to this list types 54, 61, 70, 72, 81, and CP6108, which have been considered as types associated with undetermined risk by others. Further studies will be required to determine the epidemiologic classification of HPV types not assessed in our study, such as types 62 and 67, which are classified phylogenetically as low-risk and high-risk types, respectively.
This pooled analysis provided us with the opportunity to compare epidemiologic and phylogenetic classifications of HPV types. The concordance of these two classifications is remarkable (Table 5); discrepancies were found only for types 70 and 73.
Little is known about the transforming or oncogenic properties of the E6 and E7 genes of HPV types other than those of the prototype high-risk types (16 and 18) and low-risk types (6 and 11). Types 16 and 18, as well as types 31 and 33, but not types 6 and 11, can induce immortalization of primary human keratinocytes and rat kidney cells.28-30
The prevalence of multiple HPV infections varies in relation to the method used to detect HPV DNA.10 In our study, the use of the PCR assay with the GP5+/6+ primer system may have led to an underestimation of the prevalence of multiple infections. As in previous studies, infection by multiple HPV types in our study was not associated with a greater risk of cervical cancer than infection by a single HPV type.27,31
HPV type 16 was the only type whose incidence decreased significantly with age. Assessment of the distribution of HPV types in cervical cancer over the past four to five decades is needed to determine whether these age-related differences are due to a cohort effect that could predict changes in the distribution of HPV types in the years to come, with implications for HPV-vaccination efforts.
Types 16, 18, 45, 31, 33, 52, 58, and 35 accounted for 95 percent of the squamous-cell carcinomas positive for HPV DNA. These findings have important implications for the prevention of cervical cancer. They imply that an effective vaccine against the five most common HPV types could prevent about 90 percent of the cases of cervical cancer worldwide. However, regional variation in the distribution of certain HPV types should be taken into account in the creation of vaccines tailored to different geographic regions.
Our results also have important implications for patient care and screening strategies. The similarity of the odds ratios for individual high-risk HPV types and their combinations clearly indicates that testing for groups of high-risk HPV types is sufficient and that the composition of screening “cocktails” for high-risk HPV types could be revised in view of our results and those from other populations.
Supported in part by grants from the Spanish Ministerio de Educación, Cultura y Deporte for short-term visiting scientists (SAB2000-0261, to Dr. Muñoz), the Fondo de Investigaciones Sanitarias, Spain (FIS 01/1236, FIS 01/1237, and BAE 01/5013), the Programa Interministerial de Investigación y Desarrollo, Spain (SAF 96/0323), and the Preventiefonds, the Netherlands (28-1502.1).
We are indebted to Mireia Díaz and Annie Arslan for statistical analysis and data management; to Cristina Rajo for her secretarial assistance; to René Pol, Jolein Pleijster, and Nathalie Fransen-Daalmeijer for their expert technical assistance; to Victor Moreno at the Institut Català d'Oncologia for useful comments on the manuscript; and to the gynecologists, pathologists, and supervisors of the fieldwork in the studies and to the many persons who volunteered to participate in them.
Source Information
From the International Agency for Research on Cancer, Lyons, France (N.M.); the Epidemiology and Cancer Registration Unit, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain (F.X.B., S.S., X.C.); Costa Rican Foundation for Health Sciences, San José, Costa Rica (R.H.); the Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore (K.V.S.); and the Department of Pathology, Vrije Universiteit Medical Center, Amsterdam (P.J.F.S., C.J.L.M.M.).
Address reprint requests to Dr. Muñoz at the Servei d'Epidemiologia i Registre del Càncer, Institut Català d'Oncologia, Hospital Duran i Reynals, Av. Gran Via, s/n km. 2,7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain, or at cris@ico.scs.es.
Members of the study group are listed in the Appendix.
Appendix
The International Agency for Research on Cancer Multicenter Cervical Cancer Study Group is composed of the following researchers: N. Muñoz, S. Franceschi, M. Plummer, and J. Smith (International Agency for Research on Cancer, Lyons, France); F.X. Bosch, V. Moreno, S. de Sanjosé, and X. Castellsagué (Institut Català d'Oncologia, Barcelona, Spain); R. Herrero (Foundation for Health Sciences, San José, Costa Rica); C.J.L.M. Meijer, J.M.M. Walboomers (deceased), A.J.C. van den Brule, and P.J.F. Snijders (Vrije Universiteit Medical Center, Amsterdam); K.V. Shah (Johns Hopkins University, Baltimore); S. Chichareon (Prince of Songkla University, Hat-Yai, Thailand); C. Ngelangel (University of the Philippines, Manila); N. Chaouki and B. El Gueddari (Institut National d'Oncologie, Rabat, Morocco); J. Eluf Neto (São Paulo University, São Paulo, Brazil); P.A. Rolón (Laboratorio de Anatomía Patológica y Citología, Asunción, Paraguay); C. Santos and E. Caceres (Maes Heller Cancer Research Institute, Lima, Peru); S. Bayo (Institut National de Recherche en Santé Publique, Bamako, Mali); I. Izarzugaza (Euskadi Cancer Registry, Vitoria Gasteiz, Spain); M. Gili (Cátedra de Medicina Preventiva y Social, Seville, Spain); P. Viladiu (Cancer Registry of Catalunya, Barcelona, Spain); L.A. Tafur (University of Valle, Cali, Colombia); C. Navarro (Health Council, Murcia, Spain); N. Ascunce (Breast Cancer Prevention Center, Pamplona, Spain); L.C. González (Delegation of Social Welfare, Salamanca, Spain); M. Santamaria (Navarra Hospital, Pamplona, Spain); P. Alonso de Ruiz (General Hospital of Mexico, Mexico City); N. Aristizabal (Cali, Colombia); and J. Deacon (Institute of Cancer Research, Belmont, United Kingdom).
- References
References
1
Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase no. 5. Lyons, France: IARC Press, 2001.
2
Munoz N ,Bosch FX ,de Sanjose S , et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52:743-749
CrossRef | Web of Science | Medline3
Bosch FX ,Lorincz A ,Munoz N ,Meijer CJ ,Shah KV . The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265
CrossRef | Web of Science | Medline4
Walboomers JMM ,Jacobs MV ,Manos MM , et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
CrossRef | Web of Science | Medline5
Schiffman MH ,Bauer HM ,Hoover RN , et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-964
CrossRef | Web of Science | Medline6
Kjaer SK ,van den Brule AJC ,Bock JE , et al. Human papillomavirus -- the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65:601-606
CrossRef | Web of Science | Medline7
de Villiers E-M . Taxonomic classification of papillomaviruses. Papillomavirus Rep 2001;12:57-638
Jacobs MV ,de Roda Husman AM ,van den Brule AJC ,Snijders PJF ,Meijer CJLM ,Walboomers JMM . Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 1995;33:901-905
Web of Science | Medline9
van den Brule AJ ,Pol R ,Fransen-Daalmeijer N ,Schouls LM ,Meijer CJLM ,Snijders PJ . GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002;40:779-787
CrossRef | Web of Science | Medline10
Davies P ,Kornegay J ,Iftner T . Current methods of testing for human papillomavirus. Best Pract Res Clin Obstet Gynaecol 2001;15:677-700
CrossRef | Web of Science | Medline11
Gravitt PE ,Peyton CL ,Apple RJ ,Wheeler CM . Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-3027
Web of Science | Medline12
Van Ranst M ,Kaplan JB ,Burk RD . Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 1992;73:2653-2660
CrossRef | Web of Science | Medline13
IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human papillomaviruses. Lyons, France: International Agency for Research on Cancer, 1995.
14
Chaouki N ,Bosch FX ,Munoz N , et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998;75:546-554
CrossRef | Web of Science | Medline15
Bayo S ,Bosch FX ,de Sanjose S , et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol 2002;31:202-209
CrossRef | Web of Science | Medline16
Bosch FX ,Munoz N ,de Sanjose S , et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:415-422
Web of Science | Medline17
Eluf-Neto J ,Booth M ,Munoz N ,Bosch FX ,Meijer CJLM ,Walboomers JMM . Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994;69:114-119
CrossRef | Web of Science | Medline18
Rolon PA ,Smith JS ,Munoz N , et al. Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000;85:486-491
CrossRef | Web of Science | Medline19
Santos C ,Munoz N ,Klug S , et al. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 2001;85:966-971
CrossRef | Web of Science | Medline20
Chichareon S ,Herrero R ,Munoz N , et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-57
CrossRef | Web of Science | Medline21
Ngelangel C ,Munoz N ,Bosch FX , et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998;90:43-49
CrossRef | Web of Science | Medline22
Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M, eds. Cancer cells. Vol. 7. Molecular diagnostics of human cancer. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1989:209-14.
23
de Roda Husman AM ,Walboomers JMM ,van den Brule AJC ,Meijer CJLM ,Snijders PJF . The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-1062
CrossRef | Web of Science | Medline24
Myers G, Sverdrup F, Baker C, et al., eds. Human papillomaviruses 1997: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, N.M.: Theoretical Biology and Biophysics, Los Alamos National Laboratory, 1997.
25
Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case–control studies. Lyons, France: International Agency for Research on Cancer, 1980. (IARC scientific publications no. 32.)
26
de Sanjose S ,Bosch XF ,Munoz N , et al. Screening for genital human papillomavirus: results from an international validation study on human papillomavirus sampling techniques. Diagn Mol Pathol 1999;8:26-31
CrossRef | Web of Science | Medline27
Herrero R ,Hildesheim A ,Bratti C , et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-474
CrossRef | Web of Science | Medline28
Durst M ,Dzarlieva-Petrusevska RT ,Boukamp P ,Fusenig NE ,Gissmann L . Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1987;1:251-256
Web of Science | Medline29
Storey A ,Pim D ,Murray A ,Osborn K ,Banks L ,Crawford L . Comparison of the in vitro transforming activities of human papillomavirus types. EMBO J 1988;7:1815-1820
Web of Science | Medline30
McDougall JK . Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 1994;186:101-119
Medline31
Kleter B ,van Doorn LJ ,Schrauwen L , et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-2517
Web of Science | Medline
- Citing Articles (1305)
Citing Articles
1
Cristina Pérez, Jo Ellen Klaustermeier, Laia Alemany, Sara Tous, Silvia de Sanjosé, Julio Velasco. (2012) Comparison of 2 Different PCR-Based Technologies for the Detection of Human Papilloma Virus from Paraffin-Embedded Tissue. Diagnostic Molecular Pathology 21:1, 45-52
CrossRef2
Viviane do Carmo Vasconcelos de Carvalho, Jamilly Lopes Macêdo, Camilla Albertina Dantas Lima, Maria da Conceição Gomes de Lima, Sandra Andrade Heráclio, Melânia Amorim, Maria Mascena Diniz Maia, Ana Lúcia Figueiredo Porto, Paulo Roberto Eleutério Souza. (2012) IFN-gamma and IL-12B polymorphisms in women with cervical intraepithellial neoplasia caused by human papillomavirus. Molecular Biology Reports
CrossRef3
Jean-Philippe Lanoix, Christine Pannier, Alice Borel, Youssef El Samad, Christine Robin, Youcef Douadi, Marine Woimant, Bernadette Fouche, Caroline Lecaque, Olivier Ganry, Gilles Duverlie, Henri Sevestre, Jean-Luc Schmit. (2012) Assessing Urine Human Papillomavirus Polymerase Chain Reaction Testing As a Tool for Screening Anal HPV infection in HIV-Positive MSM. AIDS Patient Care and STDs120209124454004
CrossRef4
M Kang, S Cu-Uvin. (2012) Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy. HIV Medicinen/a-n/a
CrossRef5
Magda Carvajal, Jaime Berumen, Mariano Guardado-Estrada. (2012) The presence of aflatoxin B 1 -FAPY adduct and human papilloma virus in cervical smears from cancer patients in Mexico. Food Additives & Contaminants: Part A 29:2, 258-268
CrossRef6
S. Guihard, A.-C. Jung, G. Noël. (2012) Carcinomes épidermoïdes oropharyngés liés à l’infection par les papillomavirus humains de haut risque oncogénique : aspects cliniques, biologiques et perspectives thérapeutiques. Cancer/Radiothérapie
CrossRef7
Christopher D. Sibley, Gisele Peirano, Deirdre L. Church. (2012) Molecular Methods for Pathogen and Microbial Community Detection and Characterization: Current and Potential Application in Diagnostic Microbiology. Infection, Genetics and Evolution
CrossRef8
Tania Tabone, Suzanne M. Garland, Glen Mola, Miriam O'Connor, Jennifer Danielewski, Sepehr N. Tabrizi. (2012) Prevalence of human papillomavirus genotypes in women with cervical cancer in Papua New Guinea. International Journal of Gynecology & Obstetrics
CrossRef9
Shikha Srivastava, Sadhana Gupta, Jagat Kumar Roy. (2012) High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: A population-based study. Journal of Biosciences
CrossRef10
F. Sitas, S. Egger, M. I. Urban, P. R. Taylor, C. C. Abnet, P. Boffetta, D. L. O'Connell, D. C. Whiteman, P. Brennan, R. Malekzadeh, M. Pawlita, S. M. Dawsey, T. Waterboer, . (2012) InterSCOPE Study: Associations Between Esophageal Squamous Cell Carcinoma and Human Papillomavirus Serological Markers. JNCI Journal of the National Cancer Institute 104:2, 147-158
CrossRef11
Mona Saraiya, Joelle I. Rosser, Crystale Purvis Cooper. (2012) Cancers That U.S. Physicians Believe the HPV Vaccine Prevents: Findings from a Physician Survey, 2009. Journal of Women's Health120104063751005
CrossRef12
Tanya H. Burkholder, Garry Linton, Robert F. Hoyt, Richard Young. 2012. The Rabbit as an Experimental Model. , 529-560.
CrossRef13
Joe B. Harford. (2012) Viral infections and human cancers: the legacy of Denis Burkitt. British Journal of Haematologyno-no
CrossRef14
Steffi Silling, Alexander Kreuter, Martin Hellmich, Jochen Swoboda, Herbert Pfister, Ulrike Wieland. (2012) Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men. Journal of Clinical Virology
CrossRef15
Dorien C Rijkaart, Johannes Berkhof, Lawrence Rozendaal, Folkert J van Kemenade, Nicole WJ Bulkmans, Daniëlle AM Heideman, Gemma G Kenter, Jack Cuzick, Peter JF Snijders, Chris JLM Meijer. (2012) Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. The Lancet Oncology 13:1, 78-88
CrossRef16
Wichai Termrungruanglert, Piyalamporn Havanond, Nipon Khemapech, Somrat Lertmaharit, Sathirakorn Pongpanich, Chonlakiet Khorprasert, Surasak Taneepanichskul. (2012) Cost and Effectiveness Evaluation of Prophylactic HPV Vaccine in Developing Countries. Value in Health 15:1, S29-S34
CrossRef17
E. Mazarico, E. Gonzalez-Bosquet. (2012) Prevalence of infection by different genotypes of human papillomavirus in women with cervical pathology. Gynecologic Oncology
CrossRef18
Youyun Zhao, Xuan Cao, Jingfeng Tang, Li Zhou, Yinglin Gao, Jiangping Wang, Yi Zheng, Shanshan Yin, Yefu Wang. (2012) A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening. Molecular and Cellular Probes
CrossRef19
Bassma M. El Sabaa, Mahmoud Meleiss, Inass Zaki. (2012) VEGF expression and microvascular density in relation to high-risk-HPV infection in cervical carcinoma – An immunohistochemical study. Alexandria Journal of Medicine
CrossRef20
Aaron A.R. Tobian, Xiangrong Kong, Patti E. Gravitt, Kevin P. Eaton, Godfrey Kigozi, David Serwadda, Amy E. Oliver, Fred Nalugoda, Frederick Makumbi, Michael Z. Chen, Maria J. Wawer, Thomas C. Quinn, Ronald H. Gray. (2011) Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda. International Journal of Cancer 129:12, 2970-2975
CrossRef21
Thomas Dreyer, Melanie Kreisel. (2011) Potentially malignant lesions of the upper aerodigestive tract. Journal of Biophotonicsn/a-n/a
CrossRef22
Yintao Ye, Wenqing Xu, Wei Zhong, Yajing Li, Chen Wang. (2011) Combination treatment with dihydrotanshinone I and irradiation enhances apoptotic effects in human cervical cancer by HPV E6 down-regulation and caspases activation. Molecular and Cellular Biochemistry
CrossRef23
Scott J. Bergman, McKenzie C. Ferguson, Cathy Santanello. (2011) Interferons as Therapeutic Agents for Infectious Diseases. Infectious Disease Clinics of North America 25:4, 819-834
CrossRef24
Shalini Kulasingam, Laura Havrilesky. (2011) Health economics of screening for gynaecological cancers. Best Practice & Research Clinical Obstetrics & Gynaecology
CrossRef25
Diego Delgado, Juan Manuel Marín, Julia de Diego, Sandra Guerra, Blanca González, Jose Luis Barrios, Andrés Canut. (2011) Human papillomavirus (HPV) genotype distribution in women with abnormal cervical cytology in the Basque Country, Spain. Enfermedades Infecciosas y Microbiología Clínica
CrossRef26
Laia Civit, Alex Fragoso, Sebastian Hölters, Matthias Dürst, Ciara K. O'Sullivan. (2011) Electrochemical genosensor array for the simultaneous detection of multiple high-risk human papillomavirus sequences in clinical samples. Analytica Chimica Acta
CrossRef27
José C. Palomares, Samuel Bernal, Antonio Artura, Manuel Parra, Jose Luis Cabezas, Jose Ma Romo, Estrella Martín-Mazuelos. (2011) Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples. Journal of Virological Methods
CrossRef28
Hong-Wei Wang, Ling-Lin Zhang, Fei Miao, Ting Lv, Xiu-Li Wang, Zheng Huang. (2011) Treatment of HPV Infection-associated Cervical Condylomata Acuminata with 5-Aminolevulinic Acid-mediated Photodynamic Therapy†. Photochemistry and Photobiologyno-no
CrossRef29
Alba Álvarez-Abella, Emili Masferrer, Sara Martín-Sala, Anna Jucglà. (2011) Carcinoma epidermoide de pene. Piel
CrossRef30
M. Marks, P. E. Gravitt, S. B. Gupta, K.-L. Liaw, A. Tadesse, E. Kim, C. Phongnarisorn, V. Wootipoom, P. Yuenyao, C. Vipupinyo, S. Sriplienchan, D. D. Celentano. (2011) Combined Oral Contraceptive Use Increases HPV Persistence but Not New HPV Detection in a Cohort of Women From Thailand. Journal of Infectious Diseases 204:10, 1505-1513
CrossRef31
Jonathan C. Hilpert, Sarah K. Brem, Melissa L. Carrion, Jenefer Husman. (2011) Learning about HPV on the Internet: the moderating role of moral values. Sex Education1-14
CrossRef32
A. F. Rositch, C. Poole, M. G. Hudgens, K. Agot, E. Nyagaya, S. Moses, P. J. F. Snijders, C. J. L. M. Meijer, R. C. Bailey, J. S. Smith. (2011) Multiple Human Papillomavirus Infections and Type Competition in Men. Journal of Infectious Diseases
CrossRef33
A. Neumeyer-Gromen, N. Bodemer, S.M. Müller, G. Gigerenzer. (2011) Ermöglichen Medienberichte und Broschüren informierte Entscheidungen zur Gebärmutterhalskrebsprävention?. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 54:11, 1197-1210
CrossRef34
Aysen Bayram, Suna Erkılıç, Özcan Balat, Fahriye Ekşi, Mete Gürol Uğur, Ebru Öztürk, Gülsüm Kaya. (2011) Prevalence and genotype distribution of human papillomavirus in non-neoplastic cervical tissue lesion: Cervical erosion. Journal of Medical Virology 83:11, 1997-2003
CrossRef35
Mosfequr Rahman, Toshiyuki Sasagawa, Rika Yamada, Alan Kingoro, Hiroshi Ichimura, Satoru Makinoda. (2011) High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of kenyan women infected with human immunodeficiency virus. Journal of Medical Virology 83:11, 1988-1996
CrossRef36
Hsu-Ko Kuo, Ken Fujise. (2011) Human Papillomavirus and Cardiovascular Disease Among U.S. Women in the National Health and Nutrition Examination Survey, 2003 to 2006. Journal of the American College of Cardiology 58:19, 2001-2006
CrossRef37
Kelley VanBuskirk, Rachel L. Winer, James P. Hughes, Qinghua Feng, Yuzo Arima, Shu-Kuang Lee, Michael E. Stern, Sandra F. OʼReilly, Laura A. Koutsky. (2011) Circumcision and Acquisition of Human Papillomavirus Infection in Young Men. Sexually Transmitted Diseases 38:11, 1074-1081
CrossRef38
Oliver Balmer, Marcel Tanner. (2011) Prevalence and implications of multiple-strain infections. The Lancet Infectious Diseases 11:11, 868-878
CrossRef39
Alaina J. Brown, Cornelia L. Trimble. (2011) New technologies for cervical cancer screening. Best Practice & Research Clinical Obstetrics & Gynaecology
CrossRef40
Y. Jiang, P. Brassard, A. Severini, V. Goleski, M. Santos, A. Leamon, S. Chatwood, C. Lys, G. Johnson, T. Wong, A. Kotaska, K. Kandola, Y. Mao. (2011) Type-specific prevalence of Human Papillomavirus infection among women in the Northwest Territories, Canada. Journal of Infection and Public Health
CrossRef41
Maria Luisa Mateos Lindemann, Mario Jose Rodriguez Dominguez, Jesús Chacón de Antonio, Maria Teresa Sandri, Alessio Tricca, Mario Sideri, Hacène Khiri, Sophie Ravet, Sean Boyle, Carrie Aldrich, Philippe Halfon. (2011) Analytical Comparison of the cobas HPV Test with Hybrid Capture 2 for the Detection of High-Risk HPV Genotypes. The Journal of Molecular Diagnostics
CrossRef42
Christos F. Maramis, Anastasios N. Delopoulos. (2011) A novel algorithm for restricting the complexity of virus typing via PCR-RFLP gel electrophoresis. Biomedical Engineering Letters 1:4, 239-246
CrossRef43
Dieter Morandell, Andreas Kaiser, Steffi Herold, Ursula Rostek, Stefan Lechner, Maria C. Mitterberger, Pidder Jansen-Dürr, Martin Eilers, Werner Zwerschke. (2011) The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-finger protein-1. Virology
CrossRef44
Cosette M Wheeler, Xavier Castellsagué, Suzanne M Garland, Anne Szarewski, Jorma Paavonen, Paulo Naud, Jorge Salmerón, Song-Nan Chow, Dan Apter, Henry Kitchener, Júlio C Teixeira, S Rachel Skinner, Unnop Jaisamrarn, Genara Limson, Barbara Romanowski, Fred Y Aoki, Tino F Schwarz, Willy A J Poppe, F Xavier Bosch, Diane M Harper, Warner Huh, Karin Hardt, Toufik Zahaf, Dominique Descamps, Frank Struyf, Gary Dubin, Matti Lehtinen. (2011) Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet Oncology
CrossRef45
R. Parvez, S. Hedau, D. Bhattacharya, H. Bhattacharjee, N. Muruganandam, B.C. Das, M.K. Saha, A.P. Sugunan, P. Vijayachari. (2011) High-risk HPV infection among the tribal and non-tribal women of the Andaman and Nicobar Islands, India. Public Health
CrossRef46
Antonio Frega, Paolo Scirpa, Francesco Sopracordevole, Alberto Biamonti, Paola Bianchi, Luana De Sanctis, Laura Lorenzon, Arianna Pacchiarotti, Deborah French, Massimo Moscarini. (2011) Impact of human papillomavirus infection on the neovaginal and vulval tissues of women who underwent surgical treatment for Mayer-Rokitansky-Kuster-Hauser syndrome. Fertility and Sterility 96:4, 969-973
CrossRef47
B. Pietrzak, K. Bobrowska, M. Szpotanska-Sikorska, Z. Jabiry-Zieniewicz, B. Kociszewska-Najman, M. Durlik, P. Kaminski, M. Wielgos. (2011) Multiple Types of High-Risk Human Papilloma Virus in the Lower Genital Tract of a Female Kidney Recipient: A Case Report. Transplantation Proceedings 43:8, 2994-2996
CrossRef48
Regina Bones Barcellos, Sabrina Esteves de Matos Almeida, Rosa Dea Sperhacke, Mirela Verza, Franciele Rosso, Rúbia Marília de Medeiros, Paulo Fernando Perizzolo, Elizabeth Cortez-Herrera, Maria Lucia Rosa Rossetti. (2011) Evaluation of a novel microplate colorimetric hybridization genotyping assay for human papillomavirus. Journal of Virological Methods 177:1, 38-43
CrossRef49
Toli S. Onon. (2011) History of human papillomavirus, warts and cancer: What do we know today?. Best Practice & Research Clinical Obstetrics & Gynaecology 25:5, 565-574
CrossRef50
Manola Comar, Daniela Bonifacio, Fabrizio Zanconati, Michela Di Napoli, Erica Isidoro, Fernanda Martini, Lucio Torelli, Mauro Tognon. (2011) High prevalence of BK Polyomavirus Sequences in Human Papillomavirus-16-Positive Precancerous Cervical Lesions. Journal of Medical Virology 83:10, 1770-1776
CrossRef51
MARIA LINA TORNESELLO, ROSARIA CASSESE, NICOLETTA DE ROSA, LUIGI BUONAGURO, ANNA MASUCCI, GABRIELE VALLEFUOCO, STEFANO PALMIERI, VINCENZO SCHIAVONE, ROBERTO PICCOLI, FRANCO M BUONAGURO. (2011) High prevalence of human papillomavirus infection in Eastern European and West African women immigrants in South Italy. APMIS 119:10, 701-709
CrossRef52
Alexander Burges, Naim Shabani, Ansgar Brüning, Ioannis Mylonas. (2011) Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line. Archives of Gynecology and Obstetrics 284:4, 981-988
CrossRef53
Sara L. Bissett, Rebecca Howell-Jones, Craig Swift, Natasha De Silva, Leon Biscornet, John V. Parry, Nicholas A. Saunders, Mayura Nathan, Kate Soldan, Anne Szarewski, Jack Cuzick, Simon Beddows. (2011) Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. Journal of Medical Virology 83:10, 1744-1751
CrossRef54
Valeria Cento, Noor Rahmatalla, Massimo Ciccozzi, Carlo Federico Perno, Marco Ciotti. (2011) Intratype variations of HPV 31 and 58 in Italian women with abnormal cervical cytology. Journal of Medical Virology 83:10, 1752-1761
CrossRef55
Iain J. MacLeod, Belinda O'Donnell, Sikhulile Moyo, Shahin Lockman, Roger L. Shapiro, Mukendi Kayembe, Erik van Widenfelt, Joseph Makhema, M. Essex, Carolyn Wester. (2011) Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana. Journal of Medical Virology 83:10, 1689-1695
CrossRef56
F Xavier Bosch. (2011) Human papillomavirus: science and technologies for the elimination of cervical cancer. Expert Opinion on Pharmacotherapy 12:14, 2189-2204
CrossRef57
Joseph E. Tota, Myriam Chevarie-Davis, Lyndsay A. Richardson, Maaike deVries, Eduardo L. Franco. (2011) Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Preventive Medicine 53, S12-S21
CrossRef58
I. Cannavo, M. Benchetrit, C. Loubatier, G. Michel, E. Lemichez, V. Giordanengo. (2011) Characterization of a cluster of oncogenic mutations in E6 of a human papillomavirus 83 variant isolated from a high-grade squamous intraepithelial lesion. Journal of General Virology 92:10, 2428-2436
CrossRef59
Reza Shahsiah, Morteza Khademalhosseini, Nili Mehrdad, Fatemeh Ramezani, Seyed Alireza Nadji. (2011) Human papillomavirus genotypes in Iranian patients with cervical cancer. Pathology - Research and Practice
CrossRef60
Ines Badano, Silvina M. Stietz, Theodore G. Schurr, Alejandra M. Picconi, Daniel Fekete, Ivana M. Quintero, Maia D.E. Cabrera, Rodolfo H. Campos, Javier D. Liotta. (2011) Analysis of TNFα promoter SNPs and the risk of cervical cancer in urban populations of Posadas (Misiones, Argentina). Journal of Clinical Virology
CrossRef61
Ledy H.S. Oliveira, Larissa S. Santos, Everton F. Augusto, Felipe P.G. Neves. (2011) Identification of human papillomavirus type 53 L1, E6 and E7 variants in isolates from Brazilian women. Infection, Genetics and Evolution
CrossRef62
Masahito Mizuuchi, Yoshihiko Hirohashi, Toshihiko Torigoe, Kuroda Takafumi, Kazuyo Yasuda, Tsuyoshi Saito, Noriyuki Sato. (2011) Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses. Experimental and Molecular Pathology
CrossRef63
Jian Sun, Ji-Sheng Yu, Zhiwu Yu, Xiao Zha, Yuqing Wu. (2011) The differences in heparin binding for the C-terminal basic-sequence-rich peptides of HPV-16 and HPV-18 capsid protein L1. The Journal of Chemical Thermodynamics
CrossRef64
Nienke J. Veldhuijzen, Nathalie Dhont, Joseph Vyankandondera, Ammiel Gasarabwe, Rosetta Busasa, Tania Crucitti, Janneke H. H. M. van de Wijgert. (2011) Prevalence and Concordance of HPV, HIV, and HSV-2 in Heterosexual Couples in Kigali, Rwanda. Sexually Transmitted Diseases1
CrossRef65
L. Baandrup, C. Munk, K.K. Andersen, J. Junge, T. Iftner, S.K. Kjær. (2011) HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3. Gynecologic Oncology
CrossRef66
H.-C. Chen, M. Schiffman, C.-Y. Lin, M.-H. Pan, S.-L. You, L.-C. Chuang, C.-Y. Hsieh, K.-L. Liaw, A. W. Hsing, C.-J. Chen, . (2011) Persistence of Type-Specific Human Papillomavirus Infection and Increased Long-term Risk of Cervical Cancer. JNCI Journal of the National Cancer Institute 103:18, 1387-1396
CrossRef67
Xiaohong Wang, Craig Meyers, Ming Guo, Zhi-Ming Zheng. (2011) Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. International Journal of Cancer 129:6, 1362-1372
CrossRef68
D. Chen, J. D. McKay, G. Clifford, V. Gaborieau, A. Chabrier, T. Waterboer, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, V. Bencko, V. Janout, L. Foretova, I. N. Mates, N. Szeszenia-Dabrowska, M. P. Curado, S. Koifman, A. Menezes, V. Wunsch-Filho, J. Eluf-Neto, L. Fernandez Garrote, E. Matos, D. Zelenika, A. Boland, P. Boffetta, M. Pawlita, M. Lathrop, P. Brennan. (2011) Genome-wide association study of HPV seropositivity. Human Molecular Genetics
CrossRef69
G. Assmann, K. Sotlar. (2011) HPV-assoziierte Plattenepithelkarzinogenese. Der Pathologe 32:5, 391-398
CrossRef70
Laila Darwich, Maria-Paz Canadas, Guillen Sirera, Francesc Alameda, Pilar Forcada, Jordi Delas, Ines Fernandez, Mariona Llatjos, Josep Coll, Bonaventura Clotet, Sebastia Videla. (2011) Human Papillomavirus Genotype Distribution and Human Papillomavirus 16 and Human Papillomavirus 18 Genomic Integration in Invasive and In Situ Cervical Carcinoma in Human Immunodeficiency Virus-Infected Women. International Journal of Gynecological Cancer1
CrossRef71
María Sol dos Ramos Farías, María Noé Garcia, Elena Reynaga, Marcela Romero, María Lucía Gallo Vaulet, Marcelo Rodríguez Fermepín, Mauro Fernández Toscano, Jorge Rey, Rubén Marone, Luis Squiquera, Joaquín V. González, Jorge Basiletti, María Alejandra Picconi, María A. Pando, María Mercedes Ávila. (2011) First report on sexually transmitted infections among trans (male to female transvestites, transsexuals, or transgender) and male sex workers in Argentina: high HIV, HPV, HBV, and syphilis prevalence. International Journal of Infectious Diseases 15:9, e635-e640
CrossRef72
Vikrant V Sahasrabuddhe, Patricia Luhn, Nicolas Wentzensen. (2011) Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiology 6:9, 1083-1098
CrossRef73
Megan K. Bendik, Rachel M. Mayo, Veronica G. Parker. (2011) Knowledge, Perceptions, and Motivations Related to HPV Vaccination Among College Women. Journal of Cancer Education 26:3, 459-464
CrossRef74
Richard M. Haupt, Heather L. Sings. (2011) The Efficacy and Safety of the Quadrivalent Human Papillomavirus 6/11/16/18 Vaccine Gardasil. Journal of Adolescent Health
CrossRef75
Eve Draper, Sara L. Bissett, Rebecca Howell-Jones, Debbie Edwards, Graham Munslow, Kate Soldan, Simon Beddows. (2011) Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera. Vaccine
CrossRef76
Hannah P. Yang, David K. Walmer, Delson Merisier, Julia C. Gage, Laura Bell, Sameera Rangwala, Niwashin Shrestha, Lori Kobayashi, Paul S. Eder, Philip E. Castle. (2011) A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test. Journal of Virological Methods 176:1-2, 112-114
CrossRef77
Yasmin L Jayasinghe, Elya E Moore, Sepehr N Tabrizi, Sonia R Grover, Suzanne M Garland. (2011) Human papillomavirus in adolescents: Lessons learned from decades of evaluation. Journal of Paediatrics and Child Healthno-no
CrossRef78
Carla J. Chibwesha, Susan Cu-Uvin. (2011) See-and-Treat Approaches to Cervical Cancer Prevention for HIV-Infected Women. Current HIV/AIDS Reports 8:3, 192-199
CrossRef79
Rui Zhao, Zhibao Chen, Guiyan Jia, Jian Li, Yaping Cai, Xingyue Shao. (2011) Protective effects of diosmetin extracted from Galium verum L. on the thymus of U14-bearing mice. Canadian Journal of Physiology and Pharmacology 89:9, 665-673
CrossRef80
Erik Munson, Brian K. Du Chateau, Bronya Bellerose, Jolanta Czarnecka, Judy Griep. (2011) Clinical laboratory evaluation of Invader® chemistry and hybrid capture for detection of high-risk human papillomavirus in liquid-based cytology specimens. Diagnostic Microbiology and Infectious Disease
CrossRef81
Maribel Almonte, Catterina Ferreccio, Miguel Gonzales, Jose Manuel Delgado, C. Hilary Buckley, Silvana Luciani, Sylvia C. Robles, Jennifer L. Winkler, Vivien D. Tsu, Jose Jeronimo, Jack Cuzick, Peter Sasieni. (2011) Risk Factors for High-Risk Human Papillomavirus Infection and Cofactors for High-Grade Cervical Disease in Peru. International Journal of Gynecological Cancer1
CrossRef82
Diego Jacques Grauwet. (2011) Infecciones genitales por VPH tratadas por microinmunoterapia. Revista Médica de Homeopatía 4:3, 103-105
CrossRef83
Valeria Cento, Noor Rahmatalla, Massimo Ciccozzi, Alessandra Lo Presti, Carlo Federico Perno, Marco Ciotti. (2011) Human papillomaviruses 53 and 66: Clinical aspects and genetic analysis. Virus Research
CrossRef84
Ya-Ju Chang, Hui-Chi Chen, Bor-Heng Lee, San-Lin You, Ching-Yu Lin, Mei-Hung Pan, Yi-Chun Chou, Chang-Yao Hsieh, Yi-Ming A. Chen, Yu-Juen Cheng, Chien-Jen Chen, . (2011) Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia. International Journal of Cancer 129:4, 965-973
CrossRef85
S. Hariri, E. R. Unger, M. Sternberg, E. F. Dunne, D. Swan, S. Patel, L. E. Markowitz. (2011) Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. Journal of Infectious Diseases 204:4, 566-573
CrossRef86
Julie Heymans, Ina H. Benoy, Willy Poppe, Christophe E. Depuydt. (2011) Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation. International Journal of Cancer 129:4, 903-909
CrossRef87
Kevin H. Kim, William W. Greenfield, Martin J. Cannon, Hannah N. Coleman, Horace J. Spencer, Mayumi Nakagawa. (2011) CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend. Cancer Immunology, Immunotherapy
CrossRef88
Hakan Yetimalar, Burcu Kasap, Kulal Cukurova, Askin Yildiz, Adnan Keklik, Ferit Soylu. (2011) Cofactors in human papillomavirus infection and cervical carcinogenesis. Archives of Gynecology and Obstetrics
CrossRef89
S. Peeters, T. Stakenborg, F. Colle, C. X. Liu, L. Lagae, M. Ranst. (2011) Specific magnetic isolation for direct detection of HPV16. European Journal of Clinical Microbiology & Infectious Diseases
CrossRef90
L.P. Mendoza, J. Arbiza, M. Paez, E. Kasamatsu, A. Castro, G. Giménez, J. Basiletti, J. Gonzalez, P. Mongelós, M.A. Picconi. (2011) Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion. Journal of Medical Virology 83:8, 1351-1357
CrossRef91
Marianne Waldstrøm, Dorthe Ørnskov. (2011) Clinical Performance of a Human Papillomavirus Messenger RNA Test (Aptima HPV Assay) on Residual Material From Archived 3-Year-Old PreservCyt Samples With Low-Grade Squamous Intraepithelial Lesion. Archives of Pathology & Laboratory Medicine 135:8, 1052-1056
CrossRef92
Marinko Dobec, Fridolin Bannwart, Sandra Kilgus, Franz Kaeppeli, Pascal Cassinotti. (2011) Human papillomavirus infection among women with cytological abnormalities in Switzerland investigated by an automated linear array genotyping test. Journal of Medical Virology 83:8, 1370-1376
CrossRef93
Terri G. Edwards, Kevin J. Koeller, Urszula Slomczynska, Kam Fok, Michael Helmus, James K. Bashkin, Chris Fisher. (2011) HPV episome levels are potently decreased by pyrrole–imidazole polyamides. Antiviral Research 91:2, 177-186
CrossRef94
Nathalie Garçon, Sandra Morel, Arnaud Didierlaurent, Dominique Descamps, Martine Wettendorff, Marcelle Van Mechelen. (2011) Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach. BioDrugs 25:4, 217-226
CrossRef95
Jean-Sebastien Casalegno, Mehdi Benchaib, Karine Le Bail Carval, Eric Piaton, Patrice Mathevet, Yahia Mekki. (2011) Human papillomavirus genotype distribution among French women with and without cervical abnormalities. International Journal of Gynecology & Obstetrics 114:2, 116-119
CrossRef96
Anna Söderlund-Strand, Carina Eklund, Levent Kemetli, Lena Grillner, Sven Törnberg, Joakim Dillner, Lena Dillner. (2011) Genotyping of human papillomavirus in triaging of low-grade cervical cytology. American Journal of Obstetrics and Gynecology 205:2, 145.e1-145.e6
CrossRef97
Kentaro Yamasaki, Kiyonori Miura, Takako Shimada, Rie Ikemoto, Shoko Miura, Makoto Murakami, Tetsuro Sameshima, Akira Fujishita, Kouhei Kotera, Akira Kinoshita, Koh-ichiro Yoshiura, Hideaki Masuzaki. (2011) Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology. Journal of Obstetrics and Gynaecology Researchno-no
CrossRef98
Tazio Vanni, Rosa Legood, Eduardo L. Franco, Luisa L. Villa, Paula Mendes Luz, Gilberto Schwartsmann. (2011) Economic evaluation of strategies for managing women with equivocal cytological results in Brazil. International Journal of Cancer 129:3, 671-679
CrossRef99
Cláudia M.A. Jacyntho, Paulo C. Giraldo, Antônio A. Horta, Rosana Grandelle, Ana K. Gonçalves, Thaís Fonseca, José Eleutério. (2011) Association between genital intraepithelial lesions and anal squamous intraepithelial lesions in HIV-negative women. American Journal of Obstetrics and Gynecology 205:2, 115.e1-115.e5
CrossRef100
Yanjie Weng, Yongjun Wang, Ying Shi, Wenjuan Zhou, Hongyan Wang, Changyu Wang. (2011) TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro. Journal of Huazhong University of Science and Technology [Medical Sciences] 31:4, 550-554
CrossRef101
B. Weaver, M. Shew, B. Qadadri, W. Tu, Y. Tong, C. Denski, J.D. Fortenberry, A. Ermel, D. Brown. (2011) Low-level persistence of human papillomavirus 16 DNA in a cohort of closely followed adolescent women. Journal of Medical Virology 83:8, 1362-1369
CrossRef102
Sarah L. Goff, Kathleen M. Mazor, Shawn J. Gagne, Kristin C. Corey, Diane R. Blake. (2011) Vaccine counseling: A content analysis of patient–physician discussions regarding human papilloma virus vaccine. Vaccine
CrossRef103
Marie-Noelle Didelot, Nathalie Boulle, Audrey Damay, Valérie Costes, Michel Segondy. (2011) Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes. Journal of Medical Virology 83:8, 1377-1382
CrossRef104
J.-H. Lee, N.-W. Lee, S.-W. Hong, Y.-S. Nam, J.-W. Choi, Y.-S. Kim. (2011) Establishment of an efficient multiplex real-time PCR assay for human papillomavirus genotyping in cervical cytology specimens: comparison with hybrid capture II. Cytopathology 22:4, 261-268
CrossRef105
L. Bailly, A. Bongain, E. Mariné Barjoan, C. Sattonnet, J. Saos, M.-L. Durant, F. Mousteou, C. Pradier. (2011) Taux observés des CIN en 2006 avant la vaccination anti-HPV parmi les résidentes des Alpes-Maritimes. Gynécologie Obstétrique & Fertilité
CrossRef106
S. Rückert, N. Ditsch, J. Gallwas, C. Dannecker. (2011) HPV-Infektion in der Schwangerschaft. Der Gynäkologe 44:8, 630-636
CrossRef107
Angiolo Gadducci, Cecilia Barsotti, Stefania Cosio, Lavinia Domenici, Andrea Riccardo Genazzani. (2011) Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature. Gynecological Endocrinology 27:8, 597-604
CrossRef108
Sherri N. Sheinfeld Gorin, Beth A. Glenn, Rebecca B. Perkins. (2011) The human papillomavirus (HPV) vaccine and cervical cancer: Uptake and next steps. Advances in Therapy 28:8, 615-639
CrossRef109
M. Brisson, N. van de Velde, E. L. Franco, M. Drolet, M.-C. Boily. (2011) Incremental Impact of Adding Boys to Current Human Papillomavirus Vaccination Programs: Role of Herd Immunity. Journal of Infectious Diseases 204:3, 372-376
CrossRef110
Francesco Saverio Mennini, Donatella Panatto, Andrea Marcellusi, Paolo Cristoforoni, Rosa De Vincenzo, Elisa Di Capua, Gabriella Ferrandina, Marco Petrillo, Tiziana Sasso, Cristina Ricci, Nausica Trivellizzi, Alessandro Capone, Giovanni Scambia, Roberto Gasparini. (2011) Time Trade-Off Procedure for Measuring Health Utilities Loss With Human Papillomavirus–Induced Diseases: A Multicenter, Retrospective, Observational Pilot Study in Italy. Clinical Therapeutics 33:8, 1084-1095.e4
CrossRef111
Nirma A. Samarawickrema, Sepehr N. Tabrizi, Janaki Hewavisenthi, Trishe Leong, Suzanne M. Garland. (2011) Distribution of human papillomavirus genotypes in archival cervical tissue from women with cervical cancer in urban Sri Lanka. International Journal of Gynecology & Obstetrics
CrossRef112
Angela Pista, Carlos Freire de Oliveira, Maria João Cunha, Maria Teresa Paixao, Odete Real. (2011) Prevalence of Human Papillomavirus Infection in Women in Portugal. International Journal of Gynecological Cancer 21:6, 1150-1158
CrossRef113
Cosette M. Wheeler, Bryan M. Harvey, Michael E. Pichichero, Michael W. Simon, Stephen P. Combs, Mark M. Blatter, Gary S. Marshall, Grégory Catteau, Kurt Dobbelaere, Dominique Descamps, Gary Dubin, Anne Schuind. (2011) Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-adjuvanted Vaccine Coadministered With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine and/or Meningococcal Conjugate Vaccine to Healthy Girls 11 to 18 Years of Age. The Pediatric Infectious Disease Journal1
CrossRef114
D. Lutringer-Magnin, J. Kalecinski, G. Barone, H. Borne, V. Regnier, P. Vanhems, F. Chauvin, C. Lasset. (2011) Perception et pratique de la vaccination HPV par les gynécologues : une étude quantitative et qualitative en Rhône-Alpes. Gynécologie Obstétrique & Fertilité
CrossRef115
Soon-Yong Choi, Jong-Ho Lim, Eun-Jung Kim, Hei-Sung Kim, Beom-Joon Kim, Hoon Kang, Young-Min Park. (2011) Detection and Typing of Human Papillomavirus in Cutaneous Common Warts by Multiplex Polymerase Chain Reaction. Journal of Life Science 21:7, 947-952
CrossRef116
Soheila Sarmadi, Narges Izadi-mood, Mojdeh Pourlashkari, Fariba Yarandi, Sanaz Sanii. (2011) HPV L1 capsid protein expression in squamous intraepithelial lesions of cervix uteri and its relevance to disease outcome. Archives of Gynecology and Obstetrics
CrossRef117
B Saha, A Adhikary, P Ray, S Saha, S Chakraborty, S Mohanty, K Das, S Mukherjee, M Mazumdar, L Lahiri, D M S Hossain, G Sa, T Das. (2011) Restoration of tumor suppressor p53 by differentially regulating pro- and anti-p53 networks in HPV-18-infected cervical cancer cells. Oncogene
CrossRef118
Juan Du, Anders Näsman, Joseph W. Carlson, Torbjörn Ramqvist, Tina Dalianis. (2011) Prevalence of Human Papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccination. Acta Oncologica1-5
CrossRef119
Andrzej Roszak, Witold Kędzia, Blanka Malkowska-Walczak, Piotr Pawlik, Helena Kędzia, Michał Łuczak, Margarita Lianeri, Paweł P. Jagodzinski. (2011) Reduced expression of PHD2 prolyl hydroxylase gene in primary advanced uterine cervical carcinoma. Biomedicine & Pharmacotherapy 65:4, 298-302
CrossRef120
L. Saumet, A. Damay, E. Jeziorski, C. Cartier, C. Rouleau, G. Margueritte, M. Rodière, M. Segondy. (2011) Papillomatose laryngée sévère évoluant vers un carcinome bronchopulmonaire associé à HPV 11 chez une enfant de 15 ans : à propos d’un cas. Archives de Pédiatrie 18:7, 754-757
CrossRef121
Jacinthe Chenevert, Simion Chiosea. (2011) Incidence of human papillomavirus in oropharyngeal squamous cell carcinomas: now and 50 years ago. Human Pathology
CrossRef122
Chih-Ming Ho, Bor-Heng Lee, Shwu-Fen Chang, Tsai-Yen Chien, Shih-Hung Huang, Chiu-Cho Yan, Weng-Fang Cheng. (2011) Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis. Virus Research
CrossRef123
Andrea E. Knowlton, Heather M. Brown, Theresa S. Richards, Lauren A. Andreolas, Rahul K. Patel, Scott S. Grieshaber. (2011) Chlamydia trachomatis Infection Causes Mitotic Spindle Pole Defects Independently from its Effects on Centrosome Amplification. Traffic 12:7, 854-866
CrossRef124
Aaron AR Tobian, Ronald H Gray. (2011) Male foreskin and oncogenic human papillomavirus infection in men and their female partners. Future Microbiology 6:7, 739-745
CrossRef125
M. Gottschling, M. Goker, A. Stamatakis, O. R. P. Bininda-Emonds, I. Nindl, I. G. Bravo. (2011) Quantifying the Phylodynamic Forces Driving Papillomavirus Evolution. Molecular Biology and Evolution 28:7, 2101-2113
CrossRef126
Yan Jun Lei, Kgomotso Makhaola, Daraporn Pittayakhajonwut, Charles Wood, Peter C. Angeletti. (2011) Human papillomavirus 16 variants from Zambian women with normal pap smears. Journal of Medical Virology 83:7, 1230-1237
CrossRef127
Gloria Y.F. Ho, Mark H. Einstein, Seymour L. Romney, Anna S. Kadish, Maria Abadi, Magdy Mikhail, Jayasri Basu, Benjamin Thysen, Laura Reimers, Prabhudas R. Palan, Shelly Trim, Nafisseh Soroudi, Robert D. Burk. (2011) Risk Factors for Persistent Cervical Intraepithelial Neoplasia Grades 1 and 2. Journal of Lower Genital Tract Disease1
CrossRef128
Anita Dreher, Maria Rossing, Bogumil Kaczkowski, Ditte K. Andersen, Therese Juhlin Larsen, Mikael Kronborg Christophersen, Finn Cilius Nielsen, Bodil Norrild. (2011) Differential expression of cellular microRNAs in HPV 11, -16, and -45 transfected cells. Biochemical and Biophysical Research Communications
CrossRef129
Gloria I. Sanchez, Bernhard Kleter, Tarik Gheit, Leen-Jan van Doorn, Maurits N.C. de Koning, Silvia de Sanjosé, Laia Alemany, Xavier F. Bosch, Massimo Tommasino, Nubia Muñoz, Wim G.V. Quint. (2011) Clinical evaluation of polymerase chain reaction reverse hybridization assay for detection and identification of human papillomavirus type 16 variants. Journal of Clinical Virology 51:3, 165-169
CrossRef130
Erika Marek, Timea Dergez, Antal Kricskovics, Krisztina Kovacs, Gabor Rebek-Nagy, Katalin Gocze, Istvan Kiss, Istvan Ember, Peter Gocze. (2011) Difficulties in the prevention of cervical cancer: Adults’ attitudes towards HPV vaccination 3 years after introducing the vaccine in Hungary. Vaccine 29:32, 5122-5129
CrossRef131
Matejka Rebolj, Elsebeth Lynge, Jesper Bonde. (2011) Human papillomavirus testing and genotyping in cervical screening. Expert Review of Anticancer Therapy 11:7, 1025-1033
CrossRef132
Johannes A. Bogaards, Veerle M. H. Coupé, Maria Xiridou, Chris J. L. M. Meijer, Jacco Wallinga, Johannes Berkhof. (2011) Long-term Impact of Human Papillomavirus Vaccination on Infection Rates, Cervical Abnormalities, and Cancer Incidence. Epidemiology 22:4, 505-515
CrossRef133
Lynette Denny. (2011) Cervical cancer treatment in Africa. Current Opinion in Oncology1
CrossRef134
Andreas H. Brunner, Christoph Grimm, Stephan Polterauer, Lukas Hefler, Josefine Stani, Georg Heinze, Reinhard Horvat. (2011) The Prognostic Role of Human Papillomavirus in Patients With Vaginal Cancer. International Journal of Gynecological Cancer 21:5, 923-929
CrossRef135
Claudia Teixeira Lodi, Márcia Antoniazi Michelin, Maria Inês Lima, Nara Chartuni Teixeira, Sheila Jorge Adad, Eddie Fernando Murta, Victor Hugo Melo. (2011) Factors associated with recurrence of cervical intraepithelial neoplasia after conization in HIV-infected and noninfected women. Archives of Gynecology and Obstetrics 284:1, 191-197
CrossRef136
François Aubin, Mickaël Martin, Eve Puzenat, Nadine Magy-Bertrand, Michel Segondy, Didier Riethmuller, Daniel Wendling. (2011) Infection génitale à papillomavirus humain au cours des maladies auto-inflammatoires et/ou auto-immunes. Revue du Rhumatisme 78:4, 313-318
CrossRef137
Zijun Jiang, Guangjie Tong, Beibei Cai, Yihan Xu, Jueren Lou. (2011) Purification and immunogenicity study of human papillomavirus 58 virus-like particles expressed in Pichia pastoris. Protein Expression and Purification
CrossRef138
X Castellsagué, N Muñoz, P Pitisuttithum, D Ferris, J Monsonego, K Ault, J Luna, E Myers, S Mallary, O M Bautista, J Bryan, S Vuocolo, R M Haupt, A Saah. (2011) End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age. British Journal of Cancer 105:1, 28-37
CrossRef139
G Foley, R Alston, M Geraci, L Brabin, H Kitchener, J Birch. (2011) Increasing rates of cervical cancer in young women in England: an analysis of national data 1982–2006. British Journal of Cancer 105:1, 177-184
CrossRef140
A. Ghosh, P. E. Castle. (2011) Invited Commentary: The Importance of Prevalence in the Effectiveness of a (Bio)marker. American Journal of Epidemiology 173:12, 1388-1390
CrossRef141
Päivi Rahkola, Mervi Väisänen-Tommiska, Pauliina Tuomikoski, Olavi Ylikorkala, Tomi S. Mikkola. (2011) Cervical nitric oxide release and persistence of high-risk human papillomavirus in women. International Journal of Cancer 128:12, 2933-2937
CrossRef142
Fanling Meng, Hongtao Song, Chang Luo, Mingzhu Yin, Ye Xu, Haixia Liu, Rouli Zhou, Ge Lou. (2011) Correlation of LAPTM4B polymorphisms with cervical carcinoma. Cancer 117:12, 2652-2658
CrossRef143
Morgan Marks, Patti E. Gravitt, Swati B. Gupta, Kai-Li Liaw, Esther Kim, Amha Tadesse, Chailert Phongnarisorn, Virach Wootipoom, Pissamai Yuenyao, Charoen Vipupinyo, Sungwal Rugpao, Somchai Sriplienchan, David D. Celentano. (2011) The association of hormonal contraceptive use and HPV prevalence. International Journal of Cancer 128:12, 2962-2970
CrossRef144
Koji Matsumoto, Akinori Oki, Reiko Furuta, Hiroo Maeda, Toshiharu Yasugi, Naoyoshi Takatsuka, Akira Mitsuhashi, Takuma Fujii, Yasuo Hirai, Tsuyoshi Iwasaka, Nobuo Yaegashi, Yoh Watanabe, Yutaka Nagai, Tomoyuki Kitagawa, Hiroyuki Yoshikawa, . (2011) Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study. International Journal of Cancer 128:12, 2898-2910
CrossRef145
Li Liu, Xi Yang, Xiaojun Chen, Tinjing Kan, Yan Shen, Zengyan Chen, Zhibin Hu. (2011) Association between TNF-α polymorphisms and cervical cancer risk: a meta-analysis. Molecular Biology Reports
CrossRef146
Adrianna Mostowska, Martyna Myka, Margarita Lianeri, Andrzej Roszak, Pawel P. Jagodziński. (2011) Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Clinical Biochemistry 44:8-9, 596-600
CrossRef147
François Coutlée, Samuel Ratnam, Agnihotram V. Ramanakumar, Ralph R. Insinga, James Bentley, Nicholas Escott, Prafull Ghatage, Anita Koushik, Alex Ferenczy, Eduardo L. Franco. (2011) Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Journal of Medical Virology 83:6, 1034-1041
CrossRef148
P. K. S. Chan, A. C. S. Luk, J.-S. Park, K. K. Smith-McCune, J. M. Palefsky, R. Konno, L. Giovannelli, F. Coutlee, S. Hibbitts, T.-Y. Chu, W. Settheetham-Ishida, M. A. Picconi, A. Ferrera, F. De Marco, Y.-L. Woo, T. Raiol, P. Pina-Sanchez, J. L. K. Cheung, J.-H. Bae, M. Z. Chirenje, T. Magure, A.-B. Moscicki, A. N. Fiander, R. Di Stefano, T.-H. Cheung, M. M. Y. Yu, S. K. W. Tsui, D. Pim, L. Banks. (2011) Identification of Human Papillomavirus Type 58 Lineages and the Distribution Worldwide. Journal of Infectious Diseases 203:11, 1565-1573
CrossRef149
Catherine Sauvaget, Bhagwan M. Nene, Kasturi Jayant, Rohini Kelkar, Sylla G. Malvi, Surendranath S. Shastri, Rengaswamy Sankaranarayanan. (2011) Prevalence and Determinants of High-risk Human Papillomavirus Infection in Middle-aged Indian Women. Sexually Transmitted Diseases1
CrossRef150
Maria Gabriella Donà, Maria Benevolo, Fulvia Pimpinelli, Mara Battista, Francesca Rollo, Francesca Stivali, Antonella Moscarelli, Massimo Giuliani, Aldo Di Carlo, Amina Vocaturo. (2011) Comparative evaluation of different DNA extraction methods for HPV genotyping by linear array and INNO-LiPA. Journal of Medical Virology 83:6, 1042-1047
CrossRef151
Nina Korzeniewski, Nicole Spardy, Anette Duensing, Stefan Duensing. (2011) Genomic instability and cancer: Lessons learned from human papillomaviruses. Cancer Letters 305:2, 113-122
CrossRef152
A. Pista, A. Oliveira, N. Verdasca, F. Ribeiro. (2011) Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women. Clinical Microbiology and Infection 17:6, 941-946
CrossRef153
Ghazi Alsbeih, Raef Ahmed, Najla Al-Harbi, L. Aubrey Venturina, Asma Tulbah, Khalid Balaraj. (2011) Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia. Gynecologic Oncology 121:3, 522-526
CrossRef154
Xiaoyan Yuan, Yan Yang, Donghong Gu, Haining Liu, Haiqing Yang, Mingyi Wang. (2011) Prevalence of human papillomavirus infection among women with and without normal cervical histology in Shandong Province, China. Archives of Gynecology and Obstetrics 283:6, 1385-1389
CrossRef155
Li Ping Wong. (2011) Knowledge and Attitudes About HPV Infection, HPV Vaccination, and Cervical Cancer Among Rural Southeast Asian Women. International Journal of Behavioral Medicine 18:2, 105-111
CrossRef156
Paul K.S. Chan, Shih-Jen Liu, Jo L.K. Cheung, T.H. Cheung, Winnie Yeo, Pele Chong, Stephen Man. (2011) T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer. Journal of Medical Virology 83:6, 1023-1030
CrossRef157
Maria C. Bell, Delf Schmidt-Grimminger, Clemma Jacobsen, Subhash C. Chauhan, Diane M. Maher, Dedra S. Buchwald. (2011) Risk factors for HPV infection among American Indian and white women in the Northern Plains. Gynecologic Oncology 121:3, 532-536
CrossRef158
Mélanie Drolet, Marc Brisson, Elizabeth Maunsell, Eduardo L. Franco, François Coutlée, Alex Ferenczy, William Fisher, James A. Mansi. (2011) The psychosocial impact of an abnormal cervical smear result. Psycho-Oncologyn/a-n/a
CrossRef159
Phaik-Leng Cheah, Lai-Meng Looi, Vallipuram Sivanesaratnam. (2011) Human papillomavirus in cervical cancers of Malaysians. Journal of Obstetrics and Gynaecology Research 37:6, 489-495
CrossRef160
Mario Sideri, Sarah Igidbashian, Sara Boveri, Davide Radice, Chiara Casadio, Noemi Spolti, Maria Teresa Sandri. (2011) Age distribution of HPV genotypes in cervical intraepithelial neoplasia. Gynecologic Oncology 121:3, 510-513
CrossRef161
Maria Correnti, Francisco Medina, María Eugenia Cavazza, Antonieta Rennola, Maira Ávila, Andreína Fernándes. (2011) Human papillomavirus (HPV) type distribution in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Venezuelan women. Gynecologic Oncology 121:3, 527-531
CrossRef162
María Sol dos Ramos Farías, María Alejandra Picconi, María Noé Garcia, Joaquín V. González, Jorge Basiletti, María de los Ángeles Pando, María Mercedes Ávila. (2011) Human Papilloma virus genotype diversity of anal infection among trans (male to female transvestites, transsexuals or transgender) sex workers in Argentina. Journal of Clinical Virology 51:2, 96-99
CrossRef163
C L Au Yeung, T Y Tsang, P L Yau, T T Kwok. (2011) Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene 30:21, 2401-2410
CrossRef164
J. N. Roberts, R. C. Kines, H. A. Katki, D. R. Lowy, J. T. Schiller. (2011) Effect of Pap Smear Collection and Carrageenan on Cervicovaginal Human Papillomavirus-16 Infection in a Rhesus Macaque Model. JNCI Journal of the National Cancer Institute 103:9, 737-743
CrossRef165
Nae-Fang Twu, Ming-Shyen Yen, Hei-Yu Lau, Yi-Jen Chen, Bill Ken-Jen Yu, Ching-Yu Lin. (2011) Type-specific human papillomavirus DNA testing with the genotyping array: a comparison of cervical and vaginal sampling. European Journal of Obstetrics & Gynecology and Reproductive Biology 156:1, 96-100
CrossRef166
Mariana BA Ferreira, Jonas A De Souza, Ezra EW Cohen. (2011) Role of molecular markers in the management of head and neck cancers. Current Opinion in Oncology 23:3, 259-264
CrossRef167
François Aubin, Mickaël Martin, Eve Puzenat, Nadine Magy-Bertrand, Michel Segondy, Didier Riethmuller, Daniel Wendling. (2011) Genital human Papillomavirus infection in patients with autoimmune inflammatory diseases. Joint Bone Spine
CrossRef168
Gisela Barbisan, Anahí Contreras, Luis Orlando Pérez, Leonardo Difranza, Carlos Daniel Golijow. (2011) The effect of TP53 codon 72 and RNASEL codon 462 polymorphisms on the development of cervical cancer in Argentine women. Cancer Genetics 204:5, 270-277
CrossRef169
Carmen G. Ili, Priscilla Brebi, Jaime López, Patricia García, Pamela Leal, Eugenio Suarez, Juan C. Roa. (2011) Genotyping of human papillomavirus in cervical intraepithelial neoplasia in a high-risk population. Journal of Medical Virology 83:5, 833-837
CrossRef170
Xiaojun Chen, Jie Jiang, Hongbing Shen, Zhibin Hu. (2011) Genetic susceptibility of cervical cancer. Journal of Biomedical Research 25:3, 155-164
CrossRef171
Delese E. LaCour, Connie Trimble. (2011) Human Papillomavirus in Infants: Transmission, Prevalence, and Persistence. Journal of Pediatric and Adolescent Gynecology
CrossRef172
Rachel H. Gormley, Caroline M. Groft, Christopher J. Miller, Carrie L. Kovarik. (2011) Digital squamous cell carcinoma and association with diverse high-risk human papillomavirus types. Journal of the American Academy of Dermatology 64:5, 981-985
CrossRef173
Yan Zhang, Daoxin Ma, Yong Zhang, Yongju Tian, Xuping Wang, Yunbo Qiao, Baoxia Cui. (2011) The imbalance of Th17/Treg in patients with uterine cervical cancer. Clinica Chimica Acta 412:11-12, 894-900
CrossRef174
Miki Ishibashi, Mitsunobu Kishino, Sunao Sato, Eiichi Morii, Yuzo Ogawa, Katsuyuki Aozasa, Mikihiko Kogo, Satoru Toyosawa. (2011) The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control. International Journal of Clinical Oncology
CrossRef175
C. H. LAI, A. CHAO, C. J. CHANG, C. C. HUANG, L. C. WANG, S. HSUEH, C. T. LIN, T. I. WU, M. S. JAO, H. H. CHOU. (2011) Age factor and implication of human papillomavirus type-specific prevalence in women with normal cervical cytology. Epidemiology and Infection1-8
CrossRef176
Ellen Giarelli, Deborah Watkins Bruner, Ethan Nguyen, Sarah Basham, Priya Marathe, Diane Dao, To Nhu Huynh, Joseph Cappella, Giang Nguyen. (2011) Research Participation Among Asian American Women at Risk for Cervical Cancer: Exploratory Pilot of Barriers and Enhancers. Journal of Immigrant and Minority Health
CrossRef177
Luis F. Barroso, Timothy Wilkin. (2011) Human Papillomavirus Vaccination in Males: The State of the Science. Current Infectious Disease Reports 13:2, 175-181
CrossRef178
Ned G. Powell, Sam J. Hibbitts, Adam M. Boyde, Robert G. Newcombe, Amanda J. Tristram, Alison N. Fiander. (2011) The risk of cervical cancer associated with specific types of human papillomavirus: A case-control study in a UK population. International Journal of Cancer 128:7, 1676-1682
CrossRef179
Ruth Chapman, Kate Soldan, Mark Jit. (2011) Modelling borderline and mild dysplasia associated with HPV 6 and 11 infection. Vaccine 29:16, 2881-2886
CrossRef180
Christian E. Lange, Kurt Tobler, Mathias Ackermann, Claude Favrot. (2011) Identification of two novel equine papillomavirus sequences suggests three genera in one cluster. Veterinary Microbiology 149:1-2, 85-90
CrossRef181
Nathalie Garçon, Marcelle Van Mechelen. (2011) Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems. Expert Review of Vaccines 10:4, 471-486
CrossRef182
Jonathan R. CARTER, Zongqun DING, Barbara R. ROSE. (2011) HPV infection and cervical disease: A review. Australian and New Zealand Journal of Obstetrics and Gynaecology 51:2, 103-108
CrossRef183
Mariela C. Torrente, Juan P. Rodrigo, Missak Haigentz, Frederik G. Dikkers, Alessandra Rinaldo, Robert P. Takes, Jan Olofsson, Alfio Ferlito, David W. Eisele. (2011) Human papillomavirus infections in laryngeal cancer. Head & Neck 33:4, 581-586
CrossRef184
Kentaro Yamasaki, Kiyonori Miura, Takako Shimada, Shoko Miura, Shuhei Abe, Makoto Murakami, Tetsuro Sameshima, Akira Fujishita, Kouhei Kotera, Akira Kinoshita, Koh-ichiro Yoshiura, Hideaki Masuzaki. (2011) Epidemiology of human papillomavirus genotypes in pregnant Japanese women. Journal of Human Genetics 56:4, 313-315
CrossRef185
Ryo Konno, Shinobu Tamura, Kurt Dobbelaere, Hiroyuki Yoshikawa. (2011) Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study. Cancer Science 102:4, 877-882
CrossRef186
Zhengrong Sun, Gaowei Ren, Xin Cui, Weiqiang Zhou, Chao Liu, Qiang Ruan. (2011) Genetic Diversity of HPV-16 E6, E7, and L1 Genes in Women With Cervical Lesions in Liaoning Province, China. International Journal of Gynecological Cancer 21:3, 551-558
CrossRef187
Nasuh Utku Dogan, Mehmet Coskun Salman, Kunter Yuce. (2011) The role of HPV DNA testing in the follow-up of cervical intraepithelial neoplasia after loop electrosurgical excision procedure. Archives of Gynecology and Obstetrics 283:4, 871-877
CrossRef188
Fabiana G. Melgaço, Maria L. G. Rosa, Everton F. Augusto, Jacqueline G. S. Haimuri, Claudia Jacintho, Larissa S. Santos, Silvia M. B. Cavalcanti, Ledy H. S. Oliveira. (2011) Human papillomavirus genotypes distribution in cervical samples from women living with human immunodeficiency virus. Archives of Gynecology and Obstetrics 283:4, 809-817
CrossRef189
Marc Gottschling, Ignacio G. Bravo, Eric Schulz, Maria A. Bracho, Rob Deaville, Paul D. Jepson, Marie-Françoise Van Bressem, Eggert Stockfleth, Ingo Nindl. (2011) Modular organizations of novel cetacean papillomaviruses. Molecular Phylogenetics and Evolution 59:1, 34-42
CrossRef190
M.L. Tornesello, S. Losito, G Benincasa, F. Fulciniti, G. Botti, S. Greggi, L. Buonaguro, F.M. Buonaguro. (2011) Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix. Gynecologic Oncology 121:1, 32-42
CrossRef191
Jae Hong No, Mi-Kyung Kim, Yong-Tark Jeon, Yong-Beom Kim, Yong-Sang Song. (2011) Human papillomavirus vaccine: Widening the scope for cancer prevention. Molecular Carcinogenesis 50:4, 244-253
CrossRef192
B. Piro, A. Kapella, V.H. Le, G. Anquetin, Q.D. Zhang, S. Reisberg, V. Noel, L.D. Tran, H.T. Duc, M.C. Pham. (2011) Towards the detection of human papillomavirus infection by a reagentless electrochemical peptide biosensor. Electrochimica Acta
CrossRef193
Justin M Julius, Lois Ramondeta, Katherine A Tipton, Lincy S Lal, Karen Schneider, Judith A Smith. (2011) Clinical Perspectives on the Role of the Human Papillomavirus Vaccine in the Prevention of Cancer. Pharmacotherapy 31:3, 280-297
CrossRef194
Polona J. Maver, Boštjan J. Kocjan, Katja Seme, Marko Potočnik, Nina Gale, Mario Poljak. (2011) Prevaccination genomic diversity of human papillomavirus genotype 11: A study on 63 clinical isolates and 10 full-length genome sequences. Journal of Medical Virology 83:3, 461-470
CrossRef195
Kenneth E. Youens, Gregory A. Hosler, Paula J. Washington, E. Patrick Jenevein, Kathleen M. Murphy. (2011) Clinical Experience with the Cervista HPV HR Assay. The Journal of Molecular Diagnostics 13:2, 160-166
CrossRef196
Michael Max Sachse, Jürgen Schmoll, Gunnar Wagner. (2011) Cornu cutaneum-like HPV 45 positive subungual squamous cell carcinoma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 9:3, 226-228
CrossRef197
E.A. Burger, H. Kornør, M. Klemp, V. Lauvrak, I.S. Kristiansen. (2011) HPV mRNA tests for the detection of cervical intraepithelial neoplasia: A systematic review. Gynecologic Oncology 120:3, 430-438
CrossRef198
Rana Al-Awadhi, Wassim Chehadeh, Kusum Kapila. (2011) Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. Journal of Medical Virology 83:3, 453-460
CrossRef199
Hee-Jeong Cho, Yu-Kyoung Oh, Young Bong Kim. (2011) Advances in human papilloma virus vaccines: a patent review. Expert Opinion on Therapeutic Patents 21:3, 295-309
CrossRef200
Michael J. Thrall, Dina R. Mody. (2011) Clinical Human Papillomavirus Testing Modalities. Pathology Case Reviews 16:2, 55-61
CrossRef201
Susanna Esposito, Victoria Birlutiu, Pavol Jarcuska, Antonio Perino, Sorin Claudiu Man, Radu Vladareanu, Dorothée Meric, Kurt Dobbelaere, Florence Thomas, Dominique Descamps. (2011) Immunogenicity and Safety of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine Administered According to an Alternative Dosing Schedule Compared With the Standard Dosing Schedule in Healthy Women Aged 15 to 25 Years. The Pediatric Infectious Disease Journal 30:3, e49-e55
CrossRef202
Hui-Chi Chen, San-Lin You, Chang-Yao Hsieh, Mark Schiffman, Ching-Yu Lin, Mei-Hung Pan, Yi-Chun Chou, Kai-Li Liaw, Ann W. Hsing, Chien-Jen Chen, . (2011) Prevalence of genotype-specific human papillomavirus infection and cervical neoplasia in Taiwan: A community-based survey of 10,602 women. International Journal of Cancer 128:5, 1192-1203
CrossRef203
Ioannis N. Mammas, George Sourvinos, Apostolos Zaravinos, Demetrios A. Spandidos. (2011) Vaccination against Human Papilloma Virus (HPV): Epidemiological Evidence of HPV in Non-genital Cancers. Pathology & Oncology Research 17:1, 103-119
CrossRef204
, José Ramet, Diego Esso, Zsofia Meszner. (2011) Position paper—HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians. European Journal of Pediatrics 170:3, 309-321
CrossRef205
Luciana Y. Tomita, Cecília M. Roteli-Martins, Luisa L. Villa, Eduardo L. Franco, Marly A. Cardoso. (2011) Associations of dietary dark-green and deep-yellow vegetables and fruits with cervical intraepithelial neoplasia: modification by smoking. British Journal of Nutrition 105:06, 928-937
CrossRef206
F.W. Djigma, C. Ouédraogo, D.S. Karou, T. Sagna, C. Bisseye, M. Zeba, D. Ouermi, C. Gnoula, V. Pietra, N.W. Ghilat-Avoid-Belem, K. Sanogo, J. Sempore, S. Pignatelli, A.M. Ferri, J.-B. Nikiema, J. Simpore. (2011) Prevalence and genotype characterization of Human Papillomaviruses among HIV-seropositive in Ouagadougou, Burkina Faso. Acta Tropica 117:3, 202-206
CrossRef207
S. Laurenson, M.R. Pett, K. Hoppe-Seyler, C. Denk, F. Hoppe-Seyler, N. Coleman, P. Ko Ferrigno. (2011) Development of peptide aptamer microarrays for detection of HPV16 oncoproteins in cell extracts. Analytical Biochemistry 410:2, 161-170
CrossRef208
Teresa Warchoł, Łukasz Kruszyna, Margarita Lianeri, Andrzej Roszak, Paweł P. Jagodziński. (2011) Distribution of CCND1 A870G Polymorphism in Patients with Advanced Uterine Cervical Carcinoma. Pathology & Oncology Research 17:1, 133-137
CrossRef209
Hyo-Pyo Lee, Soo-Ok Kim, Tae Sook Hwang, Jae-Man Bae, Soo Nyung Kim, Jae Won Kim, Sun Young Hwang, Han Sung Lee, Soo-Kyung Shin, Woojae Cho, Sun Pyo Hong. (2011) Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses. Journal of Medical Virology 83:3, 471-482
CrossRef210
ANA PASTORA OTERO-MOTTA, JOSÉ LUIS ORDÓÑEZ, RAFAEL GONZÁLEZ-CELADOR, BELEN RIVAS, MARÍA DEL CARMEN GARCÍA MACÍAS, AGUSTÍN BULLÓN, MARÍA DEL MAR ABAD. (2011) Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain. APMIS 119:3, 204-215
CrossRef211
L. Tracy, H. D. Gaff, C. Burgess, S. Sow, P. E. Gravitt, J. K. Tracy. (2011) Estimating the Impact of Human Papillomavirus (HPV) Vaccination on HPV Prevalence and Cervical Cancer Incidence in Mali. Clinical Infectious Diseases 52:5, 641-645
CrossRef212
C.-M. Ho, B.-H. Lee, S.-F. Chang, T.-Y. Chien, S.-H. Huang, C.-C. Yan, W.-F. Cheng. (2011) Clinical significance of signal pattern of high-risk human papillomavirus using a novel fluorescence in situ hybridization assay in cervical cytology. Clinical Microbiology and Infection 17:3, 386-394
CrossRef213
Ibrahim I. Daud, Mark E. Scott, Yifei Ma, Stephen Shiboski, Sepideh Farhat, Anna-Barbara Moscicki. (2011) Association between toll-like receptor expression and human papillomavirus type 16 persistence. International Journal of Cancer 128:4, 879-886
CrossRef214
Tamar Alibegashvili, Gary M. Clifford, Salvatore Vaccarella, Alexi Baidoshvili, Liana Gogiashvili, Zurab Tsagareli, Ioseb Kureli, Peter J.F. Snijders, Daniëlle A.M. Heideman, Folkert J. van Kemenade. (2011) Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia. Cancer Epidemiology
CrossRef215
Lai-Shan Tam, Paul K. S. Chan, Suzanne C. Ho, Mei-Yung Yu, So-Fan Yim, Tak-Hong Cheung, Martin C. S. Wong, Jo L. K. Cheung, Edmund K. Li. (2011) Risk factors for squamous intraepithelial lesions in systemic lupus erythematosus: A prospective cohort study. Arthritis Care & Research 63:2, 269-276
CrossRef216
Hee Jung An, Ji Min Sung, Ae Ran Park, Ki Jun Song, Young Nam Lee, Young Tae Kim, Yoon Jin Cha, Suki Kang, Nam Hoon Cho. (2011) Prospective evaluation of longitudinal changes in human papillomavirus genotype and phylogenetic clade associated with cervical disease progression. Gynecologic Oncology 120:2, 284-290
CrossRef217
Lu Kong, Zhihong Deng, Haiying Shen, Yuxiang Zhang. (2011) Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173. Molecular and Cellular Biochemistry 348:1-2, 11-19
CrossRef218
Deborah WILLIAMSON, Radhika NAGAPPAN, Rao SIRIKONDA, Fahimeh RAHNAMA, Stephen THOMAS, Margaret LOVELL-SMITH, Margaret CROXSON. (2011) Distribution of HPV genotypes in women with cervical cancer in Auckland, New Zealand; a review of 50 specimens between 2000-2006. Australian and New Zealand Journal of Obstetrics and Gynaecology 51:1, 67-70
CrossRef219
Angel Chao, Mei-Shan Jao, Chu-Chun Huang, Huei-Jean Huang, Hui-Hsin Cheng, Jung-Erh Yang, Swei Hsueh, Tse-Ching Chen, Jian-Tai Qiu, Cheng-Tao Lin, Chang-Jui Fu, Hung-Hsueh Chou, Chyong-Huey Lai. (2011) Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women. International Journal of Cancer 128:3, 653-659
CrossRef220
Torbjörn Ramqvist, Juan Du, Mikaela Lundén, Sofie Ährlund-Richter, Joana Ferreira, Lena Marions, Pär Sparén, Sören Andersson, Tina Dalianis. (2011) Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15–23-year-old women attending a youth health clinic in Stockholm, Sweden. Scandinavian Journal of Infectious Diseases 43:2, 115-121
CrossRef221
KAROLINA LOUVANTO, KARI J. SYRJÄNEN, MARJUT A. RINTALA, SEIJA E. GRÉNMAN, STINA M. SYRJÄNEN. (2011) Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study. Acta Obstetricia et Gynecologica Scandinavica 90:2, 167-173
CrossRef222
Ignacio G. Bravo, Silvia de Sanjosé, Marc Gottschling. (2011) Papillomaviruses and Darwinian classification: response to Van Doorslaer et al.. Trends in Microbiology 19:2, 50-51
CrossRef223
Antonio Huertas-Salgado, Diana C. Martín-Gámez, Pablo Moreno, Raúl Murillo, María Mercedes Bravo, Luisa Villa, Mónica Molano. (2011) E6 molecular variants of human papillomavirus (HPV) type 16: An updated and unified criterion for clustering and nomenclature. Virology 410:1, 201-215
CrossRef224
E. J. Cho, J. H. Do, Y. S. Kim, S. Bae, W. S. Ahn. (2011) Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with Hybrid Capture II, DNA chip and sequencing methods. Journal of Medical Microbiology 60:2, 162-171
CrossRef225
Angela Pista, Nuno Verdasca, Ana Oliveira. (2011) Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test. Journal of Medical Virology 83:2, 272-276
CrossRef226
M I Lomnytska, S Becker, I Bodin, A Olsson, K Hellman, A-C Hellström, M Mints, U Hellman, G Auer, S Andersson. (2011) Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value. British Journal of Cancer 104:1, 110-119
CrossRef227
Dunarel Badescu, Alix Boc, Abdoulaye Diallo, Vladimir Makarenkov. (2011) Detecting genomic regions associated with a disease using variability functions and Adjusted Rand Index. BMC Bioinformatics 12:Suppl 9, S9
CrossRef228
Adam Rogers, Mackenzie Waltke, Peter C Angeletti. (2011) Evolutionary variation of papillomavirus E2 protein and E2 binding sites. Virology Journal 8:1, 379
CrossRef229
Maria J Wawer, Aaron AR Tobian, Godfrey Kigozi, Xiangrong Kong, Patti E Gravitt, David Serwadda, Fred Nalugoda, Frederick Makumbi, Victor Ssempiija, Nelson Sewankambo, Stephen Watya, Kevin P Eaton, Amy E. Oliver, Michael Z Chen, Steven J Reynolds, Thomas C Quinn, Ronald H Gray. (2011) Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. The Lancet 377:9761, 209-218
CrossRef230
Yvonne A. Maldonado. 2011. Less Common Viral Infections. , 905-916.
CrossRef231
Sung Taek Park, Min Jong Song, Jong Sup Park, Soo Young Hur, Chung Won Lee. (2011) Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients. World Journal of Surgical Oncology 9:1, 72
CrossRef232
Kerstin Dreier, René Scheiden, Barbara Lener, Daniela Ehehalt, Haymo Pircher, Elisabeth Müller-Holzner, Ursula Rostek, Andreas Kaiser, Marc Fiedler, Sigrun Ressler, Stefan Lechner, Andreas Widschwendter, Jos Even, Catherine Capesius, Pidder Jansen-Dürr, Werner Zwerschke. (2011) Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ. Virology 409:1, 54-68
CrossRef233
J. Dillner, M. Arbyn, E. Unger, L. Dillner. (2011) Monitoring of human papillomavirus vaccination. Clinical & Experimental Immunology 163:1, 17-25
CrossRef234
Rana Al-Awadhi, Wassim Chehadeh, Mohammad Jaragh, Azza Al-Shaheen, Prem Sharma, Kusum Kapila. (2011) Distribution of human papillomavirus among women with abnormal cervical cytology in Kuwait. Diagnostic Cytopathologyn/a-n/a
CrossRef235
Rabia Faridi, Amreen Zahra, Khalida Khan, Muhammad Idrees. (2011) Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virology Journal 8:1, 269
CrossRef236
Andrea C Tricco, Carmen H Ng, Vladimir Gilca, Andrea Anonychuk, Ba' Pham, Shirra Berliner. (2011) Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis. BMC Infectious Diseases 11:1, 235
CrossRef237
Chloé Tarnaud, Pascale Lissouba, Ewalde Cutler, Adrian Puren, Dirk Taljaard, Bertran Auvert. (2011) Association of Low-Risk Human Papillomavirus Infection with Male Circumcision in Young Men: Results from a Longitudinal Study Conducted in Orange Farm (South Africa). Infectious Diseases in Obstetrics & Gynecology 2011, 1-7
CrossRef238
Yuanming Shen, Yang Li, Feng Ye, Fenfen Wang, Xiaoyun Wan, Weiguo Lu, Xing Xie. (2011) Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Experimental and Molecular Medicine 43:6, 358
CrossRef239
Wei Wang, Yong Fang, Ni Sima, Yan Li, Wei Li, Li Li, Linfei Han, Shujie Liao, Zhiqiang Han, Qinglei Gao, Kezhen Li, Dongrui Deng, Li Meng, Jianfeng Zhou, Shixuan Wang, Ding Ma. (2011) Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP. Apoptosis 16:1, 55-66
CrossRef240
Sunphil Jang, Young Tae Kim, Hye Won Chung, Kyoung-Ryul Lee, Jong-Baeck Lim, Kyungwon Lee. (2011) Identification of novel immunogenic human leukocyte antigen-A*2402-binding epitopes of human papillomavirus type 16 E7 for immunotherapy against human cervical cancer. Cancern/a-n/a
CrossRef241
Maryem Ansari, Ghazala Mehdi, S. H. Arif, Hena Ansari, Tamkin Khan. (2011) Smear patterns and spectrum of premalignant and malignant cervical epithelial lesions in postmenopausal Indian women: A hospital-based study. Diagnostic Cytopathologyn/a-n/a
CrossRef242
Shoufang Qu, Jie Huang, Jinyin Zhao, Xuequan Zhao, Haijun Deng, Huawei Yang, Weijun Chen, Licheng Liu, Lining Zhang, Shangxian Gao. (2011) A Comparison of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and Surface Plasmon Resonance for Genotyping of High-Risk Human Papillomaviruses. Intervirology 54:6, 326-332
CrossRef243
Delf C Schmidt-Grimminger, Maria C Bel, Clemma J Muller, Diane M Maher, Subhash C Chauhan, Dedra S Buchwald. (2011) HPV infection among rural American Indian women and urban White women in South Dakota: an HPV prevalence study. BMC Infectious Diseases 11:1, 252
CrossRef244
Tazio Vanni, Paula Mendes Luz, Beatriz Grinsztejn, Valdilea G. Veloso, Anna Foss, Marco Mesa-frias, Rosa Legood. (2011) Cervical cancer screening among HIV-infected women: An economic evaluation in a middle-income country. International Journal of Cancern/a-n/a
CrossRef245
Ivonne Rubio, Hanna Seitz, Elena Canali, Peter Sehr, Angelo Bolchi, Massimo Tommasino, Simone Ottonello, Martin Müller. (2011) The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies. Virology 409:2, 348-359
CrossRef246
Karolina Louvanto, Marjut A Rintala, Kari J Syrjänen, Seija E Grénman, Stina M Syrjänen. (2011) Incident cervical infections with high- and low-risk human papillomavirus (HPV) infections among mothers in the prospective Finnish Family HPV Study. BMC Infectious Diseases 11:1, 179
CrossRef247
Kwang Il Yim, Yeo-Ju Kang, Tae Eun Kim, Gyeongsin Park, Eun Sun Jung, Yeong-Jin Choi, Kyo-Young Lee, Chang Seok Kang, Ahwon Lee. (2011) The Usefulness of p16 INK4a Immunocytochemical Staining in ASC-H Patients. The Korean Journal of Pathology 45:3, 290
CrossRef248
Linda Marklund, Lalle Hammarstedt. (2011) Impact of HPV in Oropharyngeal Cancer. Journal of Oncology 2011, 1-6
CrossRef249
Richard M. Haupt, Cosette M. Wheeler, Darron R. Brown, Suzanne M. Garland, Daron G. Ferris, Jorma A. Paavonen, Matti O. Lehtinen, Marc Steben, Elmar A. Joura, Katherine E. D. Giacoletti, David R. Radley, Margaret K. James, Alfred J. Saah, Heather L. Sings, . (2011) Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. International Journal of Cancern/a-n/a
CrossRef250
Vernon J Lee, Sun Tay, Yee Teoh, Mei Tok. (2011) Cost-effectiveness of different human papillomavirus vaccines in Singapore. BMC Public Health 11:1, 203
CrossRef251
Kazuhiro Takehara, Tamaki Toda, Toshinao Nishimura, Junichi Sakane, Yosuke Kawakami, Tomoya Mizunoe, Morie Nishiwaki, Kiyomi Taniyama. (2011) Human Papillomavirus Types 52 and 58 Are Prevalent in Uterine Cervical Squamous Lesions from Japanese Women. Pathology Research International 2011, 1-7
CrossRef252
Ana M. Solares, Idania Baladron, Thelvia Ramos, Carmen Valenzuela, Zaida Borbon, Sonia Fanjull, Leonardo Gonzalez, Dagnelia Castillo, Julio Esmir, Milaid Granadillo, Aileen Batte, Alberto Cintado, Mayte Ale, Maria E. Fernandez de Cossio, Annia Ferrer, Isis Torrens, Pedro Lopez-Saura. (2011) Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial. ISRN Obstetrics and Gynecology 2011, 1-9
CrossRef253
Julia C. Gage, Kayode O. Ajenifuja, Nicolas A. Wentzensen, Akinfolarin C. Adepiti, Claire Eklund, Mary Reilly, Martha Hutchinson, Sholom Wacholder, Joe Harford, Amr S. Soliman, Robert D. Burk, Mark Schiffman. (2011) The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies. International Journal of Cancern/a-n/a
CrossRef254
Aimée R. Kreimer, Mark Schiffman, Rolando Herrero, Allan Hildesheim, Paula González, Robert D. Burk, Carolina Porras, Mark E. Sherman, Franklin Demuth, Li Cheung, Concepción Bratti, Ana Cecilia Rodríguez. (2011) Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment. International Journal of Cancern/a-n/a
CrossRef255
Raffaele Riccò, Anna Meneghello, Francesco Enrichi. (2011) Signal enhancement in DNA microarray using dye doped silica nanoparticles: Application to Human Papilloma Virus (HPV) detection. Biosensors and Bioelectronics 26:5, 2761-2765
CrossRef256
Aikaterini Chranioti, Evangelia Aga, Niki Margari, Christine Kottaridi, Asimakis Pappas, Ioannis Panayiotides, Petros Karakitsos. (2011) Performance Evaluation of Manual and Automated (MagNA Pure) Nucleic Acid Isolation in HPV Detection and Genotyping Using Roche Linear Array HPV Test. Infectious Diseases in Obstetrics & Gynecology 2011, 1-11
CrossRef257
Nadine C. Olthof, Jos M.J.A.A. Straetmans, Robert Snoeck, Frans C.S. Ramaekers, Bernd Kremer, Ernst-Jan M. Speel. (2011) Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go? : Therapies for HPV-related head and neck cancers. Reviews in Medical Virologyn/a
CrossRef258
Cecily Banura, Florence M Mirembe, Anne R Katahoire, Proscovia B Namujju, Anthony K Mbonye, Fred M Wabwire. (2011) Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review. Infectious Agents and Cancer 6:1, 11
CrossRef259
Juan Higareda-Almaraz, María Enríquez-Gasca, Magdalena Hernández-Ortiz, Osbaldo Resendis-Antonio, Sergio Encarnación-Guevara. (2011) Proteomic patterns of cervical cancer cell lines, a network perspective. BMC Systems Biology 5:1, 96
CrossRef260
GABRIELA ANTON, GHEORGHE PELTECU, DEMETRA SOCOLOV, FLORINEL CORNITESCU, CORALIA BLEOTU, ZORELA SGARBURA, SERGIU TELEMAN, DOMINIC ILIESCU, ANCA BOTEZATU, CRISTINA D. GOIA, IRINA HUICA, ANA-CRISTINA ANTON. (2011) Type-specific human papillomavirus detection in cervical smears in Romania. APMIS 119:1, 1-9
CrossRef261
Kamila M. Ostrowska, Amaya Garcia, Aidan D. Meade, Alison Malkin, Ifeoluwapo Okewumi, John J. O'Leary, Cara Martin, Hugh J. Byrne, Fiona M. Lyng. (2011) Correlation of p16INK4A expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells. The Analyst 136:7, 1365
CrossRef262
C. René Leemans, Boudewijn J. M. Braakhuis, Ruud H. Brakenhoff. (2011) The molecular biology of head and neck cancer. Nature Reviews Cancer 11:1, 9-22
CrossRef263
Aris Spathis, Evaggelia Aga, Maria Alepaki, Aikaterini Chranioti, Christos Meristoudis, Ioannis Panayiotides, Dimitrios Kassanos, Petros Karakitsos. (2011) Promoter Methylation of p16INK4A, hMLH1, and MGMT in Liquid-Based Cervical Cytology Samples Compared with Clinicopathological Findings and HPV Presence. Infectious Diseases in Obstetrics & Gynecology 2011, 1-5
CrossRef264
Dongsup Lee, Sunghyun Kim, Sangjung Park, Hyunwoo Jin, Tae Ue Kim, Kwang Hwa Park, Hyeyoung Lee. (2011) Human Papillomavirus Prevalence in Gangwon Province Using Reverse Blot Hybridization Assay. The Korean Journal of Pathology 45:4, 348
CrossRef265
Mark Jit, Nadia Demarteau, Elamin Elbasha, Gary Ginsberg, Jane Kim, Naiyana Praditsitthikorn, Edina Sinanovic, Raymond Hutubessy. (2011) Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models. BMC Medicine 9:1, 54
CrossRef266
Chonlaphat Sukasem, Wantanich Pairoj, Nipa Saekang, Hiranyaratsami Pombubpha, Chutatip Srichunrasami, Atcharaporn Pongtippan, Pairoj Junyangdikul, Wasun Chantratita. (2011) Molecular epidemiology of human papillomavirus genotype in women with high-grade squamous intraepithelial lesion and cervical cancer: Will a quadrivalent vaccine be necessary in Thailand?. Journal of Medical Virology 83:1, 119-126
CrossRef267
Rajyasree Emmadi, Jerry B. Boonyaratanakornkit, Rangaraj Selvarangan, Venkatakrishna Shyamala, Barbara L. Zimmer, Laurina Williams, Bonita Bryant, Ted Schutzbank, Michele M. Schoonmaker, Jean A. Amos Wilson. (2011) Molecular Methods and Platforms for Infectious Diseases Testing. Journal of Molecular Diagnostics 13:6, 583
CrossRef268
Na-Rae Kim, Soyi Lim, Hyun Yee Cho. (2011) Pediatric vulvar squamous cell carcinoma in a liver transplantation recipient: a case report. Journal of Gynecologic Oncology 22:3, 207
CrossRef269
Paul K.S. Chan, Tak-Hong Cheung, Wai-Hon Li, Mei Y. Yu, May Y.M. Chan, So-Fan Yim, Wendy C.S. Ho, Apple C.M. Yeung, King-Man Ho, H.K. Ng. (2011) Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China. International Journal of Cancern/a-n/a
CrossRef270
Se-Kwon Kim, Ratih Pangestuti. 2011. Potential Role of Marine Algae on Female Health, Beauty, and Longevity. , 41-55.
CrossRef271
J M Godinez, S Tous, N Baixeras, J Moreno-Crespi, M Alejo, M Lejeune, I G Bravo, F X Bosch, S de Sanjose. (2011) Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array.. Infectious Agents and Cancer 6:1, 23
CrossRef272
Paloma Martin, Linah Kilany, Diego Garcia, Ana M Lopez-Garcia, Ma Jose Martin-Azana, Victor Abraira, Carmen Bellas. (2011) Human papillomavirus genotype distribution in Madrid and correlation with cytological data. BMC Infectious Diseases 11:1, 316
CrossRef273
Wen-Ting Yang, Peng-Sheng Zheng. (2011) Krüppel-like factor 4 function as a tumor suppressor in cervical carcinoma. Cancern/a-n/a
CrossRef274
Li-Chung Chuang, Chung-Yi Hu, Hui-Chi Chen, Pei-Jung Lin, Borheng Lee, Ching-Yu Lin, Mei-Hung Pan, San-Lin You, Chang-Yao Hsieh, Chien-Jen Chen, . (2011) Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia risk. Cancern/a-n/a
CrossRef275
Nienke J Veldhuijzen, Sarah L Braunstein, Joseph Vyankandondera, Chantal Ingabire, Justin Ntirushwa, Evelyne Kestelyn, Coosje Tuijn, Ferdinand W. Wit, Aline Umutoni, Mireille Uwineza, Tania Crucitti, Janneke HHM van de Wijgert. (2011) The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. BMC Infectious Diseases 11:1, 333
CrossRef276
Ramona Gabriela Ursu, Mircea Onofriescu, Dragos Nemescu, Luminita-Smaranda Iancu. (2011) HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania. Virology Journal 8:1, 558
CrossRef277
Jennifer S. Smith, Adam K. Lewkowitz, You-Lin Qiao, Jia Ji, Shangying Hu, Wen Chen, Rong Zhang, Kai Li Liaw, Mark Esser, Frank J. Taddeo, Robert G. Pretorius, Jerome L. Belinson. (2011) Population-based human papillomavirus 16,18, 6 and 11 DNA positivity and seropositivity in chinese women. International Journal of Cancern/a-n/a
CrossRef278
Sepehr N. Tabrizi, Nicole Taylor, Michael J. McCullough, Gillian Phillips, John Wark, Dorota Gertig, Rodney W. Petersen, Marion Saville, Suzanne M. Garland. (2010) Human papillomavirus genotype detection from archival papanicolaou-stained cervical tests. Cancer Cytopathology 118:6, 482-489
CrossRef279
Annelinde Terlou, Manon van Seters, Alex Kleinjan, Claudia Heijmans-Antonissen, Lindy A.M. Santegoets, Ilse Beckmann, Marc van Beurden, Theo J.M. Helmerhorst, Leen J. Blok. (2010) Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia. International Journal of Cancer 127:12, 2831-2840
CrossRef280
Johannes Berkhof, Johannes A Bogaards. (2010) Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer. Future Oncology 6:12, 1817-1821
CrossRef281
Victoria Fuste, Marta del Pino, Assumpta Perez, Angel Garcia, Aureli Torne, Jaume Pahisa, Jaume Ordi. (2010) Primary squamous cell carcinoma of the vagina: human papillomavirus detection, p16INK4A overexpression and clinicopathological correlations. Histopathology 57:6, 907-916
CrossRef282
Dong-Hyun Kim, Roger M. Jarvis, J. William Allwood, Gavin Batman, Rowan E. Moore, Emma Marsden-Edwards, Lynne Hampson, Ian N. Hampson, Royston Goodacre. (2010) Raman chemical mapping reveals site of action of HIV protease inhibitors in HPV16 E6 expressing cervical carcinoma cells. Analytical and Bioanalytical Chemistry 398:7-8, 3051-3061
CrossRef283
L. Civit, A. Fragoso, C.K. O'Sullivan. (2010) Electrochemical biosensor for the multiplexed detection of human papillomavirus genes. Biosensors and Bioelectronics 26:4, 1684-1687
CrossRef284
Miloš Milošević, Mario Poljak, Boštjan Mlakar. (2010) Anal HPV infection in Slovenian men who have sex with men. Central European Journal of Medicine 5:6, 698-703
CrossRef285
Nienke J Veldhuijzen, Peter JF Snijders, Peter Reiss, Chris JLM Meijer, Janneke HHM van de Wijgert. (2010) Factors affecting transmission of mucosal human papillomavirus. The Lancet Infectious Diseases 10:12, 862-874
CrossRef286
Nazia Hasan, Ari Pollack, Ilseung Cho. (2010) Infectious Causes of Colorectal Cancer. Infectious Disease Clinics of North America 24:4, 1019-1039
CrossRef287
O. Richel, U. Wieland, H.J.C. De Vries, N.H. Brockmeyer, C. Van Noesel, A. Potthoff, J.M. Prins, A. Kreuter. (2010) Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men. British Journal of Dermatology 163:6, 1301-1307
CrossRef288
Hugo Vuyst, Maria Rita Parisi, Andrew Karani, Kishor Mandaliya, Lucy Muchiri, Salvatore Vaccarella, Marleen Temmerman, Silvia Franceschi, Flavia Lillo. (2010) The prevalence of human papillomavirus infection in Mombasa, Kenya. Cancer Causes & Control 21:12, 2309-2313
CrossRef289
Eda Vrtačnik Bokal, Boštjan J. Kocjan, Mario Poljak, Željka Bogovac, Nina Jančar. (2010) Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia. Journal of Obstetrics and Gynaecology Research 36:6, 1204-1213
CrossRef290
Z. Z. A. Mbulawa, D. J. Marais, L. F. Johnson, A. Boulle, D. Coetzee, A.-L. Williamson. (2010) Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. Journal of General Virology 91:12, 3023-3031
CrossRef291
Fatemeh Moosavi, Hassan Mohabatkar, Sasan Mohsenzadeh. (2010) Computer-aided analysis of structural properties and epitopes of Iranian HPV-16 E7 oncoprotein. Interdisciplinary Sciences: Computational Life Sciences 2:4, 367-372
CrossRef292
J. Monsonego, J. Cortes, C. Greppe, M. Hampl, E. Joura, A. Singer. (2010) Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. Vaccine 28:51, 8065-8072
CrossRef293
Min-Zhu Huang, Shuang Huang, Deng-Qing Li, Xin-Min Nie, Hong-Bo Li, Xiao-Man Jiang. (2010) The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions. Medical Oncology
CrossRef294
Thomas Iftner, Sonja Eberle, Angelika Iftner, Barbara Holz, Norbert Banik, Wim Quint, Anja-Natascha Straube. (2010) Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: An epidemiological observational study. Journal of Medical Virology 82:11, 1928-1939
CrossRef295
Mireia Diaz, Silvia de Sanjose, Jesse Ortendahl, Meredith O’Shea, Sue J. Goldie, F. Xavier Bosch, Jane J. Kim. (2010) Cost-effectiveness of human papillomavirus vaccination and screening in Spain. European Journal of Cancer 46:16, 2973-2985
CrossRef296
Cosette Marie Wheeler. (2010) HPV genotypes: implications for worldwide cervical cancer screening and vaccination. The Lancet Oncology 11:11, 1013-1014
CrossRef297
Marlies Heiligenberg, Kristina M. Michael, Merlijn A. Kramer, Michael Pawlita, Maria Prins, Roel A. Coutinho, Nicole H. T. M. Dukers-Muijrers, Tim Waterboer. (2010) Seroprevalence and Determinants of Eight High-Risk Human Papillomavirus Types in Homosexual Men, Heterosexual Men, and Women: A Population-Based Study in Amsterdam. Sexually Transmitted Diseases 37:11, 672-680
CrossRef298
Tae-Young Lee, Yang-Hyun Kim, Kyung-Soon Lee, Jeong-Ki Kim, Il-Han Lee, Jai-Myung Yang, Moon-Hee Sung, Jong-Sup Park, Haryoung Poo. (2010) Human papillomavirus type 16 E6-specific antitumor immunity is induced by oral administration of HPV16 E6-expressing Lactobacillus casei in C57BL/6 mice. Cancer Immunology, Immunotherapy 59:11, 1727-1737
CrossRef299
Brian Lowe, Lori Kobayashi, Attila Lorincz, Rick Mallonee, Dominic O'Neil, Ha Thai, Irina Nazarenko. (2010) HPV Genotype Detection Using Hybrid Capture Sample Preparation Combined with Whole Genome Amplification and Multiplex Detection with Luminex XMAP. The Journal of Molecular Diagnostics 12:6, 847-853
CrossRef300
Chun-Chieh Wang, Chyong-Huey Lai, Huei-Jean Huang, Angel Chao, Chee-Jen Chang, Ting-Chang Chang, Hung-Hsueh Chou, Ji-Hong Hong. (2010) Clinical Effect of Human Papillomavirus Genotypes in Patients With Cervical Cancer Undergoing Primary Radiotherapy. International Journal of Radiation Oncology*Biology*Physics 78:4, 1111-1120
CrossRef301
Johannes Berkhof, Veerle M. Coupé, Johannes A. Bogaards, Folkert J. van Kemenade, Theo J. Helmerhorst, Peter J. Snijders, Chris J. Meijer. (2010) The health and economic effects of HPV DNA screening in The Netherlands. International Journal of Cancer 127:9, 2147-2158
CrossRef302
Arthi Vijayaraghavan, Molly B. Efrusy, Karyn A. Goodman, Christopher C. Santas, Warner K. Huh. (2010) Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening. Gynecologic Oncology 119:2, 237-242
CrossRef303
Marie-Hélène Mayrand, Eduardo L Franco. (2010) Integrating novel primary- and secondary-prevention strategies: the next challenge for cervical cancer control. Future Oncology 6:11, 1725-1733
CrossRef304
Silvia de Sanjose, Wim GV Quint, Laia Alemany, Daan T Geraets, Jo Ellen Klaustermeier, Belen Lloveras, Sara Tous, Ana Felix, Luis Eduardo Bravo, Hai-Rim Shin, Carlos S Vallejos, Patricia Alonso de Ruiz, Marcus Aurelho Lima, Nuria Guimera, Omar Clavero, Maria Alejo, Antonio Llombart-Bosch, Chou Cheng-Yang, Silvio Alejandro Tatti, Elena Kasamatsu, Ermina Iljazovic, Michael Odida, Rodrigo Prado, Muhieddine Seoud, Magdalena Grce, Alp Usubutun, Asha Jain, Gustavo Adolfo Hernandez Suarez, Luis Estuardo Lombardi, Aekunbiola Banjo, Clara Menéndez, Efrén Javier Domingo, Julio Velasco, Ashrafun Nessa, Saibua C Bunnag Chichareon, You Lin Qiao, Enrique Lerma, Suzanne M Garland, Toshiyuki Sasagawa, Annabelle Ferrera, Doudja Hammouda, Luciano Mariani, Adela Pelayo, Ivo Steiner, Esther Oliva, Chris JLM Meijer, Waleed Fahad Al-Jassar, Eugenia Cruz, Thomas C Wright, Ana Puras, Cecilia Ladines Llave, Maria Tzardi, Theodoros Agorastos, Victoria Garcia-Barriola, Christine Clavel, Jaume Ordi, Miguel Andújar, Xavier Castellsagué, Gloria I Sánchez, Andrzej Marcin Nowakowski, Jacob Bornstein, Nubia Muñoz, F Xavier Bosch. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. The Lancet Oncology 11:11, 1048-1056
CrossRef305
Gui-Ling Li, Wei Jiang, Qing Xia, Song-Hua Chen, Xi-Rui Ge, Sui-Qi Gui, Cong-Jian Xu. (2010) HPV E6 down-regulation and apoptosis induction of human cervical cancer cells by a novel lipid-soluble extract (PE) from Pinellia pedatisecta Schott in vitro. Journal of Ethnopharmacology 132:1, 56-64
CrossRef306
Anna-Barbara Moscicki, Lea Widdice, Yifei Ma, Sepideh Farhat, Susanna Miller-Benningfield, Janet Jonte, Julie Jay, Cheryl Godwin de Medina, Evelyn Hanson, Lisa Clayton, Stephen Shiboski. (2010) Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling. International Journal of Cancer 127:8, 1882-1892
CrossRef307
Mario Poljak, Boštjan J Kocjan. (2010) Commercially available assays for multiplex detection of alpha human papillomaviruses. Expert Review of Anti-infective Therapy 8:10, 1139-1162
CrossRef308
Min-A Kim, Jin-Kyoung Oh, Doo Byung Chay, Dong Choon Park, Seok Mo Kim, Eun-Suk Kang, Jae-Hoon Kim, Chi-Heum Cho, Hai-Rim Shin, Kyung Seo. (2010) Prevalence and Seroprevalence of High-Risk Human Papillomavirus Infection. Obstetrics & Gynecology 116:4, 932-940
CrossRef309
Ivan Hirsch, Christophe Caux, Uzma Hasan, Nathalie Bendriss-Vermare, Daniel Olive. (2010) Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer. Trends in Immunology 31:10, 391-397
CrossRef310
Polona J. Maver, Mario Poljak, Katja Seme, Boštjan J. Kocjan. (2010) Detection and typing of low-risk human papillomavirus genotypes HPV 6, HPV 11, HPV 42, HPV 43 and HPV 44 by polymerase chain reaction and restriction fragment length polymorphism. Journal of Virological Methods 169:1, 215-218
CrossRef311
Kuo-Chien Tsao, Chung-Guei Huang, Yung-Bin Kuo, Ting-Chang Chang, Chien-Feng Sun, C. Allen Chang, Su-Li Yang, Err-Cheng Chan. (2010) Prevalence of human papillomavirus genotypes in northern Taiwanese women. Journal of Medical Virology 82:10, 1739-1745
CrossRef312
Maria A de Peuter, Kavi J Littlewood, Lieven Annemans, Nathalie Largeron, Sibilia Quilici. (2010) Cost–effectiveness of catch-up programs in human papillomavirus vaccination. Expert Review of Vaccines 9:10, 1187-1201
CrossRef313
Yuk-Ching Yip, Karry L.K. Ngai, Heong-Ting Vong, Lawrence C.H. Tzang, Shenglin Ji, Mengsu Yang, Paul K.S. Chan. (2010) Prevalence and genotype distribution of cervical human papillomavirus infection in Macao. Journal of Medical Virology 82:10, 1724-1729
CrossRef314
Myron J Levin, Anna-Barbara Moscicki, Lin-Ye Song, Terrence Fenton, William A Meyer, Jennifer S Read, Edward L Handelsman, Barbara Nowak, Carlos A Sattler, Alfred Saah, David R Radley, Mark T Esser, Adriana Weinberg. (2010) Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children 7 to 12 Years Old. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:2, 197-204
CrossRef315
Wendy Theelen, Ernst-Jan M. Speel, Michael Herfs, Martin Reijans, Guus Simons, Els V. Meulemans, Marcella M. Baldewijns, Frans C.S. Ramaekers, Joan Somja, Philippe Delvenne, Anton H.N. Hopman. (2010) Increase in Viral Load, Viral Integration, and Gain of Telomerase Genes during Uterine Cervical Carcinogenesis can be Simultaneously Assessed by the HPV 16/18 MLPA-Assay. The American Journal of Pathology 177:4, 2022-2033
CrossRef316
Ignacio G. Bravo, Silvia de Sanjosé, Marc Gottschling. (2010) The clinical importance of understanding the evolution of papillomaviruses. Trends in Microbiology 18:10, 432-438
CrossRef317
D C Rijkaart, V M H Coupe, F J van Kemenade, D A M Heideman, A T Hesselink, W Verweij, L Rozendaal, R H Verheijen, P J Snijders, J Berkhof, C J L M Meijer. (2010) Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test. British Journal of Cancer 103:7, 939-946
CrossRef318
Martha Luevano, Hans-Ulrich Bernard, Hugo A. Barrera-Saldaña, Victor Trevino, Alejandro Garcia-Carranca, Luisa L. Villa, Bradley J. Monk, Xiaolin Tan, D. Huw Davies, Phil L. Felgner. (2010) High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays. Virology 405:1, 31-40
CrossRef319
Fatima Galan-Sanchez, Manuel A. Rodriguez-Iglesias. (2010) Use of Cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results. APMIS 118:9, 681-684
CrossRef320
M. Evans, N.G. Powell. (2010) The Changing Aetiology of Head and Neck Cancer: the Role of Human Papillomavirus. Clinical Oncology 22:7, 538-546
CrossRef321
Thazin Hlaing, Yuk-Ching Yip, Karry L.K. Ngai, Heong-Ting Vong, Sio-In Wong, Wendy C.S. Ho, Sellma L.S.C. Batalha, Paul K.S. Chan. (2010) Distribution of human papillomavirus genotypes among cervical intraepithelial neoplasia and invasive cancers in Macao. Journal of Medical Virology 82:9, 1600-1605
CrossRef322
Mark Francis Evans, Christine Stewart-Crawford Adamson, Laura Meredith Schned, Timothy Louis St. John, Gladwyn Leiman, Takamaru Ashikaga, Kumarasen Cooper. (2010) HPV is Detectable in Virtually All Abnormal Cervical Cytology Samples After Reinvestigation of HPV Negatives With Multiple Alternative PCR Tests. Diagnostic Molecular Pathology 19:3, 144-150
CrossRef323
Theodoros Agorastos, Alexandros Sotiriadis, Konstantinos Chatzigeorgiou. (2010) Can HPV testing replace the pap smear?. Annals of the New York Academy of Sciences 1205:1, 51-56
CrossRef324
Shuang Li, Yu-Han Meng, Hu Ting, Jian Shen, Ding Ma. (2010) Clinical significance of human papilloma virus infection in the cervical lesions. Frontiers of Medicine in China 4:3, 264-270
CrossRef325
M. Meftah El khair, M. M. Ennaji, R. El kebbaj, R. Ait Mhand, M. Attaleb, M. El Mzibri. (2010) p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women. Medical Oncology 27:3, 861-866
CrossRef326
Koji Matsumoto, Akinori Oki, Reiko Furuta, Hiroo Maeda, Toshiharu Yasugi, Naoyoshi Takatsuka, Yasuo Hirai, Akira Mitsuhashi, Takuma Fujii, Tsuyoshi Iwasaka, Nobuo Yaegashi, Yoh Watanabe, Yutaka Nagai, Tomoyuki Kitagawa, Hiroyuki Yoshikawa, . (2010) Tobacco smoking and regression of low-grade cervical abnormalities. Cancer Science 101:9, 2065-2073
CrossRef327
Alexander Kreuter, Maciej Jesse, Anja Potthoff, Norbert H. Brockmeyer, Thilo Gambichler, Markus Stücker, Falk G. Bechara, Herbert Pfister, Ulrike Wieland. (2010) Expression of proliferative biomarkers in anal intraepithelial neoplasia of HIV-positive men. Journal of the American Academy of Dermatology 63:3, 490-498
CrossRef328
Christina Bennett, Allen E. Kuhn, Harry W. Haverkos. (2010) Human papillomavirus and tar hypothesis for squamous cell cervical cancer. Journal of Biosciences 35:3, 331-337
CrossRef329
Michelle Forcier, Najah Musacchio. (2010) An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention. Dermatologic Therapy 23:5, 458-476
CrossRef330
Nienke J Veldhuijzen, Joseph Vyankandondera, Janneke H van de Wijgert. (2010) HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda. AIDS 24:14, 2289-2292
CrossRef331
Sawali R. Sudarshan, Richard Schlegel, Xuefeng Liu. (2010) The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes. Biochemical and Biophysical Research Communications 399:4, 617-622
CrossRef332
Suks Minhas, Andreas Manseck, Stephen Watya, Paul K. Hegarty. (2010) Penile Cancer—Prevention and Premalignant Conditions. Urology 76:2, S24-S35
CrossRef333
Chin-Hung Wang, Ronald Garingalao Garvilles, Chung-Yung Chen. (2010) Characterization of human papillomavirus infection in north Taiwan. Journal of Medical Virology 82:8, 1416-1423
CrossRef334
Yusuke Hiraku, Shosuke Kawanishi, Takamichi Ichinose, Mariko Murata. (2010) The role of iNOS-mediated DNA damage in infection- and asbestos-induced carcinogenesis. Annals of the New York Academy of Sciences 1203:1, 15-22
CrossRef335
Ioannis N. Mammas, George Sourvinos, Elena Vakonaki, Panagiota Giamarelou, Catherine Michael, Demetrios A. Spandidos. (2010) Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis. European Journal of Pediatrics 169:8, 1017-1021
CrossRef336
Chan Joo Kim, Young Suk Lee, Hyun Sung Kwack, Won Sik Yoon, Tae Chul Park, Jong-Sup Park. (2010) Specific Human Papillomavirus Types and Other Factors on the Risk of Cervical Intraepithelial Neoplasia. International Journal of Gynecological Cancer 20:6, 1067-1073
CrossRef337
Chih-Ming Ho, Bor-Heng Lee, Shwu-Fen Chang, Tsai-Yen Chien, Shih-Hung Huang, Chiu-Cho Yan, Wen-Fang Cheng. (2010) Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia. International Journal of Cancer 127:3, 622-632
CrossRef338
Shanthi Marur, Gypsyamber D'Souza, William H Westra, Arlene A Forastiere. (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. The Lancet Oncology 11:8, 781-789
CrossRef339
A.E. Albers, T.K. Hoffmann, J.P. Klussmann, A.M. Kaufmann. (2010) Prophylaktische und therapeutische Vakzinen gegen humane Papillomviren. HNO 58:8, 778-790
CrossRef340
Alessandra Handisurya, Christina Schellenbacher, Bärbel Reininger, Frieder Koszik, Philipp Vyhnanek, Andreas Heitger, Reinhard Kirnbauer, Elisabeth Förster-Waldl. (2010) A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome. Vaccine 28:30, 4837-4841
CrossRef341
Miguel Martorell, José Ángel García-García, Cristian Ortiz, Ana Pérez-Vallés, Consuelo Calabuig, David Gómez-Cabrero, Manuel Escolano, Manel Montesinos. (2010) Prevalence and distribution of human papillomavirus findings in swab specimens from gynaecology clinics of the east coast of Spain. Scandinavian Journal of Infectious Diseases 42:6-7, 549-553
CrossRef342
S. A. Brendle, T. D. Culp, T. R. Broutian, N. D. Christensen. (2010) Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58. Journal of General Virology 91:7, 1834-1839
CrossRef343
Marta Durczak, Paweł Piotr Jagodzinski. (2010) Apicidin upregulates PHD2 prolyl hydroxylase gene expression in cervical cancer cells. Anti-Cancer Drugs 21:6, 619-624
CrossRef344
Gilbert Cornut, Simon Gagnon, Catherine Hankins, Deborah Money, Karina Pourreaux, Eduardo L. Franco, François Coutlée. (2010) Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33, and 35. Journal of Medical Virology 82:7, 1168-1178
CrossRef345
Kozeta Filipi, Alma Tedeschini, Francesca Paolini, Silva Celicu, Salvatrice Morici, Majlinda Kota, Elona Bucaj, Federico De Marco. (2010) Genital human papillomavirus infection and genotype prevalence among albanian women: A cross-sectional study. Journal of Medical Virology 82:7, 1192-1196
CrossRef346
M.P. Cañadas, S. Videla, L. Darwich, A. Tarrats, M. Piñol, F. García-Cuyás, M. Llatjos, C. Alcalde, I. Fernández, G. Sirera, B. Clotet. (2010) Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women. Journal of Clinical Virology 48:3, 198-201
CrossRef347
Dongmei Wu, Lin Cai, Meng Huang, Yizhen Zheng, Jiang Yu. (2010) Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province, PR China. European Journal of Obstetrics & Gynecology and Reproductive Biology 151:1, 86-90
CrossRef348
Maria Lina Tornesello, Giovanna Loquercio, Maria Tagliamonte, Fabio Rossano, Luigi Buonaguro, Franco Maria Buonaguro. (2010) Human papillomavirus infection in urine samples from male renal transplant patients. Journal of Medical Virology 82:7, 1179-1185
CrossRef349
Pankaj Karande, Samir Mitragotri. (2010) Transcutaneous Immunization: An Overview of Advantages, Disease Targets, Vaccines, and Delivery Technologies. Annual Review of Chemical and Biomolecular Engineering 1:1, 175-201
CrossRef350
Samantha Seresini, Massimo Origoni, Luigi Caputo, Flavia Lillo, Renato Longhi, Simone Vantini, Anna Maria Paganoni, Maria Pia Protti. (2010) CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix. Immunologyno-no
CrossRef351
Michael S. McLemore, Missak Haigentz, Richard V. Smith, Gerard J. Nuovo, Llucia Alos, Antonio Cardesa, Margaret Brandwein-Gensler. (2010) Head and Neck Squamous Cell Carcinomas in HIV-Positive Patients: A Preliminary Investigation of Viral Associations. Head and Neck Pathology 4:2, 97-105
CrossRef352
A. Kreuter, A. Potthoff, N.H. Brockmeyer, T. Gambichler, J. Swoboda, M. Stücker, M. Schmitt, H. Pfister, U. Wieland, . (2010) Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. British Journal of Dermatology 162:6, 1269-1277
CrossRef353
Ranbir C. Sobti, Neha Singh, Showket Hussain, Vanita Suri, Mausumi Bharadwaj, Bhudev C. Das. (2010) Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis. Journal of Receptors and Signal Transduction 30:3, 178-188
CrossRef354
Damayanti Das, Bornali Bhattacharjee, Shrinka Sen, Indranil Mukhopadhyay, Sharmila Sengupta. (2010) Association of viral load with HPV16 positive cervical cancer pathogenesis: Causal relevance in isolates harboring intact viral E2 gene. Virology 402:1, 197-202
CrossRef355
Hans-Ulrich Bernard, Robert D. Burk, Zigui Chen, Koenraad van Doorslaer, Harald zur Hausen, Ethel-Michele de Villiers. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:1, 70-79
CrossRef356
Wei Wang, Ni Sima, Debo Kong, Aiyue Luo, Qinglei Gao, Shujie Liao, Wei Li, Lingfei Han, Juan Wang, Shixuan Wang, Yunping Lu, Daowen Wang, Gang Xu, Jianfeng Zhou, Li Meng, Ding Ma. (2010) Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo. Cancer Letters 291:1, 67-75
CrossRef357
Michele C. Gornick, Xavier Castellsague, Gloria Sanchez, Thomas J. Giordano, Michelle Vinco, Joel K. Greenson, Gabriel Capella, Leon Raskin, Gad Rennert, Stephen B. Gruber, Victor Moreno. (2010) Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes & Control 21:5, 737-743
CrossRef358
Eric P. Dixon, Karen L. Lenz, Hema Doobay, Charlotte A. Brown, Douglas P. Malinowski, Timothy J. Fischer. (2010) Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test. Journal of Clinical Virology 48:1, 31-35
CrossRef359
Päivi Laukkanen, Esa Läärä, Pentti Koskela, Eero Pukkala, Hanna Virkkunen, Matti Lehtinen. (2010) Population fraction of cervical neoplasia attributable to high-risk human papillomaviruses. Future Oncology 6:5, 709-716
CrossRef360
Zheng-Rong Sun, Yao-Hua Ji, Wei-Qiang Zhou, Shu-Lan Zhang, Wei-Guo Jiang, Qiang Ruan. (2010) Characteristics of HPV prevalence among women in Liaoning province, China. International Journal of Gynecology & Obstetrics 109:2, 105-109
CrossRef361
Yoon Hong Choi, Mark Jit, Nigel Gay, Andrew Cox, Geoff P. Garnett, William John Edmunds. (2010) Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. Vaccine 28:24, 4091-4102
CrossRef362
Rui Jorge Nobre, Eugénia Cruz, Odete Real, Luís Pereira de Almeida, Teresa C. Martins. (2010) Characterization of common and rare human papillomaviruses in Portuguese women by the polymerase chain reaction, restriction fragment length polymorphism and sequencing. Journal of Medical Virology 82:6, 1024-1032
CrossRef363
Doris M. Rivera Medina, Alejandra Valencia, Alet de Velasquez, Li-Min Huang, Roman Prymula, Jose García-Sicilia, Lars Rombo, Marie Pierre P. David, Dominique Descamps, Karin Hardt, Gary Dubin. (2010) Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls. Journal of Adolescent Health 46:5, 414-421
CrossRef364
S Cotton, L Sharp, J Little, M Cruickshank, R Seth, L Smart, I Duncan, K Harrild, K Neal, N Waugh, . (2010) The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology 117:6, 645-659
CrossRef365
Claudio S Batista, Álvaro N Atallah, Humberto Saconato, Edina MK da Silva, Claudio S Batista. 2010. 5-FU for genital warts in non-immunocompromised individuals. .
CrossRef366
Peter F. Schnatz, Kate Humphrey, David M. O'Sullivan. (2010) Assessment of the Perceptions and Administration of the Human Papillomavirus Vaccine. Journal of Lower Genital Tract Disease 14:2, 103-107
CrossRef367
Joel M. Palefsky. (2010) Human Papillomavirus-Related Disease in Men: Not Just a Women's Issue. Journal of Adolescent Health 46:4, S12-S19
CrossRef368
J. A. Bogaards, M. Xiridou, V. M. H. Coupe, C. J. L. M. Meijer, J. Wallinga, J. Berkhof. (2010) Model-Based Estimation of Viral Transmissibility and Infection-Induced Resistance From the Age-Dependent Prevalence of Infection for 14 High-Risk Types of Human Papillomavirus. American Journal of Epidemiology 171:7, 817-825
CrossRef369
Giancarlo Ripabelli, Guido M. Grasso, Ilenia Del Riccio, Manuela Tamburro, Michela L. Sammarco. (2010) Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, Central Italy. Cancer Epidemiology 34:2, 162-167
CrossRef370
Betti Schopp, Barbara Holz, Manola Zago, Frank Stubenrauch, Karl-Ulrich Petry, Susanne Krüger Kjaer, Thomas Iftner. (2010) Evaluation of the performance of the novel PapilloCheck® HPV genotyping test by comparison with two other genotyping systems and the HC2 test. Journal of Medical Virology 82:4, 605-615
CrossRef371
Nelba Tabora, Willem J.G. Melchers, Leen-Jan van Doorn, Wim Quint, Annabelle Ferrera. (2010) Molecular Variants of HPV Type 16 E6 Among Honduran Women. International Journal of Gynecological Cancer 20:3, 323-328
CrossRef372
Jun-Han Su, Anjui Wu, Elizabeth Scotney, Barbara Ma, Archana Monie, Chien-Fu Hung, T.-C. Wu. (2010) Immunotherapy for Cervical Cancer. BioDrugs 24:2, 109-129
CrossRef373
Mayumi Nakagawa, Sushil K. Gupta, Hannah N. Coleman, Matthew A. Sellers, Joseph A. Banken, William W. Greenfield. (2010) A Favorable Clinical Trend Is Associated With CD8 T-Cell Immune Responses to the Human Papillomavirus Type 16 E6 Antigens in Women Being Studied for Abnormal Pap Smear Results. Journal of Lower Genital Tract Disease 14:2, 124-129
CrossRef374
María de Oña, Marta E. Alvarez-Argüelles, Magdalena Torrents, Laura Villa, Asunción Rodriguez-Feijoo, Ana Palacio, Jose A. Boga, Angel Tamargo, Santiago Melón. (2010) Prevalence, evolution, and features of infection with human papillomavirus: A 15-year longitudinal study of routine screening of a women population in the north of Spain. Journal of Medical Virology 82:4, 597-604
CrossRef375
Ryo Konno, Toshiyuki Sasagawa, Takashi Fukuda, Georges Van Kriekinge, Nadia Demarteau. (2010) Cost-Effectiveness Analysis of Prophylactic Cervical Cancer Vaccination in Japanese Women. International Journal of Gynecological Cancer 20:3, 385-392
CrossRef376
Diane S Tider, Gabriela Rodriguez Caprio, Michael Gaisa, Robert S Klein, Stephen E Goldstone. (2010) Successful initiation of an anal cancer screening and treatment program at a New York City HIV clinic. AIDS 24:7, 1085-1086
CrossRef377
Audrey Damay, Jaqueline Fabre, Valérie Costes, Jean-Michel Didelot, Marie-Noëlle Didelot, Nathalie Boulle, Michel Segondy. (2010) Human papillomavirus (HPV) prevalence and type distribution, and HPV-associated cytological abnormalities in anal specimens from men infected with HIV who have sex with men. Journal of Medical Virology 82:4, 592-596
CrossRef378
Łukasz Kruszyna, Margarita Lianeri, Andrzej Roszak, Paweł P. Jagodziński. (2010) HER2 codon 655 polymorphism is associated with advanced uterine cervical carcinoma. Clinical Biochemistry 43:6, 545-548
CrossRef379
Anja Köhler, Marc Gottschling, Jana Förster, Joachim Röwert-Huber, Eggert Stockfleth, Ingo Nindl. (2010) Genomic characterization of a novel human papillomavirus (HPV-117) with a high viral load in a persisting wart
. Virology 399:1, 129-133
CrossRef380
A. C. Rodriguez, M. Schiffman, R. Herrero, A. Hildesheim, C. Bratti, M. E. Sherman, D. Solomon, D. Guillen, M. Alfaro, J. Morales, M. Hutchinson, H. Katki, L. Cheung, S. Wacholder, R. D. Burk. (2010) Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection. JNCI Journal of the National Cancer Institute 102:5, 315-324
CrossRef381
N. Munoz, S. K. Kjaer, K. Sigurdsson, O.-E. Iversen, M. Hernandez-Avila, C. M. Wheeler, G. Perez, D. R. Brown, L. A. Koutsky, E. H. Tay, P. J. Garcia, K. A. Ault, S. M. Garland, S. Leodolter, S.-E. Olsson, G. W. K. Tang, D. G. Ferris, J. Paavonen, M. Steben, F. X. Bosch, J. Dillner, W. K. Huh, E. A. Joura, R. J. Kurman, S. Majewski, E. R. Myers, L. L. Villa, F. J. Taddeo, C. Roberts, A. Tadesse, J. T. Bryan, L. C. Lupinacci, K. E. D. Giacoletti, H. L. Sings, M. K. James, T. M. Hesley, E. Barr, R. M. Haupt. (2010) Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women. JNCI Journal of the National Cancer Institute 102:5, 325-339
CrossRef382
ND Christensen, CE Bounds. (2010) Cross-protective responses to human papillomavirus infection. Future Virology 5:2, 163-174
CrossRef383
Maryam Esmaeili, Hassan Mohabatkar, Sasan Mohsenzadeh. (2010) Using the concept of Chou's pseudo amino acid composition for risk type prediction of human papillomaviruses. Journal of Theoretical Biology 263:2, 203-209
CrossRef384
M. Arbyn, A. Anttila, J. Jordan, G. Ronco, U. Schenck, N. Segnan, H. Wiener, A. Herbert, L. von Karsa. (2010) European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition--Summary Document. Annals of Oncology 21:3, 448-458
CrossRef385
P. Conesa-Zamora, V. Santaclara, E. Gadea-Niñoles, S. Ortiz-Reina, M. Perez-Guillermo. (2010) Association of polymorphism in FcGR3A gene and progression of low-grade precursor lesions of cervical carcinoma. Human Immunology 71:3, 314-317
CrossRef386
Ang Tshering Lama Sherpa, Gary M. Clifford, Salvatore Vaccarella, Sadhina Shrestha, Mari Nygård, Balman Singh Karki, Peter J. F. Snijders, Chris J. L. M. Meijer, Silvia Franceschi. (2010) Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer Causes & Control 21:3, 323-330
CrossRef387
Cynthia Firnhaber, Hoa Le, Audrey Pettifor, Doreen Schulze, Pam Michelow, Ian M. Sanne, David A. Lewis, Anna-Lise Williamson, Bruce Allan, Sophia Williams, Allen Rinas, Simon Levin, Jennifer S. Smith. (2010) Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes & Control 21:3, 433-443
CrossRef388
Alcides Chaux, Rolf Pfannl, Belén Lloveras, María Alejo, Omar Clavero, Cecilia Lezcano, Nubia Muñoz, Silvia de Sanjosé, Xavier Bosch, Marier Hernández-Pérez, Elsa F. Velazquez, Antonio L. Cubilla. (2010) Distinctive Association of p16INK4a Overexpression With Penile Intraepithelial Neoplasia Depicting Warty and/or Basaloid Features: A Study of 141 Cases Evaluating a New Nomenclature. The American Journal of Surgical Pathology 34:3, 385-392
CrossRef389
Charlene Wong, Jamie Krashin, Alison Rue-Cover, Mona Saraiya, Elizabeth Unger, Angela Calugar, Lauri Markowitz. (2010) Invasive and In Situ Cervical Cancer Reported to the Vaccine Adverse Event Reporting System (VAERS). Journal of Women's Health 19:3, 365-370
CrossRef390
Sharmila Pimple, Richard Muwonge, Geetanjali Amin, Smriti Goswami, Rengaswamy Sankaranarayanan, Surendra S. Shastri. (2010) Cytology versus HPV testing for the detection of high-grade cervical lesions in women found positive on visual inspection in Mumbai, India. International Journal of Gynecology & Obstetrics 108:3, 236-239
CrossRef391
Nathalie Dauphin McKenzie, Erin N. Kobetz, James Hnatyszyn, Leo B. Twiggs, Joseph A. Lucci III. (2010) Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecologic Oncology 116:3, 572-577
CrossRef392
Yusuke Hiraku. (2010) Formation of 8-nitroguanine, a nitrative DNA lesion, in inflammation-related carcinogenesis and its significance. Environmental Health and Preventive Medicine 15:2, 63-72
CrossRef393
Mina Kalantari, Dana M. Chase, Krishnansu S. Tewari, Hans-Ulrich Bernard. (2010) Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: A pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression. Journal of Medical Virology 82:2, 311-320
CrossRef394
Leszek K Borysiewicz. (2010) Prevention is better than cure. The Lancet 375:9713, 513-523
CrossRef395
Theodoros Agorastos, Alexandros Sotiriadis, Christos J. Emmanouilides. (2010) Effect of Type-Specific Human Papillomavirus Incidence on Screening Performance and Cost. International Journal of Gynecological Cancer 20:2, 276-282
CrossRef396
Marjan Javanbakht, Pamina M. Gorbach, Bita Amani, Susan Walker, Ross D. Cranston, S Deblina Datta, Peter R. Kerndt. (2010) Concurrency, Sex Partner Risk, and High-Risk Human Papillomavirus Infection Among African American, Asian, and Hispanic Women. Sexually Transmitted Diseases 37:2, 68-74
CrossRef397
Luciana Yuki Tomita, Adhemar Longatto Filho, Maria CecÃlia Costa, Maria Antonieta Avilla Andreoli, Luisa Lina Villa, Eduardo Luiz Franco, Marly Augusto Cardoso. (2010) Diet and serum micronutrients in relation to cervical neoplasia and cancer among low-income Brazilian women. International Journal of Cancer 126:3, 703-714
CrossRef398
J. Kathleen Tracy, Alison D. Lydecker, Lynda Ireland. (2010) Barriers to Cervical Cancer Screening Among Lesbians. Journal of Women's Health 19:2, 229-237
CrossRef399
Jen-Yu Tseng, Ming-Shien Yen, Nae-Fong Twu, Chiung-Ru Lai, Huann-Cheng Horng, Chien-Chih Tseng, Kuan-Chong Chao, Chi-Mou Juang. (2010) Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy. American Journal of Obstetrics and Gynecology 202:2, 174.e1-174.e7
CrossRef400
Raffaella Ghittoni, Rosita Accardi, Uzma Hasan, Tarik Gheit, Bakary Sylla, Massimo Tommasino. (2010) The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 40:1, 1-13
CrossRef401
Neerja Bhatla, Vanita Suri, Partha Basu, Surendra Shastri, Sanjoy K. Datta, Dan Bi, Dominique J. Descamps, Hans L. Bock, . (2010) Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women. Journal of Obstetrics and Gynaecology Research 36:1, 123-132
CrossRef402
Koenraad Van Doorslaer, Laura L. Reimers, Yevgeniy Y. Studentsov, Mark H. Einstein, Robert D. Burk. (2010) Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia. Gynecologic Oncology 116:2, 208-212
CrossRef403
Ji Eun Han, Hye Kyeong Kim, Shin Ae Park, Seung Jae Lee, Hyoung Jin Kim, Ga Hyun Son, Young Tae Kim, Yang Je Cho, Hong-Jin Kim, Na Gyong Lee. (2010) A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil® HPV vaccine in mice. International Immunopharmacology 10:2, 169-176
CrossRef404
Kymberlee Montgomery, Joan Rosen Bloch. (2010) The human papillomavirus in women over 40: Implications for practice and recommendations for screening. Journal of the American Academy of Nurse Practitioners 22:2, 92-100
CrossRef405
P. E. Castle, M. Schiffman, C. M. Wheeler, N. Wentzensen, P. E. Gravitt. (2010) Impact of Improved Classification on the Association of Human Papillomavirus With Cervical Precancer. American Journal of Epidemiology 171:2, 155-163
CrossRef406
E. L. Franco, J. Tota. (2010) Invited Commentary: Human Papillomavirus Infection and Risk of Cervical Precancer--Using the Right Methods to Answer the Right Questions. American Journal of Epidemiology 171:2, 164-168
CrossRef407
Paul K.S. Chan, Alexander R. Chang, Mei Y. Yu, Wai-Hon Li, May Y.M. Chan, Apple C.M. Yeung, Tak-Hong Cheung, Tat-Nga Yau, Sze-Man Wong, Ching-Wai Yau, Ho-Keung Ng. (2010) Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies. International Journal of Cancer 126:1, 297-301
CrossRef408
Dong-Hyun Kim, Roger M. Jarvis, Yun Xu, Anthony W. Oliver, J. William Allwood, Lynne Hampson, Ian N. Hampson, Royston Goodacre. (2010) Combining metabolic fingerprinting and footprinting to understand the phenotypic response of HPV16 E6 expressing cervical carcinoma cells exposed to the HIV anti-viral drug lopinavir. The Analyst 135:6, 1235
CrossRef409
Philippe Halfon, Dominique Benmoura, Hacene Khiri, Guillaume Penaranda, Bernard Blanc, Daniela Riggio, Maria Teresa Sandri. (2010) Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck® HPV-screening assay. Journal of Clinical Virology 47:1, 38-42
CrossRef410
Choong-Hak Park, Jae-Kyoung Kim. (2010) Detection of human papillomavirus type 16 and 18 by PCR in patients with cervical neoplasia. Korean Journal of Obstetrics and Gynecology 53:10, 894
CrossRef411
Suk-Bae Moon, Sang-Hee Moon, Kyu-Joo Park. (2010) Detection and Typing of Human Papillomavirus in Anal Condyloma Acuminatum of HIV-positive Patients. Journal of the Korean Surgical Society 78:2, 111
CrossRef412
Ingrid T. Katz, Norma C. Ware, Glenda Gray, Jessica E. Haberer, Claude A. Mellins, David R. Bangsberg. (2010) Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sexual Health 7:3, 279
CrossRef413
Satoyo Hosono, Takakazu Kawase, Keitaro Matsuo, Miki Watanabe, Hiroaki Kajiyama, Kaoru Hirose, Takeshi Suzuki, Kumiko Kidokoro, Hidemi Ito, Toru Nakanishi, Yasushi Yatabe, Nobuyuki Hamajima, Fumitaka Kikkawa, Kazuo Tajima, Hideo Tanaka. (2010) HLA-A Alleles and the Risk of Cervical Squamous Cell Carcinoma in Japanese Women. Journal of Epidemiology 20:4, 295-301
CrossRef414
Aimée R. Kreimer, Rohini K. Bhatia, Andrea L. Messeguer, Paula González, Rolando Herrero, Anna R. Giuliano. (2010) Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the Literature. Sexually Transmitted Diseases1
CrossRef415
Maher A. Sughayer, Mohammad Abdelhadi, Ghadeer Abdeen, Lian Otay, Tasnim Dayeh. (2010) Human papillomavirus genotypes in invasive cervical cancer in Jordan. International Journal of Gynecology & Obstetrics 108:1, 74-75
CrossRef416
Alison C. Budd, Christine J. Sturrock. (2010) Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination. Sexual Health 7:3, 328
CrossRef417
Kyung-Tae Kim, Chan Hyun Na, Yeo Min Yun, Tae Sook Hwang, Soo Nyung Kim, Chi-Bom Chae. (2010) Dramatic increase in signal by integration of polymerase chain reaction and hybridization on surface of DNA microarray. Analytical Biochemistry 396:1, 139-145
CrossRef418
M. J. Thun, J. O. DeLancey, M. M. Center, A. Jemal, E. M. Ward. (2010) The global burden of cancer: priorities for prevention. Carcinogenesis 31:1, 100-110
CrossRef419
Xia Liu, Shulan Zhang, Qiang Ruan, Yaohua Ji, Li Ma, Yao Zhang. (2010) Prevalence and Type Distribution of Human Papillomavirus in Women With Cervical Lesions in Liaoning Province, China. International Journal of Gynecological Cancer 20:1, 147-153
CrossRef420
Joo hyeon Jeong, Hyun Yee Cho, Na Rae Kim, Dong Hae Chung, Sanghui Park, Seung Yeon Ha. (2010) The Analysis and Clinical Usefulness of HPV DNA Chip Test in the Uterine Cervix. The Korean Journal of Pathology 44:1, 77
CrossRef421
Antonio L. Cubilla, Belén Lloveras, María Alejo, Omar Clavero, Alcides Chaux, Elena Kasamatsu, Elsa F. Velazquez, Cecilia Lezcano, Núria Monfulleda, Sara Tous, Laia Alemany, Joellen Klaustermeier, Nubia Muñoz, Wim Quint, Silvia de Sanjose, Francisco Xavier Bosch. (2010) The Basaloid Cell is the Best Tissue Marker for Human Papillomavirus in Invasive Penile Squamous Cell Carcinoma: A Study of 202 Cases From Paraguay. The American Journal of Surgical Pathology 34:1, 104-114
CrossRef422
Philippe Beutels, Mark Jit. (2010) A brief history of economic evaluation for human papillomavirus vaccination policy. Sexual Health 7:3, 352
CrossRef423
Jill Koshiol, Wen-Qiang Wei, Aimee R. Kreimer, Wen Chen, Patti Gravitt, Jian-Song Ren, Christian C. Abnet, Jian-Bing Wang, Farin Kamangar, Dong-Mei Lin, Magnus von Knebel-Doeberitz, Yu Zhang, Raphael Viscidi, Guo-Qing Wang, Maura L. Gillison, Mark J. Roth, Zhi-Wei Dong, Esther Kim, Philip R. Taylor, You-Lin Qiao, Sanford M. Dawsey. (2010) No role for human papillomavirus in esophageal squamous cell carcinoma in China. International Journal of CancerNA-NA
CrossRef424
Sharon Nofech-Mozes, Mahmoud M. Khalifa, Nadia Ismiil, Valerie Dubé, Reda S. Saad, Peizhu Sun, Arun Seth, Zeina Ghorab. (2010) Detection of HPV-DNA by a PCR-based Method in Formalin-fixed, Paraffin-embedded Tissue From Rare Endocervical Carcinoma Types. Applied Immunohistochemistry & Molecular Morphology 18:1, 80-85
CrossRef425
Kaori OKAYAMA, Mitsuaki OHKODO, Tomoko KUMAGAI, Hiromi YABUSAKI, Haruki YOSHINAGA, Tadashi FUKUI, Masahiko FUJII. (2010) New cell findings on low-grade squamous intraepithelial lesions (LSIL)-minimizing the atypical squamous cells of undetermined significance (ASC-US) diagnosis rates-. The Journal of the Japanese Society of Clinical Cytology 49:5, 321-329
CrossRef426
Mary Cairns, Kate S. Cuschieri, Heather A. Cubie, Margaret E. Cruickshank. (2010) High-Risk HPV Genotyping in the Follow-Up of Women Treated Conservatively for Microinvasive Cervical Cancer. International Journal of Gynecological Cancer 20:1, 154-157
CrossRef427
Ann N. Burchell, Pierre-Paul Tellier, James Hanley, François Coutlée, Eduardo L. Franco. (2010) Influence of Partnerʼs Infection Status on Prevalent Human Papillomavirus Among Persons With a New Sex Partner. Sexually Transmitted Diseases 37:1, 34-40
CrossRef428
Sepehr N. Tabrizi, Irwin Law, Eka Buadromo, Matthew P. Stevens, James Fong, Josaia Samuela, Mahomed Patel, E. Kim Mulholland, Fionna M. Russell, Suzanne M. Garland. (2010) Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Fiji. Sexual Health
CrossRef429
Suzanne M. Garland, Julia M. L. Brotherton, Christopher K. Fairley, Dorota M. Gertig, Marion Saville. (2010) Advancements in the control of genital human papillomavirus infections and related diseases: highlighting Australia's role. Sexual Health 7:3, 227
CrossRef430
Ian H. Frazer. (2010) Cervical cancer vaccine development. Sexual Health 7:3, 230
CrossRef431
Walayat Shah, Xiaofei Yan, Li Jing, Yi Zhou, Hongwei Chen, Yili Wang. (2010) A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cellular and Molecular Immunology 8:1, 59-66
CrossRef432
Kiyoshi Misawa, Hiroyuki Mineta. (2010) Human papilloma virus vaccine. Toukeibu Gan 36:4, 456-460
CrossRef433
Antonio Bazarra-Fernandez. (2010) Cervical cancer: education for everybody. Procedia - Social and Behavioral Sciences 2:2, 229-233
CrossRef434
Sally L. Hodder, Debra Chew, Shobha Swaminathan. 2010. Adult Immunization in Women and Men. , 563-582.
CrossRef435
James L. Klosky, Heather L. Gamble, Sheri L. Spunt, Mary E. Randolph, Daniel M. Green, Melissa M. Hudson. (2009) Human papillomavirus vaccination in survivors of childhood cancer. Cancer 115:24, 5627-5636
CrossRef436
Emma L. Ivansson, Inger M. Gustavsson, Erik Wilander, Patrik K.E. Magnusson, Ulf B. Gyllensten. (2009) Temporal trends over 3 decades and intrafamilial clustering of HPV types in Swedish patients with cervical cancer in situ. International Journal of Cancer 125:12, 2930-2935
CrossRef437
Ivan Sabol, Maja Čretnik, Ita Hadžisejdić, Ali Si-Mohamed, Mihaela Matovina, Blaženka Grahovac, Sonja Levanat, Magdalena Grce. (2009) A new approach for the evaluation of the human papillomavirus type 16 variability with high resolution melting analysis. Journal of Virological Methods 162:1-2, 142-147
CrossRef438
Rosemary E. Zuna, William E. Moore, Rebecca P. Shanesmith, S. Terence Dunn, Sophia S. Wang, Mark Schiffman, Gregory L. Blakey, Travis Teel. (2009) Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. International Journal of Cancer 125:11, 2609-2613
CrossRef439
Shishir Kumar Gupta, Archana Singh, Mugdha Srivastava, Shailendra K. Gupta, Bashir Akhlaq Akhoon. (2009) In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer. Vaccine 28:1, 120-131
CrossRef440
Stina Syrjänen, Paulo Naud, Luis Sarian, Sophie Derchain, Cecilia Roteli-Martins, Adhemar Longatto-Filho, Silvio Tatti, Margherita Branca, Mojca Eržen, L. S. Hammes, S. Costa, Kari Syrjänen. (2009) Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort. Virchows Archiv 455:6, 505-515
CrossRef441
Neerja Bhatla, Lalit Dar, A. Rajkumar Patro, Pankaj Kumar, Alka Kriplani, Arti Gulati, Venkateswaran K. Iyer, Sandeep R. Mathur, Vishnubhatla Sreenivas, Keerti V. Shah. (2009) Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?. Cancer Epidemiology 33:6, 446-450
CrossRef442
Eleni Papachristou, Vana Sypsa, Dimitrios Paraskevis, Athanasios Gkekas, Ekaterini Politi, Electra Nicolaidou, Ioannis Anifantis, Mina Psichogiou, Artemis Tsitsika, Maria Hadjivassiliou, Georgios Petrikkos, Andreas Katsambas, Georgios Creatsas, Angelos Hatzakis. (2009) Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test. Journal of Medical Virology 81:12, 2059-2065
CrossRef443
Charles A. Kunos, Song-mao Chiu, John Pink, Timothy J. Kinsella. (2009) Modulating Radiation Resistance by Inhibiting Ribonucleotide Reductase in Cancers with Virally or Mutationally Silenced p53 Protein. Radiation Research 172:6, 666-676
CrossRef444
Walayat Shah, Chen Hongwei, Zheng Jin, Dong Lifang, Yu Jun, Wang Yili. (2009) The Prevalence of Human Papillomavirus Type 58 in Chinese Patients with Cervical Carcinoma and its Influence on Survival. Clinical Oncology 21:10, 768-774
CrossRef445
R.U. Wahl, R. Knückel, M. Megahed. (2009) HPV-Typ-33-assoziierte intraepitheliale Neoplasie des Penis (PIN). Der Hautarzt 60:12, 952-954
CrossRef446
Nelson R. Tirone, Bethanea C. Peghini, Ana Cristina M. Barcelos, Eddie F. C. Murta, Marcia A. Michelin. (2009) Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia. Cancer Immunology, Immunotherapy 58:12, 2003-2010
CrossRef447
Noha Hassuna, Peter N. Monk, Gregory W. Moseley, Lynda J. Partridge. (2009) Strategies for Targeting Tetraspanin Proteins. BioDrugs 23:6, 341-359
CrossRef448
V. Kaliterna, S. Zidovec Lepej, A. Vince. (2009) Comparison between the Abbott RealTime High Risk HPV assay and the Hybrid Capture 2 assay for detecting high-risk human papillomavirus DNA in cervical specimens. Journal of Medical Microbiology 58:12, 1662-1663
CrossRef449
A. Kreuter, T. Gambichler, H. Pfister, U. Wieland. (2009) Diversity of human papillomavirus types in periungual squamous cell carcinoma. British Journal of Dermatology 161:6, 1262-1269
CrossRef450
(2009) Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years. The Lancet 374:9706, 1975-1985
CrossRef451
Silvia Franceschi, Jack Cuzick, Rolando Herrero, Joakim Dillner, Cosette M. Wheeler. (2009) EUROGIN 2008 roadmap on cervical cancer prevention. International Journal of Cancer 125:10, 2246-2255
CrossRef452
R Zhao, W Y Zhang, M H Wu, S W Zhang, J Pan, L Zhu, Y P Zhang, H Li, Y S Gu, X Z Liu. (2009) Human papillomavirus infection in Beijing, People's Republic of China: a population-based study. British Journal of Cancer 101:9, 1635-1640
CrossRef453
D.T. Geraets, D.A.M. Heideman, M.N.C. de Koning, P.J.F. Snijders, C.J.L.M. Meijer, L.J. van Doorn, W.G.V. Quint. (2009) High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products. Journal of Clinical Virology 46, S16-S20
CrossRef454
A. Hornemann, M.K. Bohlmann, K. Diedrich, A. Kavallaris. (2009) Prävention des Zervixkarzinoms. Der Gynäkologe 42:11, 853-858
CrossRef455
C. E. Lange, K. Tobler, M. Ackermann, L. Panakova, K. L. Thoday, C. Favrot. (2009) Three novel canine papillomaviruses support taxonomic clade formation. Journal of General Virology 90:11, 2615-2621
CrossRef456
E. Galani, C. Christodoulou. (2009) Human papilloma viruses and cancer in the post-vaccine era. Clinical Microbiology and Infection 15:11, 977-981
CrossRef457
C.J.L.M. Meijer, H. Berkhof, D.A.M. Heideman, A.T. Hesselink, P.J.F. Snijders. (2009) Validation of high-risk HPV tests for primary cervical screening. Journal of Clinical Virology 46, S1-S4
CrossRef458
Theodoros Agorastos, Alexandros F. Lambropoulos, Alexandros Sotiriadis, Themistoklis Mikos, Eleonora Togaridou, Christos J. Emmanouilides. (2009) Prevalence and distribution of high-risk human papillomavirus in Greece. European Journal of Cancer Prevention 18:6, 504-509
CrossRef459
Alp Usubütün, Laia Alemany, Türkan Küçükali, Ali Ayhan, Kunter Yüce, Silvia de Sanjosé, Rebeca Font, Belen Lloveras, JoEllen Klaustermeier, Wim Quint, Nubia Muñoz, Francesc Xavier Bosch. (2009) Human Papillomavirus Types in Invasive Cervical Cancer Specimens From Turkey. International Journal of Gynecological Pathology 28:6, 541-548
CrossRef460
Barbara Dal Bello, Arsenio Spinillo, Paola Alberizzi, Stefania Cesari, Barbara Gardella, Enrico Maria Silini. (2009) Time trends of human papillomavirus type distribution in Italian women with cervical intraepithelial neoplasia (CIN). Gynecologic Oncology 115:2, 262-266
CrossRef461
Wen Chen, Xun Zhang, Anco Molijn, David Jenkins, Ju-Fang Shi, Wim Quint, Johannes E. Schmidt, Ping Wang, Yu-Ling Liu, Lian-Kun Li, Hong Shi, Ji-Hong Liu, Xing Xie, Mayinuer Niyazi, Pei Yang, Li-Hui Wei, Long-Yu Li, Jie Li, Jin-Feng Liu, Qi Zhou, Ying Hong, Li Li, Qing Li, Hong-Lin Zhou, Mei-Lu Bian, Jing Chen, You-Lin Qiao, Jennifer S. Smith. (2009) Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes & Control 20:9, 1705-1713
CrossRef462
Eileen F. Dunne, Carrie M. Nielson, Michael E. Hagensee, Mary R. Papenfuss, Robin B. Harris, Nicholas Herrel, Jennifer Gourlie, Martha Abrahamsen, Lauri E. Markowitz, Anna R. Giuliano. (2009) HPV 6/11, 16, 18 Seroprevalence in Men in Two US Cities. Sexually Transmitted Diseases 36:11, 671-674
CrossRef463
Yu-Yun Hsu, Susan Jane Fetzer, Keng-Fu Hsu, Yuan-Yuan Chang, Chih-Pyng Huang, Cheng-Yang Chou. (2009) Intention to Obtain Human Papillomavirus Vaccination Among Taiwanese Undergraduate Women. Sexually Transmitted Diseases 36:11, 686-692
CrossRef464
C.-Z. Li, Z.-B. Wang, X. Yang, Y. Tang, D. Wang, Y. Huang, X.-F. Fan. (2009) Feasibility of focused ultrasound therapy for recurrent cervicitis with high-risk human papillomavirus infection. Ultrasound in Obstetrics and Gynecology 34:5, 590-594
CrossRef465
Noé Velázquez-Márquez, María Antonia Paredes-Tello, Héctor Pérez-Terrón, Gerardo Santos-López, Julio Reyes-Leyva, Verónica Vallejo-Ruiz. (2009) Prevalence of human papillomavirus genotypes in women from a rural region of Puebla, Mexico. International Journal of Infectious Diseases 13:6, 690-695
CrossRef466
Mizuho Futai, Jun Watanabe, Toshiko Jobo, Shinpei Tsunoda, Yukari Nishimura, Kayoko Watanabe, Isao Okayasu, Nobuya Unno. (2009) Clinical Significance of Human Papillomavirus Genotype by Linear Array Assay in Japanese Women With Uterine Cervical Lesions and Type 16 Physical Status by In Situ Hybridization. International Journal of Gynecological Cancer 19:8, 1396-1401
CrossRef467
Chih-Hsien Liao, Jin-Tan Liu, Raoh-Fang Pwu, San-Lin You, Ines Chow, Chao-Hsiun Tang. (2009) Valuation of the Economic Benefits of Human Papillomavirus Vaccine in Taiwan. Value in Health 12, S74-S77
CrossRef468
Roberta B. Ness, Elizabeth B. Andrews, James A. Gaudino, Anne B. Newman, Colin L. Soskolne, Til Stürmer, Daniel E. Wartenberg, Stanley H. Weiss. (2009) The Future of Epidemiology. Academic Medicine 84:11, 1631-1637
CrossRef469
Mingjun Jiang, Long Fu Xi, Zoe R. Edelstein, Denise A. Galloway, Gary J. Olsem, William Chun-Che Lin, Nancy B. Kiviat. (2009) Identification of recombinant human papillomavirus type 16 variants. Virology 394:1, 8-11
CrossRef470
D.T. Geraets, D.A.M. Heideman, M.N.C. de Koning, P.J.F. Snijders, D.C.J.G. van Alewijk, C.J.L.M. Meijer, L.J. van Doorn, W.G.V. Quint. (2009) High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology. Journal of Clinical Virology 46, S21-S26
CrossRef471
Annie-Laurie McRee, Noel T. Brewer, Paul L. Reiter, Sami L. Gottlieb, Jennifer S. Smith. (2009) The Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS): Scale Development and Associations With Intentions to Vaccinate. Sexually Transmitted Diseases1
CrossRef472
Zigui Chen, Koenraad van Doorslaer, Rob DeSalle, Charles E. Wood, Jay R. Kaplan, Janice D. Wagner, Robert D. Burk. (2009) Genomic diversity and interspecies host infection of α12 Macaca fascicularis papillomaviruses (MfPVs). Virology 393:2, 304-310
CrossRef473
Kari J. Syrjänen. (2009) Annual disease burden due to human papillomavirus 16 and 18 infections in Finland. Scandinavian Journal of Infectious Diseases 41:s108, 2-32
CrossRef474
Ann Nielsen, Thomas Iftner, Christian Munk, Susanne K. Kjaer. (2009) Acquisition of High-Risk Human Papillomavirus Infection in a Population-Based Cohort of Danish Women. Sexually Transmitted Diseases 36:10, 609-615
CrossRef475
Katja Seme, Snježana Židovec Lepej, Maja M. Lunar, Janja Iščić-Beš, Ana Planinić, Boštjan J. Kocjan, Adriana Vince, Mario Poljak. (2009) Digene HPV Genotyping RH Test RUO: Comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes. Journal of Clinical Virology 46:2, 176-179
CrossRef476
Jin Hwa Hong, Jae Kwan Lee, Eun-Seop Song, Jong-Min Lee, Mi Kyung Kim. (2009) Evaluation of the compatibility of the Digene media when performing the Roche linear array human papillomavirus genotyping test. Archives of Gynecology and Obstetrics 280:4, 613-618
CrossRef477
Paul K.S. Chan, Wendy C.S. Ho, Mei-Yung Yu, Wai-Mei Pong, Alexander C.L. Chan, Amanda K.C. Chan, Tak-Hong Cheung, Martin C.S. Wong, Ka-Fai To, Ho-Keung Ng. (2009) Distribution of human papillomavirus types in cervical cancers in Hong Kong: Current situation and changes over the last decades. International Journal of Cancer 125:7, 1671-1677
CrossRef478
H. Roggendorf. (2009) Erste Erfahrungen zur Akzeptanz der HPV-Impfung. Monatsschrift Kinderheilkunde 157:10, 982-985
CrossRef479
Gary Michael Ginsberg, Tessa Tan-Torres Edejer, Jeremy A. Lauer, Cecilia Sepulveda. (2009) Screening, prevention and treatment of cervical cancer—A global and regional generalized cost-effectiveness analysis. Vaccine 27:43, 6060-6079
CrossRef480
Inger Gustavsson, Monica Lindell, Erik Wilander, Anders Strand, Ulf Gyllensten. (2009) Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. Journal of Clinical Virology 46:2, 112-116
CrossRef481
Florian Bergauer, Ansgar Brüning, Naim Shabani, Thomas Blankenstein, Julia Jückstock, Darius Dian, Ioannis Mylonas. (2009) Inhibin/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines. Journal of Molecular Histology 40:5-6, 353-359
CrossRef482
P. Saiag, A. Bauhofer, F. Bouscarat, C. Aquilina, J.P. Ortonne, N. Dupin, C. Mougin. (2009) Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study. British Journal of Dermatology 161:4, 904-909
CrossRef483
Franco Maria Buonaguro, Maria Lina Tornesello, Luigi Buonaguro. (2009) Virus-like particle vaccines and adjuvants: the HPV paradigm. Expert Review of Vaccines 8:10, 1379-1398
CrossRef484
FATIMA GALAN-SANCHEZ, MANUEL A. RODRIGUEZ-IGLESIAS. (2009) Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods. APMIS 117:10, 708-715
CrossRef485
Lidia Rosi Medeiros, Daniela Dornelles Rosa, Maria Inês da Rosa, Mary Clarisse Bozzetti, Roselaine Ruviaro Zanini. (2009) Efficacy of Human Papillomavirus Vaccines. International Journal of Gynecological Cancer 19:7, 1166-1176
CrossRef486
Marc Gottschling, Markus Göker, Anja Köhler, Mandy D Lehmann, Eggert Stockfleth, Ingo Nindl. (2009) Cutaneotropic Human β-/γ-Papillomaviruses Are Rarely Shared between Family Members. Journal of Investigative Dermatology 129:10, 2427-2434
CrossRef487
Anette Duensing, Nicole Spardy, Payel Chatterjee, Leon Zheng, Joshua Parry, Rolando Cuevas, Nina Korzeniewski, Stefan Duensing. (2009) Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins. Environmental and Molecular Mutagenesis 50:8, 741-747
CrossRef488
(2009) 41 st National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, 2nd Joint National Event SIBioC-SIMeL. Clinical Chemistry and Laboratory Medicine 47:10, A103-A124
CrossRef489
John A. Vernon, Michael Payette, Abhishek Chatterjee. (2009) Social Welfare and Adolescent Vaccination Programs in the United States: The Economic Opportunities for a Systematic Expansion. Social Work in Public Health 24:5, 414-445
CrossRef490
Roman Prymula, Ioana Anca, Francis André, Mustafa Bakir, Hanna Czajka, Irja Lutsar, Zsófia Mészner, Nuran Salman, Pavol Šimurka, Vytautas Usonis. (2009) Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for the introduction of HPV vaccines. European Journal of Pediatrics 168:9, 1031-1035
CrossRef491
Divya A. Patel, Yang-Jen Shih, Duane W. Newton, Claire W. Michael, Paul A. Oeth, Michael D. Kane, Anthony W. Opipari, Mack T. Ruffin, IV, Linda M. Kalikin, David M. Kurnit. (2009) Development and evaluation of a PCR and mass spectroscopy (PCR–MS)-based method for quantitative, type-specific detection of human papillomavirus. Journal of Virological Methods 160:1-2, 78-84
CrossRef492
Eduardo L. Franco, Jorn Olsen, Rodolfo Saracci, Roger Detels. (2009) Epidemiologyʼs Contributions to a Nobel Prize Recognition. Epidemiology 20:5, 632-634
CrossRef493
Dagistan Tolga Arioz, Mustafa Altindis, Cigdem Tokyol, Raike Kalayci, Arif Saylan, Mehmet Yilmazer. (2009) Human papillomavirus typing and soluble interleukin-2 receptor levels in female sex workers with a negative cervical smear result. International Journal of Gynecology & Obstetrics 106:3, 210-212
CrossRef494
Yanyan Qiao, Jinyan Cao, Liangqun Xie, Xiaolin Shi. (2009) Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells. Archives of Pharmacal Research 32:9, 1309-1315
CrossRef495
Toro Méndez Morelva, Llombart Bosch Antonio. (2009) Immunohistochemical expression of ubiquitin and telomerase in cervical cancer. Virchows Archiv 455:3, 235-243
CrossRef496
Ying Ding, See Voon Seow, Chiung Hui Huang, Lee Mei Liew, Yaw Chyn Lim, I. Chun Kuo, Kaw Yan Chua. (2009) Coadministration of the fungal immunomodulatory protein FIP-Fve and a tumour-associated antigen enhanced antitumour immunity. Immunology 128:1pt2, e881-e894
CrossRef497
L. Pye. (2009) Human papillomavirus, genital warts and vaccination. InnovAiT 2:9, 522-529
CrossRef498
Xavier Vallès, Gladys Beatriz Murga, Gabriela Hernández, Meritxell Sabidó, Alejandro Chuy, Belén Lloveras, Francesc Alameda, Sílvia de San José, Francesc Xavier Bosch, Isabel Pedroza, Xavier Castellsagué, Jordi Casabona. (2009) High prevalence of human papillomavirus infection in the female population of Guatemala. International Journal of Cancer 125:5, 1161-1167
CrossRef499
Christine C. Roberts, Kai-Li Liaw, Finn Egil Skjeldestad, Kathrin U. Jansen, Janine T. Bryan. (2009) Importance of specimen type in detecting human papillomavirus DNA from the female genital tract. Journal of Medical Virology 81:9, 1620-1626
CrossRef500
A. Köhler, T. Meyer, E. Stockfleth, I. Nindl. (2009) High viral load of human wart-associated papillomaviruses (PV) but not β-PV in cutaneous warts independent of immunosuppression. British Journal of Dermatology 161:3, 528-535
CrossRef501
Valeria Cento, Massimo Ciccozzi, Luigi Ronga, Carlo Federico Perno, Marco Ciotti. (2009) Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions. Journal of Medical Virology 81:9, 1627-1634
CrossRef502
Jill Barnholtz-Sloan, Nitin Patel, Dana Rollison, Karl Kortepeter, Jill MacKinnon, Anna Giuliano. (2009) Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes & Control 20:7, 1129-1138
CrossRef503
Christophe E. Depuydt, Marc Arbyn, Ina H. Benoy, Johan Vandepitte, Annie J. Vereecken, Johannes J. Bogers. (2009) Quality control for normal liquid-based cytology: Rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection?. Journal of Cellular and Molecular Medicine 13:9b, 4051-4060
CrossRef504
Paul K.S. Chan, Wendy C.S. Ho, Martin C.S. Wong, Alexander R. Chang, Josette S.Y. Chor, Mei-Yung Yu. (2009) Epidemiologic risk profile of infection with different groups of human papillomaviruses. Journal of Medical Virology 81:9, 1635-1644
CrossRef505
S Brismar-Wendel, M Froberg, A Hjerpe, S Andersson, B Johansson. (2009) Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions. British Journal of Cancer 101:3, 511-517
CrossRef506
Partha Basu, Hextan Yuen Sheung Ngan, Tay Eng Hseon, . (2009) HPV vaccination in women over 25 years of age: Asian Cervical Cancer Prevention Advisory Board recommendations. Journal of Obstetrics and Gynaecology Research 35:4, 712-716
CrossRef507
Laura Selva, Eduardo Gonzalez-Bosquet, Maria T. Rodriguez-Plata, Cristina Esteva, Mariona Suñol, Carmen Muñoz-Almagro. (2009) Detection of human papillomavirus infection in women attending a colposcopy clinic. Diagnostic Microbiology and Infectious Disease 64:4, 416-421
CrossRef508
Min-Zhu Huang, Hong-Bo Li, Xin-Min Nie, Xiao-Man Jiang, Hui Ming, Deng-Qing Li, Xin-Yin Wu. (2009) Analysis of the dose-response relationship between high-risk human papillomavirus viral load and cervical lesions. Transactions of the Royal Society of Tropical Medicine and Hygiene 103:8, 779-784
CrossRef509
Vicente Madrid-Marina, Kirvis Torres-Poveda, Gabriela López-Toledo, Alejandro García-Carrancá. (2009) Advantages and Disadvantages of Current Prophylactic Vaccines Against HPV. Archives of Medical Research 40:6, 471-477
CrossRef510
Iyabode Akinsanya-Beysolow, Charles (Skip) Wolfe. (2009) Update: Vaccines for Women, Adolescence through Adulthood. Journal of Women's Health 18:8, 1101-1108
CrossRef511
J. Jamison, R. T. Wilson, J. Carson. (2009) The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay. Cytopathology 20:4, 242-248
CrossRef512
Mina Kalantari, Alejandro Garcia-Carranca, Claudia Dalia Morales-Vazquez, Rosemary Zuna, Delia Perez Montiel, Itzel E. Calleja-Macias, Bo Johansson, Sonia Andersson, Hans-Ulrich Bernard. (2009) Laser capture microdissection of cervical human papillomavirus infections: Copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. Virology 390:2, 261-267
CrossRef513
Nina Jančar, Boštjan J. Kocjan, Mario Poljak, Maja M. Lunar, Eda Vrtačnik Bokal. (2009) Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia. European Journal of Obstetrics & Gynecology and Reproductive Biology 145:2, 184-188
CrossRef514
Veerle M.H. Coupé, H.E. de Melker, Peter J.F. Snijders, Chris J.L.M. Meijer, Johannes Berkhof. (2009) How to screen for cervical cancer after HPV16/18 vaccination in The Netherlands. Vaccine 27:37, 5111-5119
CrossRef515
Nicoletta Termine, Lucia Giovannelli, Domenica Matranga, Antonio Perino, Vera Panzarella, Pietro Ammatuna, Matteo D'Angelo, Giuseppina Campisi. (2009) Low rate of oral human papillomavirus (HPV) infection in women screened for cervical HPV infection in Southern Italy: A cross-sectional study of 140 immunocompetent subjects. Journal of Medical Virology 81:8, 1438-1443
CrossRef516
Marcela Lizano, Jaime Berumen, Alejandro García-Carrancá. (2009) HPV-related Carcinogenesis: Basic Concepts, Viral Types and Variants. Archives of Medical Research 40:6, 428-434
CrossRef517
Elisa Leo, Simona Venturoli, Monica Cricca, Monica Musiani, Marialuisa Zerbini. (2009) High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. Journal of Clinical Virology 45:4, 304-310
CrossRef518
Paivi Rahkola, Tomi S. Mikkola, Olavi Ylikorkala, Mervi Vaisanen-Tommiska. (2009) Association between high risk papillomavirus DNA and nitric oxide release in the human uterine cervix. Gynecologic Oncology 114:2, 323-326
CrossRef519
Jessica L. Baumann, Seth Cohen, Amy N. Evjen, Jonathan H. Law, Sangeetha Vadivelu, Albert Attia, Joshua S. Schindler, Christine H. Chung, Pamela S. Wirth, Chris J.L.M. Meijer, Peter J.F. Snijders, Wendell G. Yarbrough, Robbert J.C. Slebos. (2009) Human papillomavirus in early laryngeal carcinoma. The Laryngoscope 119:8, 1531-1537
CrossRef520
Patricio Gariglio, Jorge Gutiérrez, Enoc Cortés, Juan Vázquez. (2009) The Role of Retinoid Deficiency and Estrogens as Cofactors in Cervical Cancer. Archives of Medical Research 40:6, 449-465
CrossRef521
Philip E. Castle, Barbara Fetterman, Israh Akhtar, Mujtaba Husain, Michael A. Gold, Richard Guido, Andrew G. Glass, Walter Kinney. (2009) Age-appropriate use of human papillomavirus vaccines in the U.S.. Gynecologic Oncology 114:2, 365-369
CrossRef522
Sara K. Head, Richard A. Crosby, Gregory R. Moore. (2009) Pap Smear Knowledge Among Young Women Following the Introduction of the HPV Vaccine. Journal of Pediatric and Adolescent Gynecology 22:4, 251-256
CrossRef523
Woradee Lurchachaiwong, Pairoj Junyangdikul, Sunchai Payungporn, Jira Chansaenroj, Pichet Sampathanukul, Damrong Tresukosol, Wichai Termrungruanglert, Apiradee Theamboonlers, Yong Poovorawan. (2009) Entire genome characterization of human papillomavirus type 16 from infected Thai women with different cytological findings. Virus Genes 39:1, 30-38
CrossRef524
A. Senéjoux. (2009) Condylomes anaux. Côlon & Rectum 3:3, 146-150
CrossRef525
Antonella Agodi, Martina Barchitta, Nadia La Rosa, Rosalba Cipresso, Mariella Guarnaccia, Melania Caruso, Maria Grazia Castiglione, Giuseppe Ettore, Salvatore Travali. (2009) Human Papillomavirus Infection. International Journal of Gynecological Cancer 19:6, 1094-1098
CrossRef526
HanByoul Cho, Mi Kyung Kim, Jae Kwan Lee, Sung Kyong Son, Kwang-Beom Lee, Jong-Min Lee, Jung Pil Lee, Soo Young Hur, Jae-Hoon Kim. (2009) Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study. Clinical Chemistry and Laboratory Medicine 47:8, 1005-1012
CrossRef527
Meghan Dubina, Gary Goldenberg. (2009) Viral-Associated Nonmelanoma Skin Cancers: A Review. The American Journal of Dermatopathology 31:6, 561-573
CrossRef528
Krisztina Kovács, Alinda D. Varnai, Magdolna Bollmann, Agnes Bankfalvi, Marianna Szendy, Norbert Speich, Christoph Schmitt, László Pajor, Reinhard Bollmann, Ralf Hildenbrand. (2009) A 7.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31 000 women in West Germany. European Journal of Cancer Prevention 18:4, 307-315
CrossRef529
Renata T Simões, Maria Alice G Gonçalves, Erick C Castelli, Celso M Júnior, Jussara S R Bettini, Magali L Discorde, Geraldo Duarte, Silvana M Quintana, Aguinaldo L Simões, Philippe Moreau, Edgardo D Carosella, Edson G Soares, Eduardo A Donadi. (2009) HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Modern Pathology 22:8, 1075-1082
CrossRef530
Yunxia Wang, Ming Chen, Liqun Zhang, Yi Ding, Yang Luo, Qinghua Xu, Jianfeng Shi, Liang Cao, Weiling Fu. (2009) Rapid detection of human papilloma virus using a novel leaky surface acoustic wave peptide nucleic acid biosensor. Biosensors and Bioelectronics 24:12, 3455-3460
CrossRef531
Kahn, Jessica A., . (2009) HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia. New England Journal of Medicine 361:3, 271-278
Full Text532
N Keita, G M Clifford, M Koulibaly, K Douno, I Kabba, M Haba, B S Sylla, F J van Kemenade, P J F Snijders, C J L M Meijer, S Franceschi. (2009) HPV infection in women with and without cervical cancer in Conakry, Guinea. British Journal of Cancer 101:1, 202-208
CrossRef533
Suelen Paesi, Eduardo Pretto Serafini, Fernanda Barea, Sonia Regina Cabral Madi, Sergio Echeverrigaray. (2009) High prevalence of human papillomavirus type 58 in patients with cervical pre-malignant lesions in southern Brazil. Journal of Medical Virology 81:7, 1270-1275
CrossRef534
En-qi Wu, Xiang-hui Yu, Xiao Zha, Guo-nan Zhang, Jin-hua Wang, Ying Fan, Yuan-yu Tang, Zhi-xin Zhao, Yong-ge Wu, Wei Kong. (2009) Distribution of Human Papillomavirus Genotypes in Archival Cervical Lesions in Eastern Inner Mongolian Autonomous Region, China. International Journal of Gynecological Cancer 19:5, 919-923
CrossRef535
Sacha Rothschild, I. Frank Ciernik, Matthias Hartmann, Bernhard Schuknecht, Urs M. Lütolf, Alexander M. Huber. (2009) Cholesteatoma triggering squamous cell carcinoma: case report and literature review of a rare tumor. American Journal of Otolaryngology 30:4, 256-260
CrossRef536
Janel Dockter, Astrid Schroder, Barbara Eaton, Ann Wang, Nathan Sikhamsay, Liezel Morales, Cristina Giachetti. (2009) Analytical characterization of the APTIMA® HPV Assay. Journal of Clinical Virology 45, S39-S47
CrossRef537
Kenneth H Fife, Julia W Wu, Kathleen E Squires, D Heather Watts, Janet W Andersen, Darron R Brown. (2009) Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 51:3, 274-282
CrossRef538
Maxime J. J. Fleury, Antoine Touzé, Marie-Christine Maurel, Thierry Moreau, Pierre Coursaget. (2009) Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications. Protein Science 18:7, 1425-1438
CrossRef539
Sophia Brismar, Bo Johansson, Malin Borjesson, Marc Arbyn, Sonia Andersson. (2009) Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping. American Journal of Obstetrics and Gynecology 201:1, 17.e1-17.e8
CrossRef540
R.M. Rogoza, T.A. Westra, N. Ferko, J.J. Tamminga, M.F. Drummond, T. Daemen, J.C. Wilschut, M.J. Postma. (2009) Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: Adaptation of an existing cohort model to the situation in the Netherlands. Vaccine 27:35, 4776-4783
CrossRef541
Janel Dockter, Astrid Schroder, Craig Hill, Leah Guzenski, Joseph Monsonego, Cristina Giachetti. (2009) Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions. Journal of Clinical Virology 45, S55-S61
CrossRef542
Surasak Wanram, Temduang Limpaiboon, Chanvit Leelayuwat, Pissamai Yuenyao, Donald G. Guiney, Viraphong Lulitanond, Patcharee Jearanaikoon. (2009) The use of viral load as a surrogate marker in predicting disease progression for patients with early invasive cervical cancer with integrated human papillomavirus type 16. American Journal of Obstetrics and Gynecology 201:1, 79.e1-79.e7
CrossRef543
Helen P. Cathro, Theresa Loya, Frederick Dominguez, Susan L. Howe, Renee Howell, Kyle Orndorff, Jessica Moreno, Elena Mendez, Po Chu Fung, Natalie L. Beer, Peter Allen, Alba M. Sosa, Kelly K. Gurka, Mark H. Stoler, Henry F. Frierson. (2009) Human papillomavirus profile of women in Belize City, Belize: correlation with cervical cytopathologic findings. Human Pathology 40:7, 942-949
CrossRef544
Michael Harvey, Spencer Stout, Cindi R. Starkey, Ryan Hendren, Stephanie Holt, Gerald C. Miller. (2009) The clinical performance of Invader® technology and SurePath® when detecting the presence of high-risk HPV cervical infection. Journal of Clinical Virology 45, S79-S83
CrossRef545
Matthew P. Stevens, Suzanne M. Garland, Jeffrey H. Tan, Michael A. Quinn, Rodney W. Petersen, Sepehr N. Tabrizi. (2009) HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia. Journal of Medical Virology 81:7, 1283-1291
CrossRef546
Komsun Suwannarurk, Pairath Tapanadechopol, Junya Pattaraarchachai, Sutatip Bhamarapravati. (2009) Hospital-based prevalence and sensitivity of high-risk human papillomavirus in Thai urban population. Cancer Epidemiology 33:1, 56-60
CrossRef547
(2009) Intratypic Variants of HPV-16 E6jE7 Oncogene Isolated from Sexually High-Risk Women in Busan.. Journal of Life Science 19:6, 765-769
CrossRef548
Ilona Marion, Michael Antoni, Deidre Pereira, William Wohlgemuth, Mary Ann Fletcher, Trudi Simon, Mary Jo O'Sullivan. (2009) Distress, Sleep Difficulty, and Fatigue in Women Co-Infected With HIV and HPV. Behavioral Sleep Medicine 7:3, 180-193
CrossRef549
Tilo Senger, Lysann Schädlich, Lutz Gissmann, Martin Müller. (2009) Enhanced papillomavirus-like particle production in insect cells. Virology 388:2, 344-353
CrossRef550
S. Jagu, B. Karanam, R. Gambhira, S. V. Chivukula, R. J. Chaganti, D. R. Lowy, J. T. Schiller, R. B. S. Roden. (2009) Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines. JNCI Journal of the National Cancer Institute 101:11, 782-792
CrossRef551
Enette van Dyk, Marinda C. Oosthuizen, Anna-Marie Bosman, Pierre J. Nel, David Zimmerman, Estelle H. Venter. (2009) Detection of bovine papillomavirus DNA in sarcoid-affected and healthy free-roaming zebra (Equus zebra) populations in South Africa. Journal of Virological Methods 158:1-2, 141-151
CrossRef552
Stacy M. Dodd, Deidre B. Pereira, Ilona Marion, Michele Andrasik, Rachel Rose, Trudi Simon, Mary Ann Fletcher, Joseph Lucci, Kevin Maher, Mary Jo O’Sullivan, JoNell Efantis-Potter, Michael H. Antoni. (2009) Depressive Symptoms and Cervical Neoplasia in HIV+ Low-Income Minority Women with Human Papillomavirus Infection. International Journal of Behavioral Medicine 16:2, 181-188
CrossRef553
Emilia Bailón Muñoz. (2009) Si es un problema de salud pública, cribemos a la población. Atención Primaria 41:6, 305-307
CrossRef554
Diana E. Wetzler, Mariana Gallo, Riccardo Melis, Tomasso Eliseo, Alejandro D. Nadra, Diego U. Ferreiro, Maurizio Paci, Ignacio E. Sánchez, Daniel O. Cicero, Gonzalo de Prat Gay. (2009) A strained DNA binding helix is conserved for site recognition, folding nucleation, and conformational modulation. Biopolymers 91:6, 432-443
CrossRef555
José Guzmán-Esquivel, Alicia Martínez-Contreras, Mario Ramírez-Flores, Lilia M. Jiménez Ceja, Ivan Delgado-Enciso, Sandra Martínez-Garza, Luz M. Baltazar Rodríguez. (2009) Association between human papillomavirus in men and their sexual partners and uterine cervical intraepithelial neoplasia. International Urology and Nephrology 41:2, 335-340
CrossRef556
Maria Clara Bicho, Alda Pereira da Silva, Ana Matos, Rui Medeiros Silva, Manuel Diamantino Bicho. (2009) Sex steroid hormones influence the risk for cervical cancer: modulation by haptoglobin genetic polymorphism. Cancer Genetics and Cytogenetics 191:2, 85-89
CrossRef557
Peter V Chin-Hong, Marla Husnik, Ross D Cranston, Grant Colfax, Susan Buchbinder, Maria Da Costa, Teresa Darragh, Dana Jones, Franklyn Judson, Beryl Koblin, Kenneth H Mayer, Joel M Palefsky. (2009) Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS 23:9, 1135-1142
CrossRef558
R. GASPARINI, D. AMICIZIA, P. MANFREDI, F. ANSALDI, C. LUCIONI, G. GALLELLI, D. PANATTO. (2009) Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model. Epidemiology and Infection 137:06, 794
CrossRef559
A. Kreuter, M. Skrygan, T. Gambichler, N.H. Brockmeyer, M. Stücker, C. Herzler, A. Potthoff, P. Altmeyer, H. Pfister, U. Wieland. (2009) Human papillomavirus-associated induction of human β-defensins in anal intraepithelial neoplasia. British Journal of Dermatology 160:6, 1197-1205
CrossRef560
Inger Gustavsson, Ivana Juko-Pecirep, Ingrid Backlund, Erik Wilander, Ulf Gyllensten. (2009) Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia. Journal of Clinical Virology 45:2, 85-89
CrossRef561
J.F. Rahier, S. Ben-Horin, Y. Chowers, C. Conlon, P. De Munter, G. D'Haens, E. Domènech, R. Eliakim, A. Eser, J. Frater. (2009) European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn's and Colitis 3:2, 47-91
CrossRef562
Brooke E. Hoots, Joel M. Palefsky, Jeanne M. Pimenta, Jennifer S. Smith. (2009) Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. International Journal of Cancer 124:10, 2375-2383
CrossRef563
Peter Muench, Thomas Hiller, Sonja Probst, Ana-Maria Florea, Frank Stubenrauch, Thomas Iftner. (2009) Binding of PDZ proteins to HPV E6 proteins does neither correlate with epidemiological risk classification nor with the immortalization of foreskin keratinocytes. Virology 387:2, 380-387
CrossRef564
Marinko Dobec, Fridolin Bannwart, Franz Kaeppeli, Pascal Cassinotti. (2009) Automation of the linear array HPV genotyping test and its application for routine typing of human papillomaviruses in cervical specimens of women without cytological abnormalities in Switzerland. Journal of Clinical Virology 45:1, 23-27
CrossRef565
Mario Sideri, Paolo Cristoforoni, Chiara Casadio, Sara Boveri, Sarah Igidbashian, Marcus Schmitt, Tarik Gheit, Massimo Tommasino. (2009) Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: A representative, single institution case series. Vaccine 27, A30-A33
CrossRef566
Jiangtao Fan, Xinqiu Chen, Wei Huang, Houwen Tian. (2009) Construction of non-replicating recombinant vaccinia virus expressing HPV16 L1, L2E7 proteins. The Chinese-German Journal of Clinical Oncology 8:5, 247-250
CrossRef567
Sepideh Farhat, Mayumi Nakagawa, Anna-Barbara Moscicki. (2009) Cell-Mediated Immune Responses to Human Papillomavirus 16 E6 and E7 Antigens as Measured by Interferon Gamma Enzyme-Linked Immunospot in Women With Cleared or Persistent Human Papillomavirus Infection. International Journal of Gynecological Cancer 19:4, 508-512
CrossRef568
Silvia Helena Rabelo-Santos, Sophie Françoise Mauricette Derchain, Luísa Lina Villa, Maria Cecília Costa, Luis Otávio Zanatta Sarian, Maria Cristina do Amaral Westin, Janet Kornegay, Luiz Carlos Zeferino. (2009) Human Papillomavirus-specific Genotypes in Cervical Lesions of Women Referred for Smears With Atypical Glandular Cells or Adenocarcinoma In Situ. International Journal of Gynecological Pathology 28:3, 272-278
CrossRef569
Alessandra Handisurya, Christina Schellenbacher, Reinhard Kirnbauer. (2009) Diseases caused by human papillomaviruses (HPV). Journal der Deutschen Dermatologischen Gesellschaft 7:5, 453-466
CrossRef570
Balasubramanyam Karanam, Subhashini Jagu, Warner K Huh, Richard B S Roden. (2009) Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection. Immunology and Cell Biology 87:4, 287-299
CrossRef571
Michael D. Greene. (2009) Diagnosis and management of HPV-related anal dysplasia. The Nurse Practitioner 34:5, 45-51
CrossRef572
Paolo Bonanni, Sara Boccalini, Angela Bechini. (2009) Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence. Vaccine 27, A46-A53
CrossRef573
Sandra Leon, Ricardo Sánchez, Manuel A. Patarroyo, Milena Camargo, Adriano Mejia, Mauricio Urquiza, Manuel E. Patarroyo. (2009) Prevalence of HPV-DNA and Anti-HPV Antibodies in Women From Girardot, Colombia. Sexually Transmitted Diseases 36:5, 290-296
CrossRef574
Ruth Tachezy, Jan Klozar, Linda Rubenstein, Elaine Smith, Martina Saláková, Jana Šmahelová, Viera Ludvíková, Eliška Rotnáglová, Roman Kodet, Eva Hamšíková. (2009) Demographic and risk factors in patients with head and neck tumors. Journal of Medical Virology 81:5, 878-887
CrossRef575
Giovanna Orlando, Rosangela Beretta, M. Michela Fasolo, Antonella Amendola, Silvia Bianchi, Francesca Mazza, Giuliano Rizzardini, Elisabetta Tanzi. (2009) Anal HPV genotypes and related displasic lesions in Italian and foreign born high-risk males. Vaccine 27, A24-A29
CrossRef576
Renate von Linsingen, Eni P. Bompeixe, Carlos A. Maestri, Newton S. Carvalho, Maria da Graça Bicalho. (2009) IFNG (+874 T/A) Polymorphism and Cervical Intraepithelial Neoplasia in Brazilian Women. Journal of Interferon & Cytokine Research 29:5, 285-288
CrossRef577
Emily Fukuchi, George F. Sawaya, Michael Chirenje, Tsitsi Magure, Jennifer Tuveson, Yong Ma, Stephen Shiboski, Maria Da Costa, Joel Palefsky, Anna-Barbara Moscicki, Rudo Makunike-Mutasa, Tsungai Chipato, Karen K. Smith-McCune. (2009) Cervical Human Papillomavirus Incidence and Persistence in a Cohort of HIV-Negative Women in Zimbabwe. Sexually Transmitted Diseases 36:5, 305-311
CrossRef578
N Muñoz, G Hernandez-Suarez, F Méndez, M Molano, H Posso, V Moreno, R Murillo, M Ronderos, C Meijer, Á Muñoz. (2009) Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. British Journal of Cancer 100:7, 1184-1190
CrossRef579
Pil-Soo Seo, Sun-Yeon Heo, Eun Jong Han, Jeong-Woo Seo, Shin-Je Ghim, Chul Ho Kim. (2009) Bacterial expression and purification of human papillomavirus type 18 L1. Biotechnology and Bioprocess Engineering 14:2, 168-174
CrossRef580
Germaine Wong, Kirsten Howard, Angela Webster, Jeremy R. Chapman, Jonathan C. Craig. (2009) The Health and Economic Impact of Cervical Cancer Screening and Human Papillomavirus Vaccination in Kidney Transplant Recipients. Transplantation 87:7, 1078-1091
CrossRef581
H.M. Said, K. Ahmed, R. Burnett, B.R. Allan, A.-L. Williamson, A.A. Hoosen. (2009) HPV genotypes in women with squamous intraepithelial lesions and normal cervixes participating in a community-based microbicide study in Pretoria, South Africa. Journal of Clinical Virology 44:4, 318-321
CrossRef582
Martina Schmitz, Cornelia Scheungraber, Jörg Herrmann, Karin Teller, Mieczyslaw Gajda, Ingo B. Runnebaum, Matthias Dürst. (2009) Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. Journal of Clinical Virology 44:4, 302-307
CrossRef583
Hugo De Vuyst, Gary M. Clifford, Maria Claudia Nascimento, Margaret M. Madeleine, Silvia Franceschi. (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. International Journal of Cancer 124:7, 1626-1636
CrossRef584
Barbara Dal Bello, Arsenio Spinillo, Paola Alberizzi, Stefania Cesari, Barbara Gardella, Gioacchino D'Ambrosio, Marianna Roccio, Enrico Maria Silini. (2009) Cervical infections by multiple human papillomavirus (HPV) genotypes: Prevalence and impact on the risk of precancerous epithelial lesions. Journal of Medical Virology 81:4, 703-712
CrossRef585
Massimiliano Cazzaniga, Tarik Gheit, Chiara Casadio, Noureen Khan, Debora Macis, Francesco Valenti, Mara Jo Miller, Bakary S. Sylla, Suminori Akiba, Bernardo Bonanni, Andrea Decensi, Umberto Veronesi, Massimo Tommasino. (2009) Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis. Breast Cancer Research and Treatment 114:3, 599-605
CrossRef586
M. Meftah el khair, M. El Mzibri, R. Ait Mhand, A. Benider, N. Benchekroun, E.M. El fahime, M.N. Benchekroun, M.M. Ennaji. (2009) Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women. Journal of Medical Virology 81:4, 678-684
CrossRef587
Laura Koutsky. (2009) The Epidemiology behind the HPV Vaccine Discovery. Annals of Epidemiology 19:4, 239-244
CrossRef588
Tobian, Aaron A.R., Serwadda, David, Quinn, Thomas C., Kigozi, Godfrey, Gravitt, Patti E., Laeyendecker, Oliver, Charvat, Blake, Ssempijja, Victor, Riedesel, Melissa, Oliver, Amy E., Nowak, Rebecca G., Moulton, Lawrence H., Chen, Michael Z., Reynolds, Steven J., Wawer, Maria J., Gray, Ronald H., . (2009) Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis. New England Journal of Medicine 360:13, 1298-1309
Full Text589
C. M. Wheeler, W. C. Hunt, N. E. Joste, C. R. Key, W. G. V. Quint, P. E. Castle. (2009) Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States. JNCI Journal of the National Cancer Institute 101:7, 475-487
CrossRef590
L. E. Markowitz, E. R. Unger, M. Saraiya. (2009) Primary and Secondary Prevention of Cervical Cancer--Opportunities and Challenges. JNCI Journal of the National Cancer Institute 101:7, 439-440
CrossRef591
E.-q. Wu, X. Zha, X.-h. Yu, G.-n. Zhang, Y.-g. Wu, Y. Fan, Y. Ren, L.-Q. Kong, W. Kong. (2009) Profile of physical status and gene variation of human papillomavirus 58 genome in cervical cancer. Journal of General Virology 90:5, 1229-1237
CrossRef592
Anita Satyaprakash, Rosella Creed, Parisa Ravanfar, Natalia Mendoza. (2009) Human papillomavirus vaccines. Dermatologic Therapy 22:2, 150-157
CrossRef593
Michiko Miyashita, Dorothy M. Agdamag, Toshiyuki Sasagawa, Kaori Matsushita, Lourdes Ma. Salud, Calixto O. Salud, Kunikazu Saikawa, Prisca S. Leano, Teresita Pagcaliwagan, Jessica Acuna, Azumi Ishizaki, Seiji Kageyama, Hiroshi Ichimura. (2009) High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines. Journal of Medical Virology 81:3, 545-551
CrossRef594
Elizabeth Ralston Howe, Zhongze Li, Ronald C. McGlennen, Wendy L. Hellerstedt, Levi S. Downs. (2009) Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening. American Journal of Obstetrics and Gynecology 200:3, 245.e1-245.e7
CrossRef595
Farin Kamangar, Wong-Ho Chow, Christian C. Abnet, Sanford M. Dawsey. (2009) Environmental Causes of Esophageal Cancer. Gastroenterology Clinics of North America 38:1, 27-57
CrossRef596
L. Denny. (2009) The burden of disease associated with infection with human papillomavirus. African Journal of Urology 15:1, 1-6
CrossRef597
Patricia G. Murphy, Dorian T. Henderson, Melissa D. Adams, Elizabeth A. Horlick, Eric P. Dixon, Lorraine M. King, Patricia L. Avissar, Charlotte A. Brown, Timothy J. Fischer, Douglas P. Malinowski. (2009) Isolation of RNA from cell lines and cervical cytology specimens stored in BD SurePath™ preservative fluid and downstream detection of housekeeping gene and HPV E6 expression using real time RT-PCR. Journal of Virological Methods 156:1-2, 138-144
CrossRef598
Alberto Agarossi, Enrico Ferrazzi, Fabio Parazzini, Carlo Federico Perno, Luciano Ghisoni. (2009) Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. Journal of Medical Virology 81:3, 529-535
CrossRef599
Evanthia Kostopoulou, Maria Samara, Panagoula Kollia, Konstantina Zacharouli, Iordanis Mademtzis, Alexandros Daponte, Ioannis E. Messinis, George Koukoulis. (2009) Correlation Between Cyclin B1 Immunostaining in Cervical Biopsies and HPV Detection by PCR. Applied Immunohistochemistry & Molecular Morphology 17:2, 115-120
CrossRef600
Hwan Mook Kim, Jaeseung Lim, Jong Soon Kang, Song-Kyu Park, Kiho Lee, Jee Youn Kim, Yeon Jin Kim, Jin Tae Hong, Youngsoo Kim, Sang-Bae Han. (2009) Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model. International Immunopharmacology 9:3, 375-380
CrossRef601
Itzel E. Calleja-Macias, Mina Kalantari, Hans-Ulrich Bernard. (2009) Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: An explanation for the molecular role of tobacco smoking in cervical carcinogenesis?. International Journal of Cancer 124:5, 1090-1096
CrossRef602
Véronique Dalstein, Sandra Merlin, Corinne Bali, Maëlle Saunier, Roger Dachez, Christophe Ronsin. (2009) Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus. Journal of Virological Methods 156:1-2, 77-83
CrossRef603
Ioannis N. Mammas, George Sourvinos, Demetrios A. Spandidos. (2009) Human papilloma virus (HPV) infection in children and adolescents. European Journal of Pediatrics 168:3, 267-273
CrossRef604
Aline Simen-Kapeu, Guy La Ruche, Vesa Kataja, Merja Yliskoski, Christine Bergeron, Apollinaire Horo, Kari Syrjänen, Seppo Saarikoski, Matti Lehtinen, François Dabis, Annie J. Sasco. (2009) Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d’Ivoire and Finland) with different tobacco exposure. Cancer Causes & Control 20:2, 163-170
CrossRef605
Olivier Cottier, Roland Sahli, Anca Mihaescu, Pierre De Grandi, Michel Boulvain, Stefan Gerber. (2009) Clinical follow-up of women infected with human papillomavirus-16, either alone or with other human papillomavirus types: identification of different risk groups. American Journal of Obstetrics and Gynecology 200:3, 286.e1-286.e6
CrossRef606
(2009) Prevalence of HPV Infection and HPV Genotype Spectrum among Sexually High-Risk Women in Busan. Journal of Life Science 19:2, 234-240
CrossRef607
N. Zari, A. Amine, M. M. Ennaji. (2009) Label-Free DNA Biosensor for Electrochemical Detection of Short DNA Sequences Related to Human Papilloma Virus. Analytical Letters 42:3, 519-535
CrossRef608
Anna K. Wong, Raymond C. Chan, W. Stephen Nichols, Shikha Bose. (2009) Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance. Cancer 115:4, 823-832
CrossRef609
Veerle M.H. Coupé, Joost van Ginkel, Hester E. de Melker, Peter J.F. Snijders, Chris J.L.M. Meijer, Johannes Berkhof. (2009) HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model-based cost-effectiveness. International Journal of Cancer 124:4, 970-978
CrossRef610
Jae Kwan Lee, Mi Kyung Kim, Seung Hun Song, Jin Hwa Hong, Kyung Jin Min, Jae Hoon Kim, Eun-Seop Song, Jungpil Lee, Jong-Min Lee, Soo-Young Hur. (2009) Comparison of Human Papillomavirus Detection and Typing by Hybrid Capture 2, Linear Array, DNA Chip, and Cycle Sequencing in Cervical Swab Samples. International Journal of Gynecological Cancer 19:2, 266-272
CrossRef611
Chris J.L.M. Meijer, Johannes Berkhof, Philip E. Castle, Albertus T. Hesselink, Eduardo L. Franco, Guglielmo Ronco, Marc Arbyn, F. Xavier Bosch, Jack Cuzick, Joakim Dillner, Daniëlle A.M. Heideman, Peter J.F. Snijders. (2009) Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. International Journal of Cancer 124:3, 516-520
CrossRef612
Umamaheswar Duvvuri, Jeffrey N. Myers. (2009) Contemporary Management of Oropharyngeal Cancer. Current Problems in Surgery 46:2, 119-184
CrossRef613
Maria Teresa Sandri, Daniela Riggio, Michela Salvatici, Rita Passerini, Laura Zorzino, Sara Boveri, Davide Radice, Noemi Spolti, Mario Sideri. (2009) Typing of human papillomavirus in women with cervical lesions: Prevalence and distribution of different genotypes. Journal of Medical Virology 81:2, 271-277
CrossRef614
NINA MEJLHEDE, JESPER BONDE, ANDERS FOMSGAARD. (2009) High frequency of multiple HPV types in cervical specimens from Danish women. APMIS 117:2, 108-114
CrossRef615
Jing Li, Lian-Kun Li, Jun-Fei Ma, Li-Hui Wei, Mayinuer Niyazi, Chang-Qing Li, Ai-Di Xu, Jian-Bin Wang, Hao Liang, Jerome Belinson, You-Lin Qiao. (2009) Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine 27:8, 1210-1215
CrossRef616
Francesco Broccolo, Stefania Chiari, Andrea Piana, Paolo Castiglia, Tiziana Dell'Anna, Rita Garcia-Parra, Andrea Maneo, Annalisa Villa, Eugenio B. Leone, Patrizia Perego, Alessandro Maida, Costantino Mangioni, Clementina E. Cocuzza. (2009) Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy. Journal of Medical Virology 81:2, 278-287
CrossRef617
Paul K.S. Chan, Alfred C.S. Luk, Tommy N.M. Luk, Kwong-Fai Lee, Jo L.K. Cheung, King-Man Ho, Kuen-Kong Lo. (2009) Distribution of human papillomavirus types in anogenital warts of men. Journal of Clinical Virology 44:2, 111-114
CrossRef618
Alinda Dalma Varnai, Magdolna Bollmann, Agnes Bankfalvi, Krisztina Kovacs, Hildegard Heller, Christoph Schmitt, Jan Volek, Marianna Szendy, Reinhard Bollmann, Ralf Hildenbrand. (2009) The prevalence and distribution of human papillomavirus genotypes in oral epithelial hyperplasia: proposal of a concept. Journal of Oral Pathology & Medicine 38:2, 181-187
CrossRef619
L. Stewart Massad, Eric C. Seaberg, D. Heather Watts, Howard Minkoff, Alexandra M. Levine, Donna Henry, Christine Colie, Teresa M. Darragh, Nancy A. Hessol. (2009) Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer 115:3, 524-530
CrossRef620
Lisa Kellerman, Alfred Neugut, Benita Burke, Donna Mancini. (2009) Comparison of the Incidence of De Novo Solid Malignancies After Heart Transplantation to That in the General Population. The American Journal of Cardiology 103:4, 562-566
CrossRef621
Ling Chen, Lan Yang, Zhenzhu Sun, Haiyang Zhang, Tao Ren, Xiuyun Tian, Lijuan Pang, Bin Chang, Hongan Li, Feng Li. (2009) Detection of human papillomaviral infection on Kazakh patients with esophageal squamous cell carcinoma in Xinjiang. Chinese Journal of Clinical Oncology 6:1, 64-67
CrossRef622
Chumnan Kietpeerakool, Jatupol Srisomboon. (2009) Medical treatment of cervical intraepithelial neoplasia II, III: an update review. International Journal of Clinical Oncology 14:1, 37-42
CrossRef623
L. F. Xi, L. A. Koutsky, P. E. Castle, C. M. Wheeler, D. A. Galloway, C. Mao, J. Ho, N. B. Kiviat. (2009) Human Papillomavirus Type 18 DNA Load and 2-Year Cumulative Diagnoses of Cervical Intraepithelial Neoplasia Grades 2-3. JNCI Journal of the National Cancer Institute 101:3, 153-161
CrossRef624
P. Naucler, W. Ryd, S. Tornberg, A. Strand, G. Wadell, K. Elfgren, T. Radberg, B. Strander, O. Forslund, B.-G. Hansson, B. Hagmar, B. Johansson, E. Rylander, J. Dillner. (2009) Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening. JNCI Journal of the National Cancer Institute 101:2, 88-99
CrossRef625
Albertus T. Hesselink, Johannes Berkhof, Daniëlle A.M. Heideman, Nicole W.J. Bulkmans, Jurjen E.H. van Tellingen, Chris J.L.M. Meijer, Peter J.F. Snijders. (2009) High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer. International Journal of Cancer 124:2, 381-386
CrossRef626
J. E. Balog. (2009) The Moral Justification for a Compulsory Human Papillomavirus Vaccination Program. American Journal of Public Health 99:4, 616-622
CrossRef627
Hiroyuki YOSHIKAWA. (2009) Progress and Challenges on HPV Vaccination. Uirusu 59:2, 243-248
CrossRef628
Anne M. Teitelman, Marilyn Stringer, Tali Averbuch, Amy Witkoski. (2009) Human Papillomavirus, Current Vaccines, and Cervical Cancer Prevention. Journal of Obstetric, Gynecologic, & Neonatal Nursing 38:1, 69-80
CrossRef629
Nancy A Hessol, Elizabeth A Holly, Jimmy T Efird, Howard Minkoff, Karlene Schowalter, Teresa M Darragh, Robert D Burk, Howard D Strickler, Ruth M Greenblatt, Joel M Palefsky. (2009) Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS 23:1, 59-70
CrossRef630
Jessica H. Maxwell, Bhavna Kumar, Felix Y. Feng, Jonathan B. McHugh, Kitrina G. Cordell, Avraham Eisbruch, Francis P. Worden, Gregory T. Wolf, Mark E. Prince, Jeffrey S. Moyer, Theodoros N. Teknos, Douglas B. Chepeha, Jay Stoerker, Heather Walline, Thomas E. Carey, Carol R. Bradford. (2009) HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head & NeckNA-NA
CrossRef631
Sung Ran Hong, In Sun Kim, Dong Won Kim, Mi Jin Kim, Ae Ree Kim, Young Ok Kim, Hye Sun Kim, Seo Hee Rha, Gyeong Sin Park, Yong Koo Park, Yong Wook Park, Ho Sung Park, Kwang Sun Suh, Jin Hee Sohn, Mi Kyung Shin, Hoon Kyu Oh, Ki Jung Yun, Hye Kyoung Yoon, Shi Nae Lee, Ah Won Lee, Hyo Jin Lee, Hyun Yee Cho, Chan Choi, Woon Won Jung. (2009) Prevalence and Genotype Distribution of Cervical Human Papillomavirus DNA in Korean Women: A Multicenter Study. The Korean Journal of Pathology 43:4, 342
CrossRef632
Paola Menegazzi, Luisa Barzon, Giorgio Palù, Elisa Reho, Luigi Tagliaferro. (2009) Human Papillomavirus Type Distribution and Correlation with Cyto-Histological Patterns in Women from the South of Italy. Infectious Diseases in Obstetrics & Gynecology 2009, 1-4
CrossRef633
Tino F. Schwarz, Marek Spaczynski, Achim Schneider, Jacek Wysocki, Andrzej Galaj, Pamela Perona, Sylviane Poncelet, Toufik Zahaf, Karin Hardt, Dominique Descamps, Gary Dubin. (2009) Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years. Vaccine 27:4, 581-587
CrossRef634
Sung-Hee Kim, Ka-Young Lee, Tae-Jin Park, Jun-Su Kim, Yeun-Mi Kim, Hea-Sook O. (2009) Factors Related to Human Papilloma Virus Infection Rate in Women. Korean Journal of Family Medicine 30:12, 972
CrossRef635
Raúl Murillo, Mónica Molano, Gilberto Martínez, Juan-Carlos Mejía, Oscar Gamboa. (2009) HPV Prevalence in Colombian Women with Cervical Cancer: Implications for Vaccination in a Developing Country. Infectious Diseases in Obstetrics & Gynecology 2009, 1-9
CrossRef636
Young-Tak Kim. (2009) Current status of cervical cancer and HPV infection in Korea. Journal of Gynecologic Oncology 20:1, 1
CrossRef637
Wendy Theelen, Martin Reijans, Guus Simons, Frans C.S. Ramaekers, Ernst-Jan M. Speel, Anton H.N. Hopman. (2009) A new multiparameter assay to assess HPV 16/18, viral load and physical status together with gain of telomerase genes in HPV-related cancers. International Journal of CancerNA-NA
CrossRef638
A.E. Albers, B. Sinikovic, A.V. Banko, S. Jovanovic, A.M. Kaufmann. (2009) Developments in therapeutic human papillomavirus vaccination. Acta chirurgica iugoslavica 56:3, 29-37
CrossRef639
Berenice Illades-Aguiar, Enoc-Mariano Cortés-Malagón, Verónica Antonio-Véjar, Noelio Zamudio-López, Luz del Carmen Alarcón-Romero, Gloria Fernández-Tilapa, Daniel Hernández-Sotelo, Marco-Antonio Terán-Porcayo, Eugenia Flores-Alfaro, Marco-Antonio Leyva-Vázquez. (2009) Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors
CrossRef640
Hee Eun Kyeong, Seung Yeon Ha, Dong Hae Chung, Na Rae Kim, Sanghui Park, Hyun Yee Cho. (2009) The Usefulness of the HPV DNA Microchip Test for Women with ASC-US. The Korean Journal of Pathology 43:3, 254
CrossRef641
Melissa A. Minor. (2009) Is it time for increased pap performance? Cervical cancer and pap testing in women with inflammatory bowel disease. Inflammatory Bowel DiseasesNA-NA
CrossRef642
Tarik Gheit, Salvatore Vaccarella, Markus Schmitt, Michael Pawlita, Silvia Franceschi, Rengaswamy Sankaranarayanan, Bakary S. Sylla, Massimo Tommasino, Nitin Gangane. (2009) Prevalence of human papillomavirus types in cervical and oral cancers in central India. Vaccine 27:5, 636-639
CrossRef643
Andrew J. Desruisseau, Delf Schmidt-Grimminger, Edith Welty. (2009) Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa. Infectious Diseases in Obstetrics & Gynecology 2009, 1-6
CrossRef644
Krystal Madden, Lisa Flowers, Ritu Salani, Ira Horowitz, Sanjay Logan, Kevin Kowalski, Jun Xie, Sulma I. Mohammed. (2009) Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer. Prostaglandins, Leukotrienes and Essential Fatty Acids 80:1, 9-18
CrossRef645
A. M. Khan, T. Freeman-Wang, N. Pisal, A. Singer. (2009) Smoking and multicentric vulval intraepithelial neoplasia. Journal of Obstetrics & Gynaecology 29:2, 123-125
CrossRef646
You Jin Hwang, Soon Pyo Lee, Suk Young Kim, Young Hwan Choi, Min Ji Kim, Choong Ho Lee, Joo Young Lee, Dae Young Kim. (2009) Expression of Heat Shock Protein 60 kDa Is Upregulated in Cervical Cancer. Yonsei Medical Journal 50:3, 399
CrossRef647
Fawziah Marra, Karine Cloutier, Bridgette Oteng, Carlo Marra, Gina Ogilvie. (2009) Effectiveness and Cost Effectiveness of Human Papillomavirus Vaccine. PharmacoEconomics 27:2, 127-147
CrossRef648
Kyung-Ok Lee, Su-Jin Jeong, Min-Young Park, Hye-Soon Seong, Eun-Sim Shin, Kyeong-Hwan Choi, Gee-Young Kim, Sun-Hwa Lee. (2009) Prevalence of Human Papillomavirus Genotypes in Routine Pap Smear of 2,562 Korean Women Determined by PCR-DNA Sequencing. Journal of Bacteriology and Virology 39:4, 337
CrossRef649
Branko Stanimirovic, Dusan Stanojevic, Mladenko Vasiljevic, Snezana Rakic, Ana Mitrovic. (2009) The effect of anogenital warts on life quality of affected patients. Medicinski pregled 62:3-4, 177-179
CrossRef650
M. Achour, D. Zeghal, L. Kochbati, S. Kahla, F. Zouari, M. Maâlej, R. Oueslati. (2008) Antibody Response for L1, E6, E7 HPV 16, and HPV 18 Antigens in Tunisian Women with Cervical Cancer. Journal of Immunoassay and Immunochemistry 30:1, 82-96
CrossRef651
Jae-Woo Kim, Yun-Tae Kim, Dae-Sik Kim, Seok-Cheol Choi. (2008) Prevalence of Human Papillomavirus by DNA Chip Test in Women. Journal of Life Science 18:12, 1657-1664
CrossRef652
Brigiet M. Hoevenaars, Irene A.M. van der Avoort, Peter C.M. de Wilde, Leon F.A.G. Massuger, Willem J.G. Melchers, Joanne A. de Hullu, Johan Bulten. (2008) A panel of p16 INK4A , MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. International Journal of Cancer 123:12, 2767-2773
CrossRef653
A. S. Kapeu, T. Luostarinen, E. Jellum, J. Dillner, M. Hakama, P. Koskela, P. Lenner, A. Love, E. Mahlamaki, S. Thoresen, L. Tryggvadottir, G. Wadell, L. Youngman, M. Lehtinen. (2008) Is Smoking an Independent Risk Factor for Invasive Cervical Cancer? A Nested Case-Control Study Within Nordic Biobanks. American Journal of Epidemiology 169:4, 480-488
CrossRef654
M. Stanley. (2008) HPV vaccines: are they the answer?. British Medical Bulletin 88:1, 59-74
CrossRef655
Tino F Schwarz. (2008) AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention. Expert Review of Vaccines 7:10, 1465-1473
CrossRef656
Paolo Lenzi, Nunzia Scotti, Fiammetta Alagna, Maria L. Tornesello, Andrea Pompa, Alessandro Vitale, Angelo Stradis, Luigi Monti, Stefania Grillo, Franco M. Buonaguro, Pal Maliga, Teodoro Cardi. (2008) Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. Transgenic Research 17:6, 1091-1102
CrossRef657
Peter Mulligan, Thomas F. Westbrook, Matthias Ottinger, Natalya Pavlova, Bin Chang, Eric Macia, Yu-Jiang Shi, Jordi Barretina, Jinsong Liu, Peter M. Howley, Stephen J. Elledge, Yang Shi. (2008) CDYL Bridges REST and Histone Methyltransferases for Gene Repression and Suppression of Cellular Transformation. Molecular Cell 32:5, 718-726
CrossRef658
Laura Vidal, Maura L. Gillison. (2008) Human Papillomavirus in HNSCC: Recognition of a Distinct Disease Type. Hematology/Oncology Clinics of North America 22:6, 1125-1142
CrossRef659
Fatima Azerkan, Kazem Zendehdel, Per Tillgren, Elisabeth Faxelid, Pär Sparén. (2008) Risk of cervical cancer among immigrants by age at immigration and follow-up time in Sweden, from 1968 to 2004. International Journal of Cancer 123:11, 2664-2670
CrossRef660
E DIXON, L KING, M ADAMS, P GRONN, P MURPHY, C BROWN, G BROUGH, H SKOMEDAL, D MALINOWSKI, T FISCHER. (2008) Isolation of RNA from residual BD SurePath™ liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTect™ HPV-Proofer assay. Journal of Virological Methods 154:1-2, 220-222
CrossRef661
Chun-lian Nie, Guo-lan Gao, Jie Han, Hua Li, He-ping Chen, Ming He. (2008) Human papillomavirus 16 E6, E7 siRNAs inhibit proliferation and induce apoptosis of SiHa cervical cancer cells. Chinese Journal of Cancer Research 20:4, 301-306
CrossRef662
Ivan Sabol, Mihaela Matovina, Nina Milutin Gasperov, Magdalena Grce. (2008) Identification of a novel human papillomavirus type 16 E1 gene variant with potentially reduced oncogenicity. Journal of Medical Virology 80:12, 2134-2140
CrossRef663
Nina Milutin Gašperov, Ivan Sabol, Mihaela Matovina, Šime Spaventi, Magdalena Grce. (2008) Detection and Typing of Human Papillomaviruses Combining Different Methods: Polymerase Chain Reaction, Restriction Fragment Length Polymorphism, Line Probe Assay and Sequencing. Pathology & Oncology Research 14:4, 355-363
CrossRef664
Cosette Marie Wheeler. (2008) Natural History of Human Papillomavirus Infections, Cytologic and Histologic Abnormalities, and Cancer. Obstetrics and Gynecology Clinics of North America 35:4, 519-536
CrossRef665
A. Gauthier, V. Martin-Escudero, L. Moore, N. Ferko, S. de Sanjose, I. Perez-Escolano, F. Catala-Lopez, E. Ferrer, F. X. Bosch. (2008) Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain. The European Journal of Public Health 18:6, 674-680
CrossRef666
I NAZARENKO, L KOBAYASHI, J GILES, C FISHMAN, G CHEN, A LORINCZ. (2008) A novel method of HPV genotyping using Hybrid Capture® sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex® XMAP®. Journal of Virological Methods 154:1-2, 76-81
CrossRef667
Ana Oaknin, M. Pilar Barretina. (2008) Human papillomavirus vaccine and cervical cancer prevention. Clinical and Translational Oncology 10:12, 804-811
CrossRef668
Virginie M.G. Renoux, Maxime J.J. Fleury, Latifa Bousarghin, Julien Gaitan, Pierre-yves Sizaret, Antoine Touzé, Pierre Coursaget. (2008) Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice. Vaccine 26:51, 6602-6607
CrossRef669
Anna-Barbara Moscicki, Yifei Ma, Charles Wibbelsman, Adaleen Powers, Teresa M. Darragh, Sepideh Farhat, Ruth Shaber, Stephen Shiboski. (2008) Risks for Cervical Intraepithelial Neoplasia 3 Among Adolescents and Young Women With Abnormal Cytology. Obstetrics & Gynecology 112:6, 1335-1342
CrossRef670
Wei Li, Wei Wang, Mani Si, Linfei Han, Qinglei Gao, Aiyue Luo, Yan Li, Yunping Lu, Shixuan Wang, Ding Ma. (2008) The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma. Journal of Cancer Research and Clinical Oncology 134:12, 1355-1361
CrossRef671
K. Itoh, A. Yamada, T. Mine, M. Noguchi. (2008) Recent Advances in Cancer Vaccines: An Overview. Japanese Journal of Clinical Oncology 39:2, 73-80
CrossRef672
Glenn Copeland, S. Deblina Datta, Georgia Spivak, Ann Davis Garvin, Michele L. Cote. (2008) Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003. Cancer 113:S10, 2946-2954
CrossRef673
Kris Khan, C. Robinette Curtis, Donatus U. Ekwueme, Shannon Stokley, Chastity Walker, Katherine Roland, Vicki Benard, Mona Saraiya. (2008) Preventing cervical cancer. Cancer 113:S10, 3004-3012
CrossRef674
Eileen F. Dunne, S. Deblina Datta, Lauri E. Markowitz. (2008) A review of prophylactic human papillomavirus vaccines: Recommendations and monitoring in the US. Cancer 113:S10, 2995-3003
CrossRef675
Silvia de Sanjosé, Laia Alemany, Xavier Castellsagué, F Xavier Bosch. (2008) Human papillomavirus vaccines and vaccine implementation. Women's Health 4:6, 595-604
CrossRef676
K. Sotlar. (2008) Die Infektion mit humanen Papillomaviren. Der Pathologe 29:S2, 153-156
CrossRef677
Maria Lina Tornesello, Luigi Buonaguro, Sergio Izzo, Guillermo Lopez, Ximena Vega, Claudio Francisco Maldonado Reyes, Franco Maria Buonaguro. (2008) A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women. Journal of Medical Virology 80:11, 1959-1965
CrossRef678
Eliav Barr, Heather L. Sings. (2008) Prophylactic HPV vaccines: New interventions for cancer control. Vaccine 26:49, 6244-6257
CrossRef679
George F. Sawaya, Mike Zvavahera Chirenje, Mildred Tsitsi Magure, Jennifer L. Tuveson, Yifei Ma, Stephen C. Shiboski, Maria M. Da Costa, Joel M. Palefsky, Anna-Barbara Moscicki, Rudo Makunike Mutasa, Tsungai Chipato, Karen K. Smith-McCune. (2008) Effect of Diaphragm and Lubricant Gel Provision on Human Papillomavirus Infection Among Women Provided With Condoms. Obstetrics & Gynecology 112:5, 990-997
CrossRef680
Nataša Vasiljević, Lone Nielsen, Geoff Doherty, Joakim Dillner, Ola Forslund, Bodil Norrild. (2008) Differences in transcriptional activity of cutaneous human papillomaviruses. Virus Research 137:2, 213-219
CrossRef681
Lucia Six, Sepp Leodolter, Heather L. Sings, Eliav Barr, Richard Haupt, Elmar A. Joura. (2008) Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women – baseline data of a phase III vaccine trial. Wiener klinische Wochenschrift 120:21-22, 666-671
CrossRef682
Whitfield B. Growdon, Susan L. Boisvert, Sara Akhavanfard, Esther Oliva, Dora C. Dias-Santagata, Sakiko Kojiro, Neil S. Horowitz, A. John Iafrate, Darrell R. Borger, Bo R. Rueda. (2008) Decreased survival in EGFR gene amplified vulvar carcinoma. Gynecologic Oncology 111:2, 289-297
CrossRef683
M. Merito, N. Largeron, C. Cohet, L. Timelli, F. Boselli, A. Matteelli, L. Naldi, G. Vittori. (2008) Treatment patterns and associated costs for genital warts in Italy. Current Medical Research and Opinion 24:11, 3175-3183
CrossRef684
Megan A. Smith, Karen Canfell, Julia M.L. Brotherton, Jie-Bin Lew, Ruanne V. Barnabas. (2008) The predicted impact of vaccination on human papillomavirus infections in Australia. International Journal of Cancer 123:8, 1854-1863
CrossRef685
Mina Kalantari, Luisa L. Villa, Itzel E. Calleja-Macias, Hans-Ulrich Bernard. (2008) Human papillomavirus-16 and -18 in penile carcinomas: DNA methylation, chromosomal recombination and genomic variation. International Journal of Cancer 123:8, 1832-1840
CrossRef686
Susanne K. Kjaer, Gabrielle Breugelmans, Christian Munk, Jette Junge, Michael Watson, Thomas Iftner. (2008) Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. International Journal of Cancer 123:8, 1864-1870
CrossRef687
Y-F Huang, M-R Shen, K-F Hsu, Y-M Cheng, C-Y Chou. (2008) Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer. British Journal of Cancer 99:7, 1096-1102
CrossRef688
Karen K. Smith-McCune. (2008) Human papillomavirus vaccine efficacy: Aligning expectations with reality. Gynecologic Oncology 111:1, 1-2
CrossRef689
M ANTONI, D PEREIRA, I MARION, N ENNIS, M ANDRASIK, R ROSE, J MCCALLA, T SIMON, M FLETCHER, J LUCCI. (2008) Stress management effects on perceived stress and cervical neoplasia in low-income HIV-infected women. Journal of Psychosomatic Research 65:4, 389-401
CrossRef690
Eduardo González-Bosquet, Cristina Esteva, Carmen Muñoz-Almagro, Patricia Ferrer, Miriam Pérez, Jose M. Lailla. (2008) Identification of vaccine human papillomavirus genotypes in squamous intraepithelial lesions (CIN2–3). Gynecologic Oncology 111:1, 9-12
CrossRef691
Anna-Barbara Moscicki. (2008) HPV Vaccines: Today and in the Future. Journal of Adolescent Health 43:4, S26-S40
CrossRef692
D RAUBER, G MEHLHORN, P FASCHING, M BECKMANN, S ACKERMANN. (2008) Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions. European Journal of Obstetrics & Gynecology and Reproductive Biology 140:2, 258-262
CrossRef693
Jennifer S. Smith, Amy Melendy, Rashida K. Rana, Jeanne M. Pimenta. (2008) Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review. Journal of Adolescent Health 43:4, S5.e1-S5.e62
CrossRef694
Katie M. Keating, Noel T. Brewer, Sami L. Gottlieb, Nicole Liddon, Christina Ludema, Jennifer S. Smith. (2008) Potential Barriers to HPV Vaccine Provision Among Medical Practices in an Area with High Rates of Cervical Cancer. Journal of Adolescent Health 43:4, S61-S67
CrossRef695
Laura K. Sycuro, Long Fu Xi, James P. Hughes, Qinghua Feng, Rachel L. Winer, Shu‐Kuang Lee, Sandra O’Reilly, Nancy B. Kiviat, Laura A. Koutsky. (2008) Persistence of Genital Human Papillomavirus Infection in a Long‐Term Follow‐Up Study of Female University Students. The Journal of Infectious Diseases 198:7, 971-978
CrossRef696
Kumiko Eiguchi, Silvio Tatti, L. Virginia Alonio, Joaquín V. González, Gustavo J. Leirós, Laura Fleider, Susana Vighi, Karin Padros, Eduardo Raimondi, Angélica Teyssié, M. Alejandra Picconi. (2008) Association of DRB1 and DQB1 HLA Class II Polymorphisms in High-Grade and Neoplastic Cervical Lesions of Women From Argentina. Journal of Lower Genital Tract Disease 12:4, 262-268
CrossRef697
Krisztina Kovács, Alinda D. Varnai, Magdolna Bollmann, Agnes Bankfalvi, Marianna Szendy, Norbert Speich, Christoph Schmitt, László Pajor, Reinhard Bollmann. (2008) Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: A 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. Journal of Medical Virology 80:10, 1814-1823
CrossRef698
D DING, H HSU, R HUANG, H LAI, C LIN, M YU, T CHU. (2008) Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: An indication of viral oncogenic potential. European Journal of Obstetrics & Gynecology and Reproductive Biology 140:2, 245-251
CrossRef699
N. Rai, G.J.S. Jenkins, E. McAdam, S.J. Hibbitts, A.N. Fiander, N.G. Powell. (2008) Human papillomavirus infection in Barrett's oesophagus in the UK: An infrequent event. Journal of Clinical Virology 43:2, 250-252
CrossRef700
Chyong-Huey Lai, Angel Chao, Chee-Jen Chang, Fang-Yu Chao, Huei-Jean Huang, Swei Hsueh, Cheng-Tao Lin, Hui-Hsin Cheng, Chu-Chun Huang, Jung-Erh Yang, Tzu-I Wu, Hung-Hsueh Chou, Ting-Chang Chang. (2008) Host and viral factors in relation to clearance of human papillomavirus infection: A cohort study in Taiwan. International Journal of Cancer 123:7, 1685-1692
CrossRef701
Lea E. Widdice, Anna-Barbara Moscicki. (2008) Updated Guidelines for Papanicolaou Tests, Colposcopy, and Human Papillomavirus Testing in Adolescents. Journal of Adolescent Health 43:4, S41-S51
CrossRef702
S HAN, E CHO, T LEE, J KIM, N PARK, Y SONG, J KIM, H LEE, S KANG. (2008) Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical caner in Korean women. European Journal of Obstetrics & Gynecology and Reproductive Biology 140:1, 71-75
CrossRef703
Diane M. Harper. (2008) Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of age. Gynecologic Oncology 110:3, S11-S17
CrossRef704
José-María Bayas, Laura Costas, Amparo Muñoz. (2008) Cervical cancer vaccination indications, efficacy, and side effects. Gynecologic Oncology 110:3, S11-S14
CrossRef705
J. Ryding, K.M. French, P. Naucler, R.V. Barnabas, G.P. Garnett, J. Dillner. (2008) Seroepidemiology as basis for design of a human papillomavirus vaccination program. Vaccine 26:41, 5263-5268
CrossRef706
David Guerrero, Rosa Guarch, Amaya Ojer, Juan Manuel Casas, Santiago Ropero, Ana Mancha, Carlo Pesce, Belen Lloveras, Federico Garcia-Bragado, Ana Puras. (2008) Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma. BJU International 102:6, 747-755
CrossRef707
T. MATSUKURA, M. SUGASE. (2008) Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger. International Journal of Gynecological Cancer 18:5, 1042-1050
CrossRef708
Yi Guo, Wei Li, Qian Wang, Hui Li. (2008) Detection and identification of human papillomavirus in cervical adenocarcinoma. Chinese Journal of Cancer Research 20:3, 177-180
CrossRef709
Xavier Castellsagué. (2008) Natural history and epidemiology of HPV infection and cervical cancer. Gynecologic Oncology 110:3, S4-S7
CrossRef710
Linda A. Duffett-Leger, Nicole L. Letourneau, James C. Croll. (2008) Cervical Cancer Screening Practices among University Women. Journal of Obstetric, Gynecologic, & Neonatal Nursing 37:5, 572-581
CrossRef711
Alexander Kreuter, Norbert H Brockmeyer, Soenke J Weissenborn, Thilo Gambichler, Markus Stücker, Peter Altmeyer, Herbert Pfister, Ulrike Wieland. (2008) Penile Intraepithelial Neoplasia Is Frequent in HIV-Positive Men with Anal Dysplasia. Journal of Investigative Dermatology 128:9, 2316-2324
CrossRef712
Miguel Ángel Martínez-González, Silvia Carlos, Jokin de Irala. (2008) Vacuna contra el virus del papiloma humano: razones para el optimismo y razones para la prudencia. Medicina Clínica 131:7, 256-263
CrossRef713
Zainab A. Malik, Susan M. Hailpern, Robert D. Burk. (2008) Predictors of Seropositivity to Human Papillomavirus Type 53: One of the Most Prevalent High Risk–Related Cervical Human Papillomaviruses. Viral Immunology 21:3, 371-378
CrossRef714
Dieter Morandell, Ursula Rostek, Veronique Bouvard, Beatriz Campo-Fernández, Marc Fiedler, Pidder Jansen-Dürr, Werner Zwerschke. (2008) Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression. Virology 379:1, 20-29
CrossRef715
Tino F. Schwarz, Oberdan Leo. (2008) Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: Improving upon nature. Gynecologic Oncology 110:3, S1-S10
CrossRef716
A Kobayashi, V Weinberg, T Darragh, K Smith-McCune. (2008) Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunology 1:5, 412-420
CrossRef717
J SHERMAN, S MOUNT, M EVANS, J SKELLY, L SIMMONSARNOLD, G ELTABBAKH. (2008) Smoking increases the risk of high-grade vaginal intraepithelial neoplasia in women with oncogenic human papillomavirus. Gynecologic Oncology 110:3, 396-401
CrossRef718
David Jenkins. (2008) A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: Importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Gynecologic Oncology 110:3, S18-S25
CrossRef719
J.F. BRAGANÇA, L.O. SARIAN, D.R. PITTA, A.B. MAITO, J. VASSALLO, F. PIGNATARO, L.A. ANDRADE, S. DERCHAIN. (2008) Expression of p16 INK4a and cervical infection with high-risk human papillomavirus are not related to p53 activity in cervical intraepithelial neoplasia. International Journal of Gynecological Cancer 18:5, 1060-1064
CrossRef720
Urvashi Prasad Jha, Swasti. (2008) Vaccination Against Cervical Cancer. Apollo Medicine 5:3, 218-222
CrossRef721
Keerti V. Shah. (2008) Asia Pacific: Cervical Cancer Screening and Human Papillomavirus Vaccination Policy and Delivery. Vaccine 26, iii-iv
CrossRef722
Pablo Moreno-Acosta, Mónica Molano, Antonio Huertas, Myriam Sánchez Gómez, Alfredo Romero, Mauricio González, María Mercedes Bravo, Alejandro García-Carrancá. (2008) A non-radioactive PCR-SSCP analysis allows to distinguish between HPV 16 European and Asian-American variants in squamous cell carcinomas of the uterine cervix in Colombia. Virus Genes 37:1, 22-30
CrossRef723
C. Pannier-Stockman, C. Segard, S. Bennamar, J. Gondry, J.-C. Boulanger, H. Sevestre, S. Castelain, G. Duverlie. (2008) Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities. Journal of Clinical Virology 42:4, 353-360
CrossRef724
M. Stanley. (2008) Human Papillomavirus Vaccines versus Cervical Cancer Screening. Clinical Oncology 20:6, 388-394
CrossRef725
Ming Guo, Ching-Yu Lin, Yun Gong, David E Cogdell, Wei Zhang, E Lin, Nour Sneige. (2008) Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results. Modern Pathology 21:8, 1037-1043
CrossRef726
Alexander Kreuter, Anja Potthoff, Norbert H Brockmeyer, Thilo Gambichler, Markus Stücker, Peter Altmeyer, Jochen Swoboda, Herbert Pfister, Ulrike Wieland. (2008) Imiquimod Leads to a Decrease of Human Papillomavirus DNA and to a Sustained Clearance of Anal Intraepithelial Neoplasia in HIV-Infected Men. Journal of Investigative Dermatology 128:8, 2078-2083
CrossRef727
Lindy A.M. Santegoets, Manon van Seters, Claudia Heijmans-Antonissen, Alex KleinJan, Marc van Beurden, Patricia C. Ewing, Liesbeth C.M. Kühne, Ilse Beckmann, Curt W. Burger, Theo J.M. Helmerhorst, Leen J. Blok. (2008) Reduced local immunity in HPV-related VIN: Expression of chemokines and involvement of immunocompetent cells. International Journal of Cancer 123:3, 616-622
CrossRef728
Sun Pyo Hong, Soo-Kyung Shin, Eun Hee Lee, Eun Ok Kim, Seung Il Ji, Hyun Jae Chung, Sun Nie Park, Wangdon Yoo, William R Folk, Soo-Ok Kim. (2008) High-resolution human papillomavirus genotyping by MALDI-TOF mass spectrometry. Nature Protocols 3:9, 1476-1484
CrossRef729
Simona Venturoli, Simone Ambretti, Monica Cricca, Elisa Leo, Silvano Costa, Monica Musiani, Marialuisa Zerbini. (2008) Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment. Journal of Medical Virology 80:8, 1434-1440
CrossRef730
Christoph Koidl, Michael Bozic, Ita Hadzisejdic, Maja Grahovac, Blazenka Grahovac, Wolfgang Kranewitter, Egon Marth, Harald H. Kessler. (2008) Comparison of molecular assays for detection and typing of human papillomavirus. American Journal of Obstetrics and Gynecology 199:2, 144.e1-144.e6
CrossRef731
Marco Ferreira, Mateus Crespo, Luis Martins, Ana Félix. (2008) HPV DNA detection and genotyping in 21 cases of primary invasive squamous cell carcinoma of the vagina. Modern Pathology 21:8, 968-972
CrossRef732
A. Jumnainsong, P. Jearanaikoon, S. Khahmahpahte, W. Wongsena, A. V. Romphruk, B. Chumworathayi, K. Vaeteewoottacharn, M. Ponglikitmongkol, A. Romphruk, C. Leelayuwat. (2008) Associations of MICB with cervical cancer in north-eastern Thais: identification of major histocompatibility complex class I chain-related gene B motifs influencing natural killer cell activation. Clinical & Experimental Immunology 153:2, 205-213
CrossRef733
Robert Haddad, Christopher Crum, Zigui Chen, Jeffrey Krane, Marshall Posner, Yi Li, Robert Burk. (2008) HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncology 44:8, 812-815
CrossRef734
Ching-Yu Lin, Angel Chao, Yuh-Cheng Yang, Hung-Hsueh Chou, Chih-Ming Ho, Ruey-Wen Lin, Ting-Chang Chang, Jia-Yia Chiou, Fang-Yu Chao, Kung-Liahng Wang, Tsai-Yen Chien, Swei Hsueh, Chu-Chun Huang, Chien-Jen Chen, Chyong-Huey Lai. (2008) Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. Journal of Clinical Virology 42:4, 361-367
CrossRef735
A. Senéjoux. (2008) Lésions anales précancéreuses liées aux papillomavirus humains. Histoire naturelle, épidémiologie et facteurs de risque. Côlon & Rectum 2:3, 125-127
CrossRef736
Jean-Luc Prétet, Anne-Carole Jacquard, Maëlle Saunier, Christine Clavel, Roger Dachez, Jean Gondry, Pierre Pradat, Benoît Soubeyrand, Yann Leocmach, Christiane Mougin, Didier Riethmuller. (2008) Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer. Gynecologic Oncology 110:2, 179-184
CrossRef737
M Diaz, J J Kim, G Albero, S de Sanjosé, G Clifford, F X Bosch, S J Goldie. (2008) Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. British Journal of Cancer 99:2, 230-238
CrossRef738
J N I Vet, M A de Boer, B E W M van den Akker, B Siregar, Lisnawati, S Budiningsih, D Tyasmorowati, Moestikaningsih, S Cornain, A A W Peters, G J Fleuren. (2008) Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. British Journal of Cancer 99:1, 214-218
CrossRef739
Muriel van den Hende, Mariëtte I.E. van Poelgeest, Jeanette M. van der Hulst, Joan de Jong, Jan W. Drijfhout, Gert Jan Fleuren, A. Rob P.M. Valentijn, Amon R. Wafelman, Gijs M. Slappendel, Cornelis J.M. Melief, Rienk Offringa, Sjoerd H. van der Burg, Gemma G. Kenter. (2008) Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia. International Journal of Cancer 123:1, 146-152
CrossRef740
A Kathrine Lie, Gunnar Kristensen. (2008) Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Review of Molecular Diagnostics 8:4, 405-415
CrossRef741
Troy J. Kemp, Alfonso García-Piñeres, Roni T. Falk, Sylviane Poncelet, Francis Dessy, Sandra L. Giannini, Ana Cecilia Rodriguez, Carolina Porras, Rolando Herrero, Allan Hildesheim, Ligia A. Pinto. (2008) Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women. Vaccine 26:29-30, 3608-3616
CrossRef742
Joseph Menczer, Erez Ben-Shem, Abraham Golan, Tally Levy. (2008) Risk Factor Proportions in Israeli Patients With Cervical Intraepithelial Neoplasia 3 and Invasive Squamous Cell Carcinoma. Journal of Lower Genital Tract Disease 12:3, 220-223
CrossRef743
Bornali Bhattacharjee, Nidhu Ranjan Mandal, Sudipta Roy, Sharmila Sengupta. (2008) Characterization of sequence variations within HPV16 isolates among Indian women: Prediction of causal role of rare non-synonymous variations within intact isolates in cervical cancer pathogenesis. Virology 377:1, 143-150
CrossRef744
Stefanie J. Klug, Anco Molijn, Betti Schopp, Barbara Holz, Angelika Iftner, Wim Quint, Peter J.F. Snijders, Karl-Ulrich Petry, Susanne Krüger Kjær, Christian Munk, Thomas Iftner. (2008) Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. Journal of Medical Virology 80:7, 1264-1274
CrossRef745
X.M. Lu, S. Monnier-Benoit, L.Z. Mo, S.Y. Xu, J.L. Prétet, Z. Liu, D.A. Vuitton, C. Mougin. (2008) Human papillomavirus in esophageal squamous cell carcinoma of the high-risk Kazakh ethnic group in Xinjiang, China. European Journal of Surgical Oncology (EJSO) 34:7, 765-770
CrossRef746
H. MITCHELL, D. R. ENGLISH, F. ELLIOTT, M. GENGOS, J. H. BARRETT, G. G. GILES, D. FORMAN. (2008) Immunoblotting using multiple antigens is essential to demonstrate the true risk of H. pylori infection for gastric cancer. Alimentary Pharmacology & Therapeutics
CrossRef747
Gilles Grangé, Denis Malvy, Florian Lançon, Anne-Francoise Gaudin, Abdelkader El Hasnaoui. (2008) Factors associated with regular cervical cancer screening. International Journal of Gynecology & Obstetrics 102:1, 28-33
CrossRef748
Daniel Yarmel, Linnie Rabjohn, Kevin Roberts, Suganthi Soundararajan. (2008) Pedal Squamous Cell Carcinoma in an Immunocompromised Host. The Journal of Foot and Ankle Surgery 47:4, 343-349
CrossRef749
Neerja Bhatla, Lalit Dar, A. Rajkumar Patro, Pankaj Kumar, Sunil K. Pati, Alka Kriplani, Arti Gulati, Shobha Broor, Venkateswaran K. Iyer, Sandeep Mathur, Keerti V. Shah, Patti E. Gravitt. (2008) Human Papillomavirus-Type Distribution in Women With and Without Cervical Neoplasia in North India. International Journal of Gynecological Pathology 27:3, 426-430
CrossRef750
Michael J. Thrall, Stefan E. Pambuccian, Edward B. Stelow, Dan M. McKeon, Lizette Miller, Kay Savik, H. Evin Gulbahce. (2008) Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test. Cancer 114:3, 171-179
CrossRef751
Steven Ades, Anita Koushik, Eliane Duarte-Franco, Nabil Mansour, Jocelyne Arseneau, Diane Provencher, Lucy Gilbert, Walter Gotlieb, Alex Ferenczy, François Coutlée, Michel Roger, Eduardo L. Franco, . (2008) Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia. International Journal of Cancer 122:12, 2820-2826
CrossRef752
M. Achour, D. Zeghal, L. Kochbati, S. Kahla, F. Zouari, M. Maâlej, R. Oueslati. (2008) Antibody Response for L1, E6 and E7 HPV 16 and HPV 18 Antigens in Tunisian Women with Cervical Cancer and Controls. Journal of Immunoassay and Immunochemistry 29:3, 266-280
CrossRef753
N. Termine, V. Panzarella, S. Falaschini, A. Russo, D. Matranga, L. Lo Muzio, G. Campisi. (2008) HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Annals of Oncology 19:10, 1681-1690
CrossRef754
M. L. Tornesello, M. L. Duraturo, P. Giorgi-Rossi, M. Sansone, R. Piccoli, L. Buonaguro, F. M. Buonaguro. (2008) Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. Journal of General Virology 89:6, 1380-1389
CrossRef755
Raffaele Del Prete, Anna Maria Di Taranto, Maria Rosaria Lipsi, Vincenzo Nirchio, Raffaele Antonetti, Giuseppe Miragliotta. (2008) Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. Journal of Clinical Virology 42:2, 211-214
CrossRef756
Neerja Bhatla, Neena Lal, Yan-Ping Bao, Timothy Ng, You-Lin Qiao. (2008) A meta-analysis of human papillomavirus type-distribution in women from South Asia: Implications for vaccination. Vaccine 26:23, 2811-2817
CrossRef757
Jorma Paavonen. (2008) Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials. Current Medical Research and Opinion 24:6, 1623-1634
CrossRef758
A Sargent, A Bailey, M Almonte, A Turner, C Thomson, J Peto, M Desai, J Mather, S Moss, C Roberts, H C Kitchener. (2008) Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. British Journal of Cancer 98:10, 1704-1709
CrossRef759
Helen Trottier, Salaheddin Mahmud, José Carlos M. Prado, Joao S. Sobrinho, Maria C. Costa, Thomas E. Rohan, Luisa L. Villa, Eduardo L. Franco. (2008) Type‐Specific Duration of Human Papillomavirus Infection: Implications for Human Papillomavirus Screening and Vaccination. The Journal of Infectious Diseases 197:10, 1436-1447
CrossRef760
J. Koshiol, L. Lindsay, J. M. Pimenta, C. Poole, D. Jenkins, J. S. Smith. (2008) Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis. American Journal of Epidemiology 168:2, 123-137
CrossRef761
S. Vaccarella, R. Herrero, P. J F Snijders, M. Dai, J. O Thomas, N. T. Hieu, C. Ferreccio, E. Matos, H. Posso, S. de Sanjose, H. R. Shin, S. Sukvirach, E. Lazcano-Ponce, N. Munoz, C. J L M Meijer, S. Franceschi, . (2008) Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. International Journal of Epidemiology 37:3, 536-546
CrossRef762
Lynette Denny. (2008) Prevention of cervical cancer in developing countries. Therapy 5:3, 329-338
CrossRef763
Joseph Monsonego, Giuseppe Pollini, Marie José Evrard, Patrice Sednaoui, Laura Monfort, Laurent Zerat, Kari Syrjänen. (2008) Detection of Human Papillomavirus Genotypes Among High-Risk Women: A Comparison of Hybrid Capture and Linear Array Tests. Sexually Transmitted Diseases 35:5, 521-527
CrossRef764
Brigitte Samama, Christiane Schaeffer, Nelly Boehm. (2008) P16 expression in relation to human papillomavirus in liquid-based cervical smears. Gynecologic Oncology 109:2, 285-290
CrossRef765
Bhudev C. Das, Showket Hussain, Vilas Nasare, Mausumi Bharadwaj. (2008) Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 26:22, 2669-2679
CrossRef766
Karen J Nishida, J Matthew Pearson, Leo B Twiggs. (2008) Cross-protection from human papillomavirus 16/18 against types 45 and 31: fact or fancy?. Therapy 5:3, 265-268
CrossRef767
Giuseppina Capra, Lucia Giovannelli, Carmelina Bellavia, Maria Colomba Migliore, Maria Pia Caleca, Antonio Perino, Pietro Ammatuna. (2008) HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy. Virus Research 133:2, 195-200
CrossRef768
Andreas M Kaufmann, Achim Schneider. (2008) Therapeutic human papillomavirus vaccination. Therapy 5:3, 339-348
CrossRef769
Xavier Castellsagué, JoEllen Klaustermeier, Carla Carrilho, Ginesa Albero, Jahit Sacarlal, Wim Quint, Bernhard Kleter, Belen Lloveras, Mamudo Rafik Ismail, Silvia de Sanjosé, F. Xavier Bosch, Pedro Alonso, Clara Menéndez. (2008) Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: Burden and potential for prevention. International Journal of Cancer 122:8, 1901-1904
CrossRef770
H. H. Alphs, R. Gambhira, B. Karanam, J. N. Roberts, S. Jagu, J. T. Schiller, W. Zeng, D. C. Jackson, R. B. S. Roden. (2008) Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. Proceedings of the National Academy of Sciences 105:15, 5850-5855
CrossRef771
O Bruland, Ø Fluge, H Immervoll, L Balteskard, M P Myklebust, A Skarstein, O Dahl. (2008) Gene expression reveals two distinct groups of anal carcinomas with clinical implications. British Journal of Cancer 98:7, 1264-1273
CrossRef772
Chien-Fu Hung, Barbara Ma, Archana Monie, Shaw-Wei Tsen, T-C Wu. (2008) Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opinion on Biological Therapy 8:4, 421-439
CrossRef773
Bruce E. Herman, Howard M. Corneli. (2008) A Practical Approach to Warts in the Emergency Department. Pediatric Emergency Care 24:4, 246-251
CrossRef774
C. Protzel, C. Kakies, B. Kleist, M. Poetsch, J. Giebel. (2008) Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma. Virchows Archiv 452:4, 369-375
CrossRef775
Kwangsoo Kim, Hong Seo Ryoo. (2008) A LAD-based method for selecting short oligo probes for genotyping applications. OR Spectrum 30:2, 249-268
CrossRef776
Tibor Takács, Csaba Jeney, Laura Kovács, Johanna Mózes, Márta Benczik, Attila Sebe. (2008) Molecular beacon-based real-time PCR method for detection of 15 high-risk and 5 low-risk HPV types. Journal of Virological Methods 149:1, 153-162
CrossRef777
Nikolai Mühlberger, Gaby Sroczynski, Eva Esteban, Thomas Mittendorf, Rebecca A. Miksad, Uwe Siebert. (2008) Cost-effectiveness of primarily human papillomavirus–based cervical cancer screening in settings with currently established Pap screening: A systematic review commissioned by the German Federal Ministry of Health. International Journal of Technology Assessment in Health Care 24:02,
CrossRef778
Jean-François Gélinas, John Manoukian, Aurore Côté. (2008) Lung involvement in juvenile onset recurrent respiratory papillomatosis: A systematic review of the literature. International Journal of Pediatric Otorhinolaryngology 72:4, 433-452
CrossRef779
Min LIN, Li-Ye YANG, Lie-Jun LI, Jiao-Ren WU, You-Peng PENG, Zhao-Yun LUO. (2008) Genital human papillomavirus screening by gene chip in Chinese women of Guangdong province. The Australian and New Zealand Journal of Obstetrics and Gynaecology 48:2, 189-194
CrossRef780
Philip E. Castle, J Thomas Cox, Jose Jeronimo, Diane Solomon, Cosette M. Wheeler, Patti E. Gravitt, Mark Schiffman. (2008) An Analysis of High-Risk Human Papillomavirus DNA-Negative Cervical Precancers in the ASCUS-LSIL Triage Study (ALTS). Obstetrics & Gynecology 111:4, 847-856
CrossRef781
J DEANTONIO, A FERNANDEZOLMOS, M MERCADILLO, M LINDEMANN, F MOCHALES. (2008) Detection of high-risk human papillomavirus by two molecular techniques: Hybrid capture and linear array. Journal of Virological Methods 149:1, 163-166
CrossRef782
Bo Liu, Dongxia Ye, Xinxin Song, Xinhua Zhao, Linan Yi, Jietao Song, Zhiyuan Zhang, Qingzheng Zhao. (2008) A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis. Vaccine 26:10, 1387-1396
CrossRef783
Cheryl M. Travasso, Mona Anand, Mansi Samarth, Aditi Deshpande, Chandan Kumar-Sinha. (2008) Human papillomavirus genotyping by multiplex pyrosequencing in cervical cancer patients from India. Journal of Biosciences 33:1, 73-80
CrossRef784
Eliav Barr, Christine K. Gause, Oliver M. Bautista, Radha A. Railkar, Lisa C. Lupinacci, Ralph P. Insinga, Heather L. Sings, Richard M. Haupt. (2008) Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women. American Journal of Obstetrics and Gynecology 198:3, 261.e1-261.e11
CrossRef785
Michael Waugh. (2008) Genital Human Papilloma Virus Infection: Advances in Prevention for the Long-Term Good of All. SKINmed 7:2, 87-88
CrossRef786
Y. DAI, Y.S. HUANG, M. TANG, X.P. LV, T.Y. LI, Y.B. YIN. (2008) Distribution and clinical significance of human papillomavirus subtypes in Shenzhen city, People’s Republic of China. International Journal of Gynecological Cancer 18:2, 295-299
CrossRef787
A. Bardin, S. Vaccarella, G.M. Clifford, J. Lissowska, M. Rekosz, P. Bobkiewicz, J. Kupryjańczyk, R. Krynicki, J. Jonska-Gmyrek, A. Danska-Bidzinska, P.J.F. Snijders, C.J.L.M. Meijer, W. Zatonski, S. Franceschi. (2008) Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. European Journal of Cancer 44:4, 557-564
CrossRef788
Sumalee Siriaunkgul, Supaporn Suwiwat, Jongkolnee Settakorn, Surapan Khunamornpong, Kobkul Tungsinmunkong, Anusorn Boonthum, Vipavadee Chaisuksunt, Suree Lekawanvijit, Jatupol Srisomboon, Paul S. Thorner. (2008) HPV genotyping in cervical cancer in Northern Thailand. Gynecologic Oncology 108:3, 555-560
CrossRef789
Veerle MH Coupé, Johannes Berkhof. (2008) Human papillomavirus testing improves follow-up after treatment for cervical intraepithelial neoplasia. Women's Health 4:2, 103-105
CrossRef790
Thomas Hiller, Frank Stubenrauch, Thomas Iftner. (2008) Isolation and functional analysis of five HPVE6 variants with respect to p53 degradation. Journal of Medical Virology 80:3, 478-483
CrossRef791
Christine Orlova Urman, Alice B. Gottlieb. (2008) New viral vaccines for dermatologic disease. Journal of the American Academy of Dermatology 58:3, 361-370
CrossRef792
M. MANAVI, G. HUDELIST, A. FINK-RETTER, D. GSCHWANTLER-KAULICH, K. PISCHINGER, K. CZERWENKA. (2008) Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women. International Journal of Gynecological Cancer 18:2, 285-294
CrossRef793
Bobbie C Sutton, Richard A Allen, William E Moore, S Terence Dunn. (2008) Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva. Modern Pathology 21:3, 345-354
CrossRef794
Ann Nielsen, Susanne Krüger Kjaer, Christian Munk, Thomas Iftner. (2008) Type-Specific HPV Infection and Multiple HPV Types: Prevalence and Risk Factor Profile in Nearly 12,000 Younger and Older Danish Women. Sexually Transmitted Diseases 35:3, 276-282
CrossRef795
KJETIL K. GULDBAKKE, JOSHUA BRODSKY, MICHELLE LIANG, CARL F. SCHANBACHER. (2008) Human Papillomavirus Type 73 in Primary and Recurrent Periungual Squamous Cell Carcinoma. Dermatologic Surgery 34:3, 407-413
CrossRef796
Wei Chen, Yong Zhao, Xiu-wu Bian. (2008) Inhibitory effect of Nordy on HPV16 E6 gene in human immortalized endocervical cells. Chinese Journal of Cancer Research 20:1, 1-4
CrossRef797
Javier Pintos, Martin J. Black, Nader Sadeghi, Parviz Ghadirian, Anthony G. Zeitouni, Raphael P. Viscidi, Rolando Herrero, François Coutlée, Eduardo L. Franco. (2008) Human papillomavirus infection and oral cancer: A case-control study in Montreal, Canada. Oral Oncology 44:3, 242-250
CrossRef798
D. van Hamont, R. L. M. Bekkers, L. F. A. G. Massuger, W. J. G. Melchers. (2008) Detection, management, and follow-up of pre-malignant cervical lesions and the role for human papillomavirus. Reviews in Medical Virology 18:2, 117-132
CrossRef799
Steven L. Kahn, Brigitte M. Ronnett, Patti E. Gravitt, Karen S. Gustafson. (2008) Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests. Cancer 114:1, 57-64
CrossRef800
Jillian de Wilde, Saskia M. Wilting, Chris J.L.M. Meijer, Mark A. van de Wiel, Bauke Ylstra, Peter J.F. Snijders, Renske D.M. Steenbergen. (2008) Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer. International Journal of Cancer 122:4, 877-888
CrossRef801
V M H Coupé, J Berkhof, N W J Bulkmans, P J F Snijders, C J L M Meijer. (2008) Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening. British Journal of Cancer 98:3, 646-651
CrossRef802
Elisabete A. Campos, José Antonio Simões, Silvia H. Rabelo-Santos, Luis Otávio Sarian, Denise Rocha Pitta, José Eduardo Levi, Sophie Derchain. (2008) Recovery of DNA for the detection and genotyping of human papillomavirus from clinical cervical specimens stored for up to 2 years in a universal collection medium with denaturing reagent. Journal of Virological Methods 147:2, 333-337
CrossRef803
Mi-Kyung Woo, Jung-Mo An, Jun-Dong Kim, Sue-Nie Park, Hong-Jin Kim. (2008) Expression and purification of human papillomavirus 18 L1 virus-like particle from Saccharomyces cerevisiae. Archives of Pharmacal Research 31:2, 205-209
CrossRef804
Sytse J. Piersma, Marij J.P. Welters, Jeanette M. van der Hulst, Judith N. Kloth, Kitty M.C. Kwappenberg, Baptist J. Trimbos, Cornelis J.M. Melief, Bart W. Hellebrekers, Gert Jan Fleuren, Gemma G. Kenter, Rienk Offringa, Sjoerd H. van der Burg. (2008) Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and –DP as a restriction element. International Journal of Cancer 122:3, 486-494
CrossRef805
Matthew P. Stevens, Suzanne M. Garland, Sepehr N. Tabrizi. (2008) Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler® 480 system. Journal of Virological Methods 147:2, 290-296
CrossRef806
L.Z. Mo, S. Monnier-Benoit, B. Kantelip, A. Petitjean, D. Riethmuller, J.L. Prétet, C. Mougin. (2008) Comparison of AMPLICOR® and Hybrid Capture II® assays for high risk HPV detection in normal and abnormal liquid-based cytology: Use of INNO-LiPA Genotyping assay to screen the discordant results. Journal of Clinical Virology 41:2, 104-110
CrossRef807
Ni Sima, Wei Wang, Debo Kong, Dongrui Deng, Qian Xu, Jianfeng Zhou, Gang Xu, Li Meng, Yunping Lu, Shixuan Wang, Ding Ma. (2008) RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Apoptosis 13:2, 273-281
CrossRef808
Kanlaya Wongworapat, Rassamee Keawvichit, Bangorn Sirirojn, Sirikwan Dokuta, Cholticha Ruangyuttikarn, Somchai Sriplienchan, Auchara Sontirat, Kanitta Thai Kla, Patti E. Gravitt, David D. Celentano. (2008) Detection of Human Papillomavirus From Self-Collected Vaginal Samples of Women in Chiang Mai, Thailand. Sexually Transmitted Diseases 35:2, 172-173
CrossRef809
Isabelle Heard. (2008) La fin du cancer du col de l'utérus grâce á la vaccination?. Revue Francophone des Laboratoires 2008:399, 6-8
CrossRef810
Shreya Kanodia, Diane M. Da Silva, W. Martin Kast. (2008) Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions. International Journal of Cancer 122:2, 247-259
CrossRef811
Jean-Luc Prétet, Anne-Carole Jacquard, Xavier Carcopino, Jean-François Charlot, Damien Bouhour, Bernadette Kantelip, Benoit Soubeyrand, Yann Leocmach, Christiane Mougin, Didier Riethmuller, . (2008) Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study. International Journal of Cancer 122:2, 428-432
CrossRef812
Jean-Luc Prétet, Anne-Carole Jacquard, Xavier Carcopino, Sylvain Monnier-Benoit, Gerlinde Averous, Benoit Soubeyrand, Yann Leocmach, Christiane Mougin, Didier Riethmuller, . (2008) Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. International Journal of Cancer 122:2, 424-427
CrossRef813
Prabodh K. Gupta, Cindy McGrath. 2008. Microbiology, Inflammation, and Viral infections. , 91-129.
CrossRef814
Camille C. Rose Ragin, Emanuela Taioli. (2008) Second primary head and neck tumor risk in patients with cervical cancer—SEER data analysis. Head & Neck 30:1, 58-66
CrossRef815
Magnus von Knebel Doeberitz, Nicolas Wentzensen. 2008. The Cell: Basic Structure and Function. , 3-22.
CrossRef816
J. Mariategui, C. Santos, L. Taxa, J. Jeronimo, P.E. Castle. (2008) Comparison of depth of necrosis achieved by CO2- and N2O-cryotherapy. International Journal of Gynecology & Obstetrics 100:1, 24-26
CrossRef817
Ritu Nayar, David C. Wilbur, Diane Solomon. 2008. The Bethesda System for Reporting Cervical Cytology. , 77-90.
CrossRef818
Y.-P. BAO, N. LI, J.S. SMITH, Y.-L. QIAO, . (2008) Human papillomavirus type distribution in women from Asia: a meta-analysis. International Journal of Gynecological Cancer 18:1, 71-79
CrossRef819
W. Muranyi, M. Knebel Doeberitz. (2008) Hautveränderungen durch Papillomviren nach Nierentransplantation. Der Nephrologe 3:1, 30-35
CrossRef820
Howard Minkoff, Ye Zhong, Howard D. Strickler, D. Heather Watts, Joel M. Palefsky, Alexandra M. Levine, Gypsyamber D'Souza, Andrea A. Howard, Michael Plankey, L. Stewart Massad, Robert Burk. (2008) The Relationship between Cocaine Use and Human Papillomavirus Infections in HIV-Seropositive and HIV-Seronegative Women. Infectious Diseases in Obstetrics & Gynecology 2008, 1-7
CrossRef821
G SCHNEIDER. 2008. Human Papillomavirus and Cervical Dysplasia. , 202-210.
CrossRef822
Alison Hann, Stephen Peckham. (2008) To vaccinate or to screen—is that the question?. The International Journal of Health Planning and Management 23:1, 69-78
CrossRef823
D. HONG, F. YE, H. CHEN, W. LÜ, Q. CHENG, Y. HU, X. XIE. (2008) Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China. International Journal of Gynecological Cancer 18:1, 104-109
CrossRef824
Xavier Castellsagué Piqué, F. Xavier Bosch José. (2008) Vacunas frente al virus del papiloma humano. Enfermedades Infecciosas y Microbiología Clínica 26, 65-77
CrossRef825
Maria Lina Tornesello, Maria Luisa Duraturo, Simona Losito, Gerardo Botti, Silvana Pilotti, Bernardina Stefanon, Giuseppe De Palo, Antonio Gallo, Luigi Buonaguro, Franco M Buonaguro. (2008) Human papillomavirus genotypes and HPV16 variants in penile carcinoma. International Journal of Cancer 122:1, 132-137
CrossRef826
Mohsen Esmaeili, Mortaza Bonyadi, Ali Dastranj, Masoumeh Alizadeh, Manizheh Sayyah Melli, Mehri Jafari Shobeiri. (2008) HPV Typing in Women with Cervical Precancerous and Cancerous Lesions in Northwestern Iran. Gynecologic and Obstetric Investigation 66:1, 68-72
CrossRef827
L. H. S. Oliveira, M. L. G. Rosa, S. M. B. Cavalcanti. (2008) Patterns of genotype distribution in multiple human papillomavirus infections. Clinical Microbiology and Infection 14:1, 60-65
CrossRef828
Gudrun C. Rieck, Alison N. Fiander. (2008) Human papillomavirus, cervical carcinogenesis and chemoprevention with Indole derivates – a review of pathomechanisms. Molecular Nutrition & Food Research 52:1, 105-113
CrossRef829
Kyung Hyo Kim. (2008) Human Papillomavirus Vaccine. Journal of the Korean Medical Association 51:2, 144
CrossRef830
M DEFRANCESCO, F GARGIULO, C SCHREIBER, G CIRAVOLO, F SALINARO, N MANCA. (2008) Comparison of the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay for detection of high-risk human papillomavirus in women with abnormal PAP smear. Journal of Virological Methods 147:1, 10-17
CrossRef831
Enrique Lerma, Marisa Romero, Alberto Gallardo, Cristina Pons, Josefina Muñoz, Josefina Fuentes, Belen Lloveras, Lluis Catasus, Jaime Prat. (2008) Prognostic significance of the Fas-receptor/Fas-ligand system in cervical squamous cell carcinoma. Virchows Archiv 452:1, 65-74
CrossRef832
Francesco Broccolo, G. Cassina, S. Chiari, R. Garcia-Parra, A. Villa, B.E. Leone, A. Brenna, G. Locatelli, C. Mangioni, C.E. Cocuzza. (2008) Frequency and clinical significance of human β-herpesviruses in cervical samples from Italian women. Journal of Medical Virology 80:1, 147-153
CrossRef833
T. YOSHIDA, T. SANO, T. KANUMA, N. OWADA, S. SAKURAI, T. FUKUDA, T. NAKAJIMA. (2008) Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions. International Journal of Gynecological Cancer 18:1, 121-127
CrossRef834
Monika Hampl. (2008) Impfung gegen humane Papillomaviren. Eine neue Präventionsstrategie gegen Krebs. Pharmazie in unserer Zeit 37:1, 78-85
CrossRef835
Katerina Strati, Paul F Lambert. (2008) Human papillomavirus association with head and neck cancers: understanding virus biology and using it in the development of cancer diagnostics. Expert Opinion on Medical Diagnostics 2:1, 11-20
CrossRef836
Richard Crosby, Lee Warner. (2008) Pending research issues in male condom use promotion. Sexual Health 5:4, 317
CrossRef837
R. Z. Rizk, N. D. Christensen, K. M. Michael, M. Muller, P. Sehr, T. Waterboer, M. Pawlita. (2008) Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. Journal of General Virology 89:1, 117-129
CrossRef838
Lukas Bubendorf, Hans Jürgen Grote, Kari Syrjänen. 2008. Molecular Techniques. , 1071-1090.
CrossRef839
Milana Panjkovic, Tatjana Ivkovic-Kapicl. (2008) Etiology and pathogenesis of precancerous lesions and invasive cervical carcinoma. Medicinski pregled 61:7-8, 364-368
CrossRef840
J PAAVONEN. (2007) Human papillomavirus infection and the development of cervical cancer and related genital neoplasias. International Journal of Infectious Diseases 11, S3-S9
CrossRef841
Serge J. Smeets, Albertus T. Hesselink, Ernst-Jan M. Speel, Annick Haesevoets, Peter J.F. Snijders, Michael Pawlita, Chris J.L.M. Meijer, Boudewijn J.M. Braakhuis, C. René Leemans, Ruud H. Brakenhoff. (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. International Journal of Cancer 121:11, 2465-2472
CrossRef842
Magnus Lindh, Staffan Görander, Elin Andersson, Peter Horal, Inger Mattsby-Balzer, Walter Ryd. (2007) Real-time Taqman PCR targeting 14 human papilloma virus types. Journal of Clinical Virology 40:4, 321-324
CrossRef843
Efstathia Panotopoulou, Aliki Tserkezoglou, Maria Kouvousi, Ioanna Tsiaousi, George Chatzieleftheriou, Demitra Daskalopoulou, George Magiakos. (2007) Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women. Journal of Medical Virology 79:12, 1898-1905
CrossRef844
Luisa Lina Villa. (2007) Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine. International Journal of Infectious Diseases 11, S17-S25
CrossRef845
Angela Pista, Ana Oliveira, Andreia Barateiro, Helena Costa, Nuno Verdasca, Maria Teresa Paixão. (2007) Molecular variants of human papillomavirus type 16 and 18 and risk for cervical Neoplasia in Portugal. Journal of Medical Virology 79:12, 1889-1897
CrossRef846
Lucia Giovannelli, Carmelina Bellavia, Giuseppina Capra, Maria Colomba Migliore, MariaPia Caleca, Maria Giglio, Antonio Perino, Domenica Matranga, Pietro Ammatuna. (2007) HPV group- and type-specific concordance in HPV infected sexual couples. Journal of Medical Virology 79:12, 1882-1888
CrossRef847
Amy A. Hakim, Paul S. Lin, Sharon Wilczynski, Kimhuynh Nguyen, Billie Lynes, Mark T. Wakabayashi. (2007) Indications and Efficacy of the Human Papillomavirus Vaccine. Current Treatment Options in Oncology 8:6, 393-401
CrossRef848
William W. Au, Salama Abdou-Salama, Carlos H. Sierra-Torres, Ayman Al-Hendy. (2007) Environmental risk factors for prevention and molecular intervention of cervical cancer. International Journal of Hygiene and Environmental Health 210:6, 671-678
CrossRef849
H PEIGUELAFEUILLE. (2007) Les vaccins contre les papillomavirus: enjeux et débats. La Revue de Médecine Interne 28:12, 805-809
CrossRef850
Francisco A.R. Garcia, Debbie Saslow. (2007) Prophylactic Human Papillomavirus Vaccination: A Breakthrough in Primary Cervical Cancer Prevention. Obstetrics and Gynecology Clinics of North America 34:4, 761-781
CrossRef851
F E Henken, S M Wilting, R M Overmeer, J G I van Rietschoten, A O H Nygren, A Errami, J P Schouten, C J L M Meijer, P J F Snijders, R D M Steenbergen. (2007) Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. British Journal of Cancer 97:10, 1457-1464
CrossRef852
Jenny Briolat, Véronique Dalstein, Maëlle Saunier, Karine Joseph, Stéphanie Caudroy, Jean-Luc Prétet, Philippe Birembaut, Christine Clavel. (2007) HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. International Journal of Cancer 121:10, 2198-2204
CrossRef853
Sharon Guilfoyle, Rebeca Franco, Sherri Sheinfeld Gorin. (2007) Exploring Older Women's Approaches to Cervical Cancer Screening. Health Care for Women International 28:10, 930-950
CrossRef854
R. Nicollas, M. Henry, J.M. Triglia, C. Tamalet. (2007) HPV type 6 and 16 co-infection in a 11-year-old girl presenting laryngeal papillomatosis. Journal of Clinical Virology 40:3, 252-254
CrossRef855
Kevin A. Ault. (2007) Human papillomavirus vaccines and the potential for cross-protection between related HPV types. Gynecologic Oncology 107:2, S31-S33
CrossRef856
M.M. INAL, Ş. KÖSE, Y. YILDIRIM, Y. ÖZDEMIR, E. TÖZ, K. ERTOPÇU, İ. ÖZELMAS, Ş. TINAR. (2007) The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. International Journal of Gynecological Cancer 17:6, 1266-1270
CrossRef857
Bradley J. Monk, Krishnansu S. Tewari. (2007) The spectrum and clinical sequelae of human papillomavirus infection. Gynecologic Oncology 107:2, S6-S13
CrossRef858
C. Derancourt. (2007) Prophylaxie vaccinale de l’infection à papillomavirus humains. Annales de Dermatologie et de Vénéréologie 134:11, 882-885
CrossRef859
(2007) Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. The Lancet 370:9599, 1609-1621
CrossRef860
A. Potthoff, N.H. Brockmeyer, . (2007) Immundefizienz und Krebs. Der Onkologe 13:11, 993-999
CrossRef861
Bernard Duval, Vladimir Gilca, Shelly McNeil, Simon Dobson, Deborah Money, Ian M. Gemmill, Chantal Sauvageau, France Lavoie, Manale Ouakki. (2007) Vaccination against human papillomavirus: A baseline survey of Canadian clinicians’ knowledge, attitudes and beliefs. Vaccine 25:45, 7841-7847
CrossRef862
Marc Steben, Eliane Duarte-Franco. (2007) Human papillomavirus infection: Epidemiology and pathophysiology. Gynecologic Oncology 107:2, S2-S5
CrossRef863
Alicia Algeciras-Schimnich, Frank Policht, Svetlana Sitailo, Minghao Song, Larry Morrison, Irina Sokolova. (2007) Evaluation of quantity and staining pattern of human papillomavirus (HPV)-infected epithelial cells in thin-layer cervical specimens using optimized HPV-CARD assay. Cancer 111:5, 330-338
CrossRef864
Stefan Duensing, Patrick S. Moore, Julie Parsonnet. 2007. Infectious Agents and Cancer. .
CrossRef865
W CHEN. (2007) Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior. Virology 367:1, 168-174
CrossRef866
M MANSOUR. (2007) E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development. Virology 367:1, 1-9
CrossRef867
Mako Narisawa-Saito, Tohru Kiyono. (2007) Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Science 98:10, 1505-1511
CrossRef868
A. Handisurya, A. Rieger, A. Bankier, A. Koller, A. Salat, G. Stingl, R. Kirnbauer. (2007) Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy. British Journal of Dermatology 157:4, 788-794
CrossRef869
S. Kösel, S. Burggraf, W. Engelhardt, B. Olgemöller. (2007) Increased levels of HPV16 E6*I transcripts in high-grade cervical cytology and histology (CIN II+) detected by rapid real-time RT-PCR amplification. Cytopathology 18:5, 290-299
CrossRef870
A. Kreuter, N.H. Brockmeyer, P. Altmeyer, H. Pfister, U. Wieland, . (2007) Rapid onset of multifocal human papillomavirus 72-associated oral intraepithelial neoplasia in a human immunodeficiency virus-infected patient. British Journal of Dermatology 157:4, 826-828
CrossRef871
Kay Park, Lora H. Ellenson, Edyta C. Pirog. (2007) Low-Grade Squamous Intraepithelial Lesions of the Cervix With Marked Cytological Atypia-Clinical Follow-Up and Human Papillomavirus Genotyping. International Journal of Gynecological Pathology 26:4, 457-462
CrossRef872
Salaheddin M. Mahmud, Anita Koushik, Eliane Duarte-Franco, Joana Costa, Gabriela Fontes, Manuel Bicho, François Coutlée, Eduardo L. Franco. (2007) Haptoglobin phenotype and risk of cervical neoplasia: A case-control study. Clinica Chimica Acta 385:1-2, 67-72
CrossRef873
Snježana Židovec Lepej, Ivana Grgić, Mario Poljak, Janja Iščić-Beš, Višnja Škerk, Davor B. Vince, Davorka Dušek, Adriana Vince. (2007) Detection of human papillomavirus genotypes 16/18/45 by hybrid capture hybridisation genotyping probe in clinical specimens: The first report. Journal of Clinical Virology 40:2, 171-172
CrossRef874
Miguel A. Márquez-Gutiérrez, María L. Benítez-Hess, Joseph A. DiPaolo, Luis M. Alvarez-Salas. (2007) Effect of Combined Antisense Oligodeoxynucleotides Directed against the Human Papillomavirus Type 16 on Cervical Carcinoma Cells. Archives of Medical Research 38:7, 730-738
CrossRef875
Yu-Jeung Lee. (2007) Human Papillomavirus Vaccine. The Journal of Applied Pharmacology 15:3, 133-136
CrossRef876
Kari Syrjänen, Irena Shabalova, Nicolay Petrovichev, Vladimir Kozachenko, Tatjana Zakharova, Julia Pajanidi, Jurij Podistov, Galina Chemeris, Larisa Sozaeva, Elena Lipova, Irena Tsidaeva, Olga Ivanchenko, Alla Pshepurko, Sergej Zakharenko, Raisa Nerovjna, Ludmila Kljukina, Oksana Erokhina, Marina Branovskaja, Maritta Nikitina, Valerija Grunberga, Alexandr Grunberg, Anna Juschenko, Rosa Santopietro, Marcella Cintorino, Piero Tosi, Stina Syrjänen. (2007) Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN. European Journal of Epidemiology 22:10, 723-735
CrossRef877
Jo-Ann S. Passmore, Dianne J. Marais, Candice Sampson, Bruce Allan, Neelofar Parker, Michelle Milner, Lynnette Denny, Anna-Lise Williamson. (2007) Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia. Journal of Medical Virology 79:9, 1375-1380
CrossRef878
B. Gellin, J. F. Modlin, E. Barr, G. Tamms. (2007) Quadrivalent Human Papillomavirus Vaccine. Clinical Infectious Diseases 45:5, 609-617
CrossRef879
Xiu-Li Wang, Hong-Wei Wang, Zheng Huang, Herbert Stepp, Reinhold Baumgartner, Christian Dannecker, Peter Hillemanns. (2007) Study of Protoporphyrin IX (PpIX) Pharmacokinetics After Topical Application of 5-Aminolevulinic Acid in Urethral Condylomata Acuminata. Photochemistry and Photobiology 83:5, 1069-1073
CrossRef880
Gary Michael Ginsberg, Menachem Fisher, Inbar Ben-Shahar, Jacob Bornstein. (2007) Cost–utility analysis of vaccination against HPV in Israel. Vaccine 25:37-38, 6677-6691
CrossRef881
Sabrina S. Plitt, Susan G. Sherman, Raphael P. Viscidi, Steffanie A. Strathdee, Crystal M. Fuller, Taha E. Taha. (2007) Human Papillomavirus Seroprevalence Among Young Male and Female Drug Users. Sexually Transmitted Diseases 34:9, 676-680
CrossRef882
Karen Orjuela, Catalina Amador, Manuel A. Patarroyo. (2007) Synthetic genes: a tool for identifying human papillomavirus genotypes by hybridization and polymerase chain reaction-based assays. Diagnostic Microbiology and Infectious Disease 59:1, 101-104
CrossRef883
Barbara Tringler, Christoph Grimm, Grazyna Dudek, Robert Zeillinger, Clemens Tempfer, Paul Speiser, Elmar Joura, Alexander Reinthaller, Lukas A. Hefler. (2007) p16INK4a Expression in Invasive Vulvar Squamous Cell Carcinoma. Applied Immunohistochemistry & Molecular Morphology 15:3, 279-283
CrossRef884
G Sanclemente, S Herrera, SK Tyring, PL Rady, J-J Zuleta, L-A Correa, Q He, J-C Wolff. (2007) Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia. Journal of the European Academy of Dermatology and Venereology 21:8, 1054-1060
CrossRef885
Mark H. Einstein, Anna S. Kadish, Robert D. Burk, Mimi Y. Kim, Scott Wadler, Howard Streicher, Gary L. Goldberg, Carolyn D. Runowicz. (2007) Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecologic Oncology 106:3, 453-460
CrossRef886
Tiffany G Harris, Robert D Burk, Xiaonan Xue, Kathryn Anastos, Howard Minkoff, L Stewart Massad, Mary A Young, Alexandra M Levine, Stephen J Gange, D Heather Watts, Joel M Palefsky, Howard D Strickler. (2007) Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women. AIDS 21:14, 1933-1941
CrossRef887
Nicolas Clere, Laurent Bermont, Sylvie Fauconnet, Isabelle Lascombe, Maëlle Saunier, Lucie Vettoretti, Marie-Laure Plissonnier, Christiane Mougin. (2007) The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism. Experimental Cell Research 313:15, 3239-3250
CrossRef888
P. MENDOZA-LORENZO, R. MALDONADO, R. PACHECO, A. MÉNDEZ, P. PIÑA-SÁNCHEZ, A. RANGEL, G. VAZQUEZ-ORTÍZ, M. SALCEDO. (2007) An oligoarray for the detection of human papillomavirus type 16 variants. International Journal of Gynecological Cancer 17:5, 1083-1091
CrossRef889
L.D. Roman, S. Wilczynski, L.I. Muderspach, A.F. Burnett, A. O'Meara, J.A. Brinkman, W.M. Kast, G. Facio, J.C. Felix, M. Aldana, J.S. Weber. (2007) A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. Gynecologic Oncology 106:3, 558-566
CrossRef890
Susanna Esposito, Samantha Bosis, Claudio Pelucchi, Enrica Begliatti, Alessandro Rognoni, Marta Bellasio, Francesca Tel, Silvia Consolo, Nicola Principi. (2007) Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention. Vaccine 25:35, 6437-6446
CrossRef891
M Jit, A Vyse, R Borrow, R Pebody, K Soldan, E Miller. (2007) Prevalence of human papillomavirus antibodies in young female subjects in England. British Journal of Cancer
CrossRef892
Iver Petersen, Christiane Schewe, Karsten Schlüns, Manfred Dietel, Norbert Speich, Christoph Schmitt, Magdolna Bollmann, Karl Sotlar, Burkhard Bültmann, Maria T. Dours-Zimmermann, Barbara Padberg, Dieter R. Zimmermann. (2007) Inter-laboratory validation of PCR-based HPV detection in pathology specimens. Virchows Archiv 451:3, 701-716
CrossRef893
Alejandro García Carrancá, Silvia C Galván. (2007) Vaccines against human papillomavirus: perspectives for controlling cervical cancer. Expert Review of Vaccines 6:4, 497-510
CrossRef894
Alex Ferenczy, Eduardo L Franco. (2007) Prophylactic human papillomavirus vaccines: potential for sea change. Expert Review of Vaccines 6:4, 511-525
CrossRef895
CFM Prinsen, R Fles, CW Wijnen-Dubbers, HA de Valk, CHW Klaassen, M Mravunac, AM Horrevorts, FBJM Thunnissen. (2007) Baseline human papillomavirus status of women with abnormal smears in cervical screening: a 5-year follow-up study in the Netherlands. BJOG: An International Journal of Obstetrics & Gynaecology 114:8, 951-957
CrossRef896
Sally E. Jensen, Brandy Lehman, Michael H. Antoni, Deidre B. Pereira. (2007) Virally mediated cervical cancer in the iatrogenically immunocompromised: Applications for psychoneuroimmunology. Brain, Behavior, and Immunity 21:6, 758-766
CrossRef897
Daniela Dell’Atti, Michele Zavaglia, Sara Tombelli, Gloria Bertacca, Andrea O. Cavazzana, Generoso Bevilacqua, Maria Minunni, Marco Mascini. (2007) Development of combined DNA-based piezoelectric biosensors for the simultaneous detection and genotyping of high risk Human Papilloma Virus strains. Clinica Chimica Acta 383:1-2, 140-146
CrossRef898
V.K. Madkan, R.H. Cook-Norris, M.C. Steadman, A. Arora, N. Mendoza, S.K. Tyring. (2007) The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors. British Journal of Dermatology 157:2, 228-241
CrossRef899
C. KROUPIS, G. THOMOPOULOU, T. G. PAPATHOMAS, N. VOURLIDIS, A. C. LAZARIS. (2007) Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece. Epidemiology and Infection 135:06, 943
CrossRef900
Guillem Sirera, Sebastià Videla, Raquel López-Blázquez, Mariona Llatjos, Antoni Tarrats, Eva Castellà, Nuria Grane, Carmen Alcalde, Cristina Tural, Celestino Rey-Joly, Bonaventura Clotet. (2007) Evolution of Cervical Cytologic Changes among HIV-Infected Women with Normal Cytology in the HAART Era. AIDS Research and Human Retroviruses 23:8, 965-971
CrossRef901
Ni Sima, Shixuan Wang, Wei Wang, Debo Kong, Qian Xu, Xu Tian, Aiyue Luo, Jianfeng Zhou, Gang Xu, Li Meng, Yunping Lu, Ding Ma. (2007) Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Gynecologic Oncology 106:2, 299-304
CrossRef902
Ni Sima, Liping Cai, Yuanfang Zhu, Wei Wang, Shixuan Wang, Ding Ma. (2007) Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma. Journal of Huazhong University of Science and Technology 27:4, 451-453
CrossRef903
Cecilia Wahlström, Thomas Iftner, Joakim Dillner, Lena Dillner, . (2007) Population-based study of screening test performance indices of three human papillomavirus DNA tests. Journal of Medical Virology 79:8, 1169-1175
CrossRef904
S. H. van der Burg, S. J. Piersma, A. de Jong, J. M. van der Hulst, K. M. C. Kwappenberg, M. van den Hende, M. J. P. Welters, J. J. Van Rood, G. J. Fleuren, C. J. M. Melief, G. G. Kenter, R. Offringa. (2007) Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. Proceedings of the National Academy of Sciences 104:29, 12087-12092
CrossRef905
Paul K.S. Chan, Tak-Hong Cheung, C. K. Lin, Shing-Shun N. Siu, So-Fan Yim, Keith W.K. Lo, Jo L. K. Cheung, Ann O.Y. Tam, Julian W. Tang. (2007) Association Between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese. Journal of Medical Virology 79:7, 970-976
CrossRef906
Gypsyamber D'Souza, Carole Fakhry, Elizabeth A. Sugar, Eric C. Seaberg, Kathleen Weber, Howard L. Minkoff, Kathryn Anastos, Joel M. Palefsky, Maura L. Gillison. (2007) Six-month natural history of oralversus cervical human papillomavirus infection. International Journal of Cancer 121:1, 143-150
CrossRef907
Jose Jeronimo, L. Stewart Massad, Mark Schiffman. (2007) Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type. American Journal of Obstetrics and Gynecology 197:1, 47.e1-47.e8
CrossRef908
S DUNN, R ALLEN, S WANG, J WALKER, M SCHIFFMAN. (2007) DNA extraction: An understudied and important aspect of HPV genotyping using PCR-based methods. Journal of Virological Methods 143:1, 45-54
CrossRef909
Sanjay Gupta, Veena Singh, Ashok Sehgal, Pushpa Sodhani. (2007) Cervical cancer in resource-limited settings: preventable but not yet prevented. Expert Review of Obstetrics & Gynecology 2:4, 515-527
CrossRef910
Marc Brisson, Nicolas Van de Velde, Philippe De Wals, Marie-Claude Boily. (2007) The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine 25:29, 5399-5408
CrossRef911
Yusuke Hiraku, Tsutomu Tabata, Ning Ma, Mariko Murata, Xiaohui Ding, Shosuke Kawanishi. (2007) Nitrative and oxidative DNA damage in cervical intraepithelial neoplasia associated with human papilloma virus infection. Cancer Science 98:7, 964-972
CrossRef912
Zigui Chen, Leiping Fu, Rolando Herrero, Mark Schiffman, Robert D. Burk. (2007) Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45. International Journal of Cancer 121:1, 193-198
CrossRef913
Silvia de Sanjosé, Mireia Diaz, Xavier Castellsagué, Gary Clifford, Laia Bruni, Nubia Muñoz, F Xavier Bosch. (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet Infectious Diseases 7:7, 453-459
CrossRef914
C. E. Depuydt, G. A. V. Boulet, C. A. J. Horvath, I. H. Benoy, A. J. Vereecken, J. J. Bogers. (2007) Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. Journal of Cellular and Molecular Medicine 11:4, 881-891
CrossRef915
Anna Severino, Claudia Abbruzzese, Lucrezia Manente, Álvaro Avivar Valderas, Stefano Mattarocci, Antonio Federico, Giuseppe Starace, Alberto Chersi, Anna Maria Mileo, Marco G. Paggi. (2007) Human papillomavirus-16 E7 interacts with siva-1 and modulates apoptosis in HaCaT human immortalized keratinocytes. Journal of Cellular Physiology 212:1, 118-125
CrossRef916
S C Cotton, L Sharp, R Seth, L F Masson, J Little, M E Cruickshank, K Neal, N Waugh. (2007) Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. British Journal of Cancer 97:1, 133-139
CrossRef917
P Naucler, W Ryd, S Törnberg, A Strand, G Wadell, B G Hansson, E Rylander, J Dillner. (2007) HPV type-specific risks of high-grade CIN during 4 years of follow-up: A population-based prospective study. British Journal of Cancer 97:1, 129-132
CrossRef918
Gerd Gross. (2007) HPV-vaccination against cervical carcinoma: will it really work?. Medical Microbiology and Immunology 196:3, 121-125
CrossRef919
Ruanne V Barnabas, Shalini L Kulasingam. (2007) Economic evaluations of human papillomavirus vaccines. Expert Review of Pharmacoeconomics & Outcomes Research 7:3, 251-267
CrossRef920
Marie-Noelle Didelot Rousseau, Valérie Costes, Issouf Konate, Nicolas Nagot, Vincent Foulongne, Abdoulaye Ouedraogo, Philippe Van de Perre, Philippe Mayaud, Michel Segondy, . (2007) Viral load and genomic integration of HPV 16 in cervical samples from HIV-1-infected and uninfected women in Burkina Faso. Journal of Medical Virology 79:6, 766-770
CrossRef921
Marie-Noelle Didelot-Rousseau, François Diafouka, Eric Yayo, Luc-Philippe Kouadio, Dagui Monnet, Michel Segondy. (2007) HPV seminal shedding among men seeking fertility evaluation in Abidjan, Ivory Coast. Journal of Clinical Virology 39:2, 153-155
CrossRef922
Eduardo L Franco, Alex Ferenczy. (2007) Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination. Future Oncology 3:3, 319-327
CrossRef923
Jorma Paavonen, David Jenkins, F Xavier Bosch, Paulo Naud, Jorge Salmerón, Cosette M Wheeler, Song-Nan Chow, Dan L Apter, Henry C Kitchener, Xavier Castellsague, Newton S de Carvalho, S Rachel Skinner, Diane M Harper, James A Hedrick, Unnop Jaisamrarn, Genara AM Limson, Marc Dionne, Wim Quint, Bart Spiessens, Pascal Peeters, Frank Struyf, Susan L Wieting, Matti O Lehtinen, Gary Dubin. (2007) Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. The Lancet 369:9580, 2161-2170
CrossRef924
K.U. Petry. (2007) Was bedeutet die HPV-Impfung für die gynäkologische Krebsvorsorge?. Der Hautarzt 58:6, 501-506
CrossRef925
Tor Molden, Irene Kraus, Hanne Skomedal, Trine Nordstrøm, Frank Karlsen. (2007) PreTect™ HPV-Proofer: Real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. Journal of Virological Methods 142:1-2, 204-212
CrossRef926
Satu-Maria A. Kulmala, Irena P. Shabalova, Nikolay Petrovitchev, Kari J. Syrjänen, Ulf B. Gyllensten, Stina M. Syrjänen. (2007) Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union. Journal of Medical Virology 79:6, 771-781
CrossRef927
Yin Ling Woo, Isabelle Damay, Margaret Stanley, Robin Crawford, Jane Sterling. (2007) The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens. Journal of Virological Methods 142:1-2, 226-230
CrossRef928
A. Manseck. (2007) Primärprävention des Peniskarzinoms. Der Urologe 46:6, 646-650
CrossRef929
Kevin A. Ault. (2007) Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. The Lancet 369:9576, 1861-1868
CrossRef930
Ivan Brukner, Razan El-Ramahi, Jacob Sawicki, Izabella Gorska-Flipot, Maja Krajinovic, Damian Labuda. (2007) Hybridization assay performed at ambient temperature for typing high-risk human papillomaviruses. Journal of Clinical Virology 39:2, 113-118
CrossRef931
Adriana Balderas-Loaeza, Gabriela Anaya-Saavedra, Velia A. Ramirez-Amador, Miriam C. Guido-Jimenez, Mina Kalantari, Itzel E. Calleja-Macias, Hans-Ulrich Bernard, Alejandro Garcia-Carranca. (2007) Human papillomavirus-16 DNA methylation patterns support a causal association of the virus with oral squamous cell carcinomas. International Journal of Cancer 120:10, 2165-2169
CrossRef932
The FUTURE II Study Group. (2007) Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions. New England Journal of Medicine 356:19, 1915-1927
Full Text933
Garland, Suzanne M., Hernandez-Avila, Mauricio, Wheeler, Cosette M., Perez, Gonzalo, Harper, Diane M., Leodolter, Sepp, Tang, Grace W.K., Ferris, Daron G., Steben, Marc, Bryan, Janine, Taddeo, Frank J., Railkar, Radha, Esser, Mark T., Sings, Heather L., Nelson, Micki, Boslego, John, Sattler, Carlos, Barr, Eliav, Koutsky, Laura A., . (2007) Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases. New England Journal of Medicine 356:19, 1928-1943
Full Text934
Sawaya, George F., Smith-McCune, Karen, . (2007) HPV Vaccination — More Answers, More Questions. New England Journal of Medicine 356:19, 1991-1993
Full Text935
Elmar A Joura, Sepp Leodolter, Mauricio Hernandez-Avila, Cosette M Wheeler, Gonzalo Perez, Laura A Koutsky, Suzanne M Garland, Diane M Harper, Grace WK Tang, Daron G Ferris, Marc Steben, Ronald W Jones, Janine Bryan, Frank J Taddeo, Oliver M Bautista, Mark T Esser, Heather L Sings, Micki Nelson, John W Boslego, Carlos Sattler, Eliav Barr, Jorma Paavonen. (2007) Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. The Lancet 369:9574, 1693-1702
CrossRef936
J CHACON. (2007) Detección y genotipado del virus del papiloma humano de alto riesgo en muestras de lesiones cervicales. Enfermedades Infecciosas y Microbiología Clínica 25:5, 311-316
CrossRef937
C.R.N. PEREIRA, M.L.G. ROSA, G.A.L.B.M. VASCONCELOS, P.C.P. FARIA, S.M.B. CAVALCANTI, L.H.S. OLIVEIRA. (2007) Human papillomavirus prevalence and predictors for cervical cancer among high-risk women from Rio de Janeiro, Brazil. International Journal of Gynecological Cancer 17:3, 651-660
CrossRef938
Stefanie J. Klug, Meike Hukelmann, Bettina Hollwitz, Nurgül Düzenli, Betti Schopp, Karl-Ulrich Petry, Thomas Iftner. (2007) Prevalence of human papillomavirus types in women screened by cytology in Germany. Journal of Medical Virology 79:5, 616-625
CrossRef939
Michael Anthony Quinn. (2007) Should all women be vaccinated against human papillomavirus and what effect will this have on screening programs?. Expert Review of Obstetrics & Gynecology 2:3, 315-319
CrossRef940
J. Dillner, M. Arbyn, L. Dillner. (2007) Translational Mini-Review Series on Vaccines:
Monitoring of human papillomavirus vaccination. Clinical & Experimental Immunology 148:2, 199-207
CrossRef941
Brian J. Morris, Barbara R. Rose. (2007) Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens. Clinical Chemistry and Laboratory Medicine 45:5, 577-591
CrossRef942
Gianna Badaracco, Aldo Venuti. (2007) Human papillomavirus therapeutic vaccines in head and neck tumors. Expert Review of Anticancer Therapy 7:5, 753-766
CrossRef943
Tino F Schwarz. (2007) Human papillomavirus-16/18 candidate vaccine adjuvanted with AS04 and its impact on the incidence of cervical cancer. Expert Review of Obstetrics & Gynecology 2:3, 293-303
CrossRef944
Chyong-Huey Lai, Huei-Jean Huang, Swei Hsueh, Angel Chao, Cheng-Tao Lin, Shang-Lang Huang, Fang-Yu Chao, Jian-Tai Qiu, Ji-Hong Hong, Hung-Hsueh Chou, Ting-Chang Chang, Chee-Jen Chang. (2007) Human papillomavirus genotype in cervical cancer: A population-based study. International Journal of Cancer 120:9, 1999-2006
CrossRef945
T TURAN, M KALANTARI, K CUSCHIERI, H CUBIE, H SKOMEDAL, H BERNARD. (2007) High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 361:1, 185-193
CrossRef946
S Bulk, J Berkhof, L Rozendaal, N C Fransen Daalmeijer, M Gök, F A de Schipper, F J van Kemenade, P J F Snijders, C J L M Meijer. (2007) The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency. British Journal of Cancer 96:8, 1234-1236
CrossRef947
Claudio S Batista, Álvaro N Atallah, Humberto Saconato, Claudio S Batista. 2007. 5-FU for genital warts in non-immunocompromised individuals. .
CrossRef948
V V Sahasrabuddhe, M H Mwanahamuntu, S H Vermund, W K Huh, M D Lyon, J S A Stringer, G P Parham. (2007) Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. British Journal of Cancer
CrossRef949
Laura Sichero, Silvaneide Ferreira, Helen Trottier, Eliane Duarte-Franco, Alex Ferenczy, Eduardo Luis Franco, Luisa Lina Villa. (2007) High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. International Journal of Cancer 120:8, 1763-1768
CrossRef950
Z CHEN. (2007) Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology 360:2, 447-453
CrossRef951
Bor-Ching Sheu, Wen-Chun Chang, Ho-Hsiung Lin, Song-Nan Chow, Su-Cheng Huang. (2007) Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia. Journal of Obstetrics and Gynaecology Research 33:2, 103-113
CrossRef952
Rubén Cabanillas, Juan P. Rodrigo, Alfio Ferlito, Alessandra Rinaldo, Manuel F. Fresno, Carolina Aguilar, Marta E. Alvarez, Carlos Suárez. (2007) Is there an epidemiological link between human papillomavirus DNA and basaloid squamous cell carcinoma of the pharynx?. Oral Oncology 43:4, 327-332
CrossRef953
Boštjan J. Kocjan, Katja Seme, Tina Močilnik, Nina Jančar, Eda Vrtačnik-Bokal, Mario Poljak. (2007) Genomic diversity of human papillomavirus genotype 53 in an ethnogeographically closed cohort of white European women. Journal of Medical Virology 79:4, 431-438
CrossRef954
Francisco Danilo Ferreira de Paula, Ana Paula Fernandes, Bianca Bianco do Carmo, Daniela Cristina Duarte Vieira, Miriam Santos Dutra, Caleb Guedes Miranda dos Santos, Maria do Carmo M. Souza, Túlio César Alvim Andrade, Annamaria Ravara Vago, Paula Ávila Fernandes. (2007) Molecular detection ofChlamydia trachomatis and HPV infections in cervical samples with normal and abnormal cytopathological findings. Diagnostic Cytopathology 35:4, 198-202
CrossRef955
John S Lambert. (2007) Long-term follow-up of a quadrivalent HPV vaccine. Expert Review of Vaccines 6:2, 141-145
CrossRef956
Silvia Franceschi, Jennifer S. Smith, Adriaan van den Brule, Rolando Herrero, Annie Arslan, Pham-Thi-Hoang Anh, F Xavier Bosch, Nguyen-Trong Hieu, Elena Matos, Hector Posso, You-Lin Qiao, Hai-Rim Shin, Sukhon Sukvirach, Jaiye O. Thomas, Peter J. F. Snijders, Nubia Mu??oz, Chris J. L. M. Meijer. (2007) Cervical Infection With Chlamydia trachomatis and Neisseria gonorrhoeae in Women From Ten Areas in Four Continents: A Cross-Sectional Study. Sexually Transmitted Diseases PAP,
CrossRef957
Cosette M Wheeler. (2007) Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nature Clinical Practice Oncology 4:4, 224-235
CrossRef958
Ignacio G. Bravo, Ángel Alonso. (2007) Phylogeny and evolution of papillomaviruses based on the E1 and E2 proteins. Virus Genes 34:3, 249-262
CrossRef959
Seung-Hun Song, Jae-Kwan Lee, Oye-Sun Seok, Ho-Suk Saw. (2007) The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix. Gynecologic Oncology 104:3, 732-738
CrossRef960
Keith S. Reisinger, Stan L. Block, Eduardo Lazcano-Ponce, Rudiwilai Samakoses, Mark T. Esser, Joanne Erick, Derek Puchalski, Katherine E. D. Giacoletti, Heather L. Sings, Suzanne Lukac, Frances B. Alvarez, Eliav Barr. (2007) Safety and Persistent Immunogenicity of a Quadrivalent Human Papillomavirus Types 6, 11, 16, 18 L1 Virus-Like Particle Vaccine in Preadolescents and Adolescents. The Pediatric Infectious Disease Journal 26:3, 201-209
CrossRef961
Marc Arbyn, Joakim Dillner. (2007) Review of current knowledge on HPV vaccination: An Appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. Journal of Clinical Virology 38:3, 189-197
CrossRef962
Emma J Crosbie, Henry C Kitchener. (2007) Cervarix™ – a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer. Expert Opinion on Biological Therapy 7:3, 391-396
CrossRef963
Maaike A.P.C. van Ham, Dennis van Hamont, Ruud L.M. Bekkers, Johan Bulten, Willem J.G. Melchers, Leon F.A.G. Massuger. (2007) High-risk HPV presence in cervical specimens after a large loop excision of the cervical transformation zone: Significance of newly detected hr-HPV genotypes. Journal of Medical Virology 79:3, 314-319
CrossRef964
Ching-Yu Lin, Hui-Chi Chen, Ruey-Wen Lin, San-Lin You, Chiou-Mien You, Li-Chung Chuang, Mei-Hung Pan, Mei-Hsuan Lee, Yi-Chun Chou, Chien-Jen Chen. (2007) Quality assurance of genotyping array for detection and typing of human papillomavirus. Journal of Virological Methods 140:1-2, 1-9
CrossRef965
Katharina Slupetzky, Ratish Gambhira, Timothy D. Culp, Saeed Shafti-Keramat, Christina Schellenbacher, Neil D. Christensen, Richard B.S. Roden, Reinhard Kirnbauer. (2007) A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11. Vaccine 25:11, 2001-2010
CrossRef966
Csaba Jeney, Tibor Takács, Attila Sebe, Zsuzsa Schaff. (2007) Detection and typing of 46 genital human papillomaviruses by the L1F/L1R primer system based multiplex PCR and hybridization. Journal of Virological Methods 140:1-2, 32-42
CrossRef967
Hui Li, Xuan Ou, Jinhu Xiong. (2007) Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules. Gynecologic Oncology 104:3, 564-571
CrossRef968
(2007) Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. International Journal of Cancer 120:4, 885-891
CrossRef969
K M French, R V Barnabas, M Lehtinen, O Kontula, E Pukkala, J Dillner, G P Garnett. (2007) Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland. British Journal of Cancer 96:3, 514-518
CrossRef970
Ming Guo, Nour Sneige, Elvio G Silva, Yee Jee Jan, David E Cogdell, E Lin, Rajyalakshmi Luthra, Wei Zhang. (2007) Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Modern Pathology 20:2, 256-266
CrossRef971
M BRANCA, M CIOTTI, C GIORGI, D SANTINI, L DIBONITO, S COSTA, A BENEDETTO, D BONIFACIO, P DIBONITO, P PABA. (2007) Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology 130:2, 223-231
CrossRef972
Y STUDENTSOV, R BURK. (2007) Development of a non-denaturing electrophoresis system for characterization of neutralizing epitopes on HPV virus-like particles. Journal of Virological Methods 139:2, 208-219
CrossRef973
Mariam Mansour, Majid Touka, Adriana Malena, Cesare Indiveri, Wen Dong, Ilaria Gionfriddo, Rosita Accardi, Angelo Paradiso, Bakary S. Sylla, Anne-Sophie Gabet, Massimo Tommasino. (2007) Human papillomavirus type 77 E7 protein is a weak deregulator of cell cycle. Cancer Letters 246:1-2, 274-281
CrossRef974
Antonio Mastrolorenzo, Claudiu T Supuran, Giuliano Zuccati. (2007) The sexually transmitted papillomavirus infections: clinical manifestations, current and future therapies. Expert Opinion on Therapeutic Patents 17:2, 173-211
CrossRef975
Rosemary E Zuna, Richard A Allen, William E Moore, You Lu, Rubina Mattu, S Terence Dunn. (2007) Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type. Modern Pathology 20:2, 167-174
CrossRef976
Satoko Morishima, Yoshiki Akatsuka, Akihiro Nawa, Eisei Kondo, Tohru Kiyono, Hiroki Torikai, Toru Nakanishi, Yoshinori Ito, Kunio Tsujimura, Kosuke Iwata, Koji Ito, Yoshihisa Kodera, Yasuo Morishima, Kiyotaka Kuzushima, Toshitada Takahashi. (2007) Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: The combined effects of bortezomib and interferon-γ on the presentation of a cryptic epitope. International Journal of Cancer 120:3, 594-604
CrossRef977
Michael W. Schmitz, Leslie J. Goldberg, Arvin J. Adler. (2007) An Extensive Case of Bowen's Disease in An HIV-Positive Male. AIDS Patient Care and STDs 21:2, 78-80
CrossRef978
Cuizhen Li, Kenneth L Rock, Bruce A Woda, Zhong Jiang, Armando E Fraire, Karen Dresser. (2007) IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16INK4a expression. Modern Pathology 20:2, 242-247
CrossRef979
Shalini Kulasingam, Luke Connelly, Elizabeth Conway, Jane S. Hocking, Evan Myers, David G. Regan, David Roder, Jayne Ross, Gerard Wain. (2007) A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. Sexual Health 4:3, 165
CrossRef980
Richard Crosby, Nancy Schoenberg, Claudia Hopenhayn, Greg Moore, William Melhan. (2007) Correlates of intent to be vaccinated against human papillomavirus: an exploratory study of college-aged women. Sexual Health 4:1, 71
CrossRef981
Ciaran B. J. Woodman, Stuart I. Collins, Lawrence S. Young. (2007) The natural history of cervical HPV infection: unresolved issues. Nature Reviews Cancer 7:1, 11-22
CrossRef982
Laura De Marco, Anna Gillio-Tos, Lisa Bonello, Valeria Ghisetti, Guglielmo Ronco, Franco Merletti. (2007) Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. Journal of Clinical Virology 38:1, 7-13
CrossRef983
Christina S. Kong, Bonnie L. Balzer, Megan L. Troxell, Bruce K. Patterson, Teri A. Longacre. (2007) p16INK4A Immunohistochemistry is Superior to HPV In Situ Hybridization for the Detection of High-risk HPV in Atypical Squamous Metaplasia. The American Journal of Surgical Pathology 31:1, 33-43
CrossRef984
E. Riva, D. Serraino, A. Pierangeli, F. Bambacioni, S. Zaniratti, C. Minosse, M. Selleri, M. Bucci, C. Scagnolari, A. M. Degener, M. R. Capobianchi, G. Antonelli, F. Dianzani, . (2007) Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women. Clinical Microbiology and Infection 13:1, 94-97
CrossRef985
Mark H. Einstein, Yevgeniy Y. Studentsov, Gloria Y.F. Ho, Melissa Fazzari, Morgan Marks, Anna S. Kadish, Gary L. Goldberg, Carolyn D. Runowicz, Robert D. Burk. (2007) Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia. International Journal of Cancer 120:1, 55-59
CrossRef986
Mariela C. Torrente, Jose M. Ojeda. (2007) Exploring the relation between human papilloma virus and larynx cancer. Acta Oto-laryngologica 127:9, 900-906
CrossRef987
Eun Hee Lee, Hyun Jae Chung, Heung Bum Oh, Hyun Sook Chi, Mi Sun Jee, Sun Nie Park, Sun Pyo Hong, Wangdon Yoo, Soo-Ok Kim. (2007) Human Papilloma Virus Genotyping Assay using Restriction Fragment Mass Polymorphism Analysis, and Its Comparison with Sequencing and Hybrid Capture Assays. The Korean Journal of Laboratory Medicine 27:1, 62
CrossRef988
Ana Cecilia Rodriguez, Robert Burk, Rolando Herrero, Allan Hildesheim, Concepcion Bratti, Mark E. Sherman, Diane Solomon, Diego Guillen, Mario Alfaro, Raphael Viscidi, Jorge Morales, Martha Hutchinson, Sholom Wacholder, Mark Schiffman. (2007) The Natural History of Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Among Young Women in the Guanacaste Cohort Shortly After Initiation of Sexual Life. Sexually Transmitted Diseases PAP,
CrossRef989
Young Tae Kim. (2007) Causes and Diagnoses of Cervical Cancer. Journal of the Korean Medical Association 50:9, 769
CrossRef990
C. C. R. Ragin, V. W. Wheeler, J. B. Wilson, C. H. Bunker, S. M. Gollin, A. L. Patrick, E. Taioli. (2007) Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago. Biomarkers 12:5, 510-522
CrossRef991
Eun-Seop Song, Hun Jae Lee, Tae Sook Hwang. (2007) Clinical Efficacy of Human Papillomavirus DNA Detection in Urine from Patients with Various Cervical Lesions. Journal of Korean Medical Science 22:1, 99
CrossRef992
PD Griffiths. (2007) Anticipating full benefits from the new papillomavirus vaccines. Reviews in Medical Virology 17:1, 1-3
CrossRef993
Aagje G. Bais, Ilse Beckmann, Patricia C. Ewing, Marinus J. C. Eijkemans, Chris J. L. M. Meijer, Peter J. F. Snijders, Theo J. M. Helmerhorst. (2007) Cytokine Release in HR-HPV(+) Women without and with Cervical Dysplasia (CIN II and III) or Carcinoma, Compared with HR-HPV(−) Controls. Mediators of Inflammation 2007, 1-8
CrossRef994
Simon Gagnon, Catherine Hankins, Deborah Money, Karina Pourreaux, Eduardo Franco, Fran??ois Coutl??e. (2007) Polymorphism of the L1 Capsid Gene and Persistence of Human Papillomavirus Type 52 Infection in Women at High Risk or Infected by HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 44:1, 61-65
CrossRef995
F. Aubin, J.-L. Pretet, C. Mougin, D. Riethmuller. (2007) Infection à Papillomavirus humains. Annales de Dermatologie et de Vénéréologie 134:1, 94-99
CrossRef996
L L Villa, R L R Costa, C A Petta, R P Andrade, J Paavonen, O-E Iversen, S-E Olsson, J Høye, M Steinwall, G Riis-Johannessen, A Andersson-Ellstrom, K Elfgren, G von Krogh, M Lehtinen, C Malm, G M Tamms, K Giacoletti, L Lupinacci, R Railkar, F J Taddeo, J Bryan, M T Esser, H L Sings, A J Saah, E Barr. (2006) High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer 95:11, 1459-1466
CrossRef997
Silvia Franceschi, Rolando Herrero, Gary M. Clifford, Peter J.F. Snijders, Annie Arslan, Pham Thi Hoang Anh, F. Xavier Bosch, Catterina Ferreccio, Nguyen Trong Hieu, Eduardo Lazcano-Ponce, Elena Matos, Monica Molano, You-Lin Qiao, Raj Rajkumar, Guglielmo Ronco, Silvia de Sanjosé, Hai-Rim Shin, Sukhon Sukvirach, Jaiye O. Thomas, Chris J.L.M. Meijer, Nubia Muñoz, . (2006) Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. International Journal of Cancer 119:11, 2677-2684
CrossRef998
Monika Hampl, Heidi Sarajuuri, Nicolas Wentzensen, Hans G. Bender, Volkmar Kueppers. (2006) Effect of Human Papillomavirus Vaccines on Vulvar, Vaginal, and Anal Intraepithelial Lesions and Vulvar Cancer. Obstetrics & Gynecology 108:6, 1361-1368
CrossRef999
Jo-Ann S. Passmore, Michelle Milner, Lynnette Denny, Candice Sampson, Dianne J. Marais, Bruce Allan, Pam P. Gumbi, Inga I. Hitzeroth, Edward P. Rybicki, Anna-Lise Williamson. (2006) Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia. Immunology 119:4, 507-514
CrossRef1000
Qing Li, Weihong Li, Huanzi Li, Zhihua Liu. (2006) A correlative analysis of cervical lesions in patients with vulva condyloma acuminatum. Chinese Journal of Clinical Oncology 3:6, 419-422
CrossRef1001
Shiho Miura, Koji Matsumoto, Akinori Oki, Toyomi Satoh, Hajime Tsunoda, Toshiharu Yasugi, Yuji Taketani, Hiroyuki Yoshikawa. (2006) Do we need a different strategy for HPV screening and vaccination in East Asia?. International Journal of Cancer 119:11, 2713-2715
CrossRef1002
Maria Lina Tornesello, Maria Luisa Duraturo, Gerardo Botti, Stefano Greggi, Roberto Piccoli, Giuseppe De Palo, Maurizio Montella, Luigi Buonaguro, Franco M. Buonaguro, . (2006) Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the Italian population. Journal of Medical Virology 78:12, 1663-1672
CrossRef1003
Monica Srodon, Mark H. Stoler, Gwen B. Baber, Robert J. Kurman. (2006) The Distribution of Low and High-risk HPV Types in Vulvar and Vaginal Intraepithelial Neoplasia (VIN and VaIN). The American Journal of Surgical Pathology 30:12, 1513-1518
CrossRef1004
C-M Ho, W-F Cheng, T-Y Chu, C-A Chen, M-H Chuang, S-F Chang, C-Y Hsieh. (2006) Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix. British Journal of Cancer 95:10, 1384-1389
CrossRef1005
R. Ruland, C. Prugger, R. Schiffer, M. Regidor, R. J. Lellé. (2006) Prevalence of human papilloma virus infection in women in rural Ethiopia. European Journal of Epidemiology 21:9, 727-729
CrossRef1006
U Kailash, C C Soundararajan, R Lakshmy, R Arora, S Vivekanandhan, B C Das. (2006) Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. British Journal of Cancer 95:9, 1250-1257
CrossRef1007
Y.-F. Xu, Y.-Q. Zhang, X.-M. Xu, G.-X. Song. (2006) Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes. Archives of Virology 151:11, 2133-2148
CrossRef1008
Amita Gupta, Raksha Arora, Sanjay Gupta, Bhupesh K. Prusty, Uma Kailash, Swaraj Batra, Bhudev C. Das. (2006) Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens. Journal of Clinical Virology 37:3, 190-194
CrossRef1009
M. Branca, C. Giorgi, M. Ciotti, D. Santini, L. Di Bonito, S. Costa, A. Benedetto, D. Bonifacio, P. Di Bonito, P. Paba, L. Accardi, L. Mariani, M. Ruutu, S. Syrjänen, C. Favalli, K. Syrjänen, . (2006) Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagnostic Cytopathology 34:11, 739-748
CrossRef1010
V ALBRECHT, A CHEVALLIER, V MAGNONE, P BARBRY, F VANDENBOS, A BONGAIN, J LEFEBVRE, V GIORDANENGO. (2006) Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays. Journal of Virological Methods 137:2, 236-244
CrossRef1011
F.X. Bosch, E. Bernaola Iturbe. (2006) La vacuna frente al virus del papiloma humano y la incorporación de la pediatría a la prevención del cáncer de cuello uterino. Anales de Pediatría 65:5, 411-413
CrossRef1012
F. Martinón-Torres, E. Bernaola Iturbe, F. Giménez Sánchez, M. Baca Cots, F. de Juan Martín, J. Díez Domingo, M. Garcés Sánchez, J.A. Gómez Campderá, J.J. Picazo, V. Pineda Solas. (2006) Vacuna frente al virus del papiloma humano: un nuevo reto para el pediatra. Anales de Pediatría 65:5, 461-469
CrossRef1013
S Paige Hertweck. (2006) Cervical cancer vaccine: state of the art in prevention of human papillomavirus infection. Expert Review of Obstetrics & Gynecology 1:2, 133-134
CrossRef1014
N. Becker, H. Brenner, S. J. Klug, F. H. Schilling, C. Spix. (2006) Beiträge der Epidemiologie zur Krebsfrüherkennung. Der Onkologe 12:11, 1136-1145
CrossRef1015
Kenneth R. Shroyer, Petra Homer, David Heinz, Meenakshi Singh. (2006) Validation of a novel immunocytochemical assay for topoisomerase II-α and minichromosome maintenance protein 2 expression in cervical cytology. Cancer 108:5, 324-330
CrossRef1016
Rosemary E. Zuna, Sophia S. Wang, Mark Schiffman, Diane Solomon. (2006) Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer 108:5, 288-297
CrossRef1017
Salvatore Vaccarella, Eduardo Lazcano-Ponce, José Antonio Castro-Garduño, Aurelio Cruz-Valdez, Vicente Díaz, Rafaela Schiavon, Pilar Hernández, Janet R. Kornegay, Mauricio Hernández-Avila, Silvia Franceschi. (2006) Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. International Journal of Cancer 119:8, 1934-1939
CrossRef1018
Haryoung Poo, Hyun-Mi Pyo, Tae-Young Lee, Sun-Woo Yoon, Jong-Soo Lee, Chul-Joong Kim, Moon-Hee Sung, Seung-Hoon Lee. (2006) Oral administration of human papillomavirus type 16 E7 displayed onLactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. International Journal of Cancer 119:7, 1702-1709
CrossRef1019
Howard Minkoff, Lin Shen Xian, D Heather Watts, Robert Leighty, Ron Hershow, Joel Palefsky, Ruth Tuomala, Natalie Neu, Carmen D. Zorrilla, Mary Paul, Howard Strickler. (2006) Relationship of Pregnancy to Human Papillomavirus Among Human Immunodeficiency Virus–Infected Women. Obstetrics & Gynecology 108:4, 953-960
CrossRef1020
Laura Beatriz da Silva Cardeal, Carla Abdo Brohem, Tatiana Caroline Silveira Corrêa, Sheila Maria Brochado Winnischofer, Fabio Nakano, Enrique Boccardo, Luisa Lina Villa, Mari Cleide Sogayar, Silvya Stuchi Maria-Engler. (2006) Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochemistry and Cell Biology 84:5, 713-719
CrossRef1021
Rachel L. Winer, Qinghua Feng, James P. Hughes, Mujun Yu, Nancy B. Kiviat, Sandra O???Reilly, Laura A. Koutsky. (2006) Concordance of Self-Collected and Clinician-Collected Swab Samples for Detecting Human Papillomavirus DNA in Women 18 to 32 Years of Age. Sexually Transmitted Diseases PAP,
CrossRef1022
Zhengrong Cui, Fu Qiu. (2006) Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model. Cancer Immunology, Immunotherapy 55:10, 1267-1279
CrossRef1023
Jill E. Koshiol, Jane C. Schroeder, Denise J. Jamieson, Stephen W. Marshall, Ann Duerr, Charles M. Heilig, Keerti V. Shah, Robert S. Klein, Susan Cu-Uvin, Paula Schuman, David Celentano, Jennifer S. Smith. (2006) Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. International Journal of Cancer 119:7, 1623-1629
CrossRef1024
Vandana Keskar, Prem S. Mohanty, Ernest J. Gemeinhart, Richard A. Gemeinhart. (2006) Cervical cancer treatment with a locally insertable controlled release delivery system. Journal of Controlled Release 115:3, 280-288
CrossRef1025
Chris J. Meijer, Peter J. Snijders, Philip E. Castle. (2006) Clinical utility of HPV genotyping. Gynecologic Oncology 103:1, 12-17
CrossRef1026
Karen K. Smith-McCune, Jennifer L. Tuveson, Mary M. Rubin, Maria M. Da Costa, Teresa M. Darragh, Stephen C. Shiboski, Barbara Van Der Pol, Anna-Barbara Moscicki, Joel M. Palefsky, George F. Sawaya. (2006) Effect of Replens Gel Used with a Diaphragm on Tests for Human Papillomavirus and Other Lower Genital Tract Infections. Journal of Lower Genital Tract Disease 10:4, 213-218
CrossRef1027
Neerja Bhatla, Lalit Dar, A. Raj Kumar Patro, Alka Kriplani, Arti Gulati, Kusum Verma, Shobha Broor, Keerti V. Shah, Patti E. Gravitt. (2006) Human Papillomavirus Type Distribution in Cervical Cancer in Delhi, India. International Journal of Gynecological Pathology 25:4, 398-402
CrossRef1028
Margherita Branca, Colomba Giorgi, Marco Ciotti, Donatella Santini, Luigi Di Bonito, Silvano Costa, Arrigo Benedetto, Daniela Bonifacio, Paola Di Bonito, Pierpaulo Paba, Luisa Accardi, Luciano Mariani, Merja Ruutu, Stina M. Syrj??nen, Cartesio Favalli, K. Syrj??nen. (2006) Over-Expression of Topoisomerase II?? is Related to the Grade of Cervical Intraepithelial Neoplasia (CIN) and High-Risk Human Papillomavirus (HPV), but does not Predict Prognosis in Cervical Cancer or HPV Clearance after Cone Treatment. International Journal of Gynecological Pathology 25:4, 383-392
CrossRef1029
James D. Baleja, Jonathan J. Cherry, Zhiguo Liu, Hua Gao, Marc C. Nicklaus, Johannes H. Voigt, Jason J. Chen, Elliot J. Androphy. (2006) Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins. Antiviral Research 72:1, 49-59
CrossRef1030
Mahboobeh Safaeian, Mohammed Kiddugavu, Patti E. Gravitt, Joseph Ssekasanvu, Dan Murokora, Marc Sklar, David Serwadda, Maria J. Wawer, Keerti V. Shah, Ron Gray. (2006) Comparability of Self-Collected Vaginal Swabs and Physician-Collected Cervical Swabs for Detection of Human Papillomavirus Infections in Rakai, Uganda. Sexually Transmitted Diseases PAP,
CrossRef1031
Yvonne Collins, Mark H. Einstein, Bobbie S. Gostout, Thomas J. Herzog, L. Stuart Massad, Janet S. Rader, Jason Wright. (2006) Cervical cancer prevention in the era of prophylactic vaccines: A preview for gynecologic oncologists. Gynecologic Oncology 102:3, 552-562
CrossRef1032
Y.-X. YANG, A.-H. YANG, Z.-J. YANG, Z.-R. WANG, X.-H. XIA. (2006) Involvement of tumor suppressor in lung cancer 1 gene expression in cervical carcinogenesis. International Journal of Gynecological Cancer 16:5, 1868-1872
CrossRef1033
(2006) Cervical carcinoma and reproductive factors: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. International Journal of Cancer 119:5, 1108-1124
CrossRef1034
Eileen F. Dunne, Lauri E. Markowitz. (2006) Emerging Infections: Genital Human Papillomavirus Infection. Clinical Infectious Diseases 43:5, 624-629
CrossRef1035
Oliver Brummer, Bettina Hollwitz, Gerd Böhmer, Henning Kühnle, K. Ulrich Petry. (2006) Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia. Gynecologic Oncology 102:3, 517-522
CrossRef1036
C.-A. CHEN, C.-Y LIU, H.-H CHOU, C.-Y. CHOU, C.-M HO, N.-F. TWU, Y.-Y. KAN, M.-H. CHUANG, T.-Y. CHU, C.-Y. HSIEH. (2006) The distribution and differential risks of human papillomavirus genotypes in cervical preinvasive lesions: a Taiwan Cooperative Oncologic Group Study. International Journal of Gynecological Cancer 16:5, 1801-1808
CrossRef1037
Luis Otavio Sarian, Sophie Françoise Derchain, Adriana Yoshida, José Vassallo, Francisco Pignataro, Liliana Aparecida Lucci De Angelo Andrade. (2006) Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix. Gynecologic Oncology 102:3, 537-541
CrossRef1038
M.A. de BOER, J.N.I. VET, M.F. AZIZ, S. CORNAIN, G. PURWOTO, B.E.W.M. van den AKKER, A. DIJKMAN, A.A.W. PETERS, G.J. FLEUREN. (2006) Human papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia. International Journal of Gynecological Cancer 16:5, 1809-1814
CrossRef1039
Enrique Santiago, Lucía Camacho, Maria Luisa Junquera, Fernando Vázquez. (2006) Full HPV typing by a single restriction enzyme. Journal of Clinical Virology 37:1, 38-46
CrossRef1040
Zivile Gudleviciene, Janina Didziapetriene, Marc Ramael, Saule Uleckiene, Konstantinas Povilas Valuckas. (2006) Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. Gynecologic Oncology 102:3, 530-533
CrossRef1041
C. Schreckenberger, A. M. Kaufmann, A. Schneider. (2006) Primäre Prävention des Zervixkarzinoms. Der Onkologe 12:9, 836-844
CrossRef1042
A Felsani, A M Mileo, M G Paggi. (2006) Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 25:38, 5277-5285
CrossRef1043
M-N Didelot-Rousseau, N Nagot, V Costes-Martineau, X Vallès, A Ouedraogo, I Konate, H A Weiss, P Van de Perre, P Mayaud, M Segondy. (2006) Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. British Journal of Cancer 95:3, 355-362
CrossRef1044
R. D. Burk, R. DeSalle. (2006) The Tango and Tangle of Human Papillomavirus and the Human Genome. JNCI Journal of the National Cancer Institute 98:15, 1026-1027
CrossRef1045
Nubia Muñoz, Xavier Castellsagué, Amy Berrington de González, Lutz Gissmann. (2006) Chapter 1: HPV in the etiology of human cancer. Vaccine 24, S1-S10
CrossRef1046
M. J. J. Fleury, A. Touzé, E. Alvarez, G. Carpentier, C. Clavel, J.-F. Vautherot, P. Coursaget. (2006) Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31. Archives of Virology 151:8, 1511-1523
CrossRef1047
Marcela Lizano, Erick De la Cruz-Hernández, Adela Carrillo-García, Alejandro García-Carrancá, Sergio Ponce de Leon-Rosales, Alfonso Dueñas-González, Dulce Maria Hernández-Hernández, Alejandro Mohar. (2006) Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecologic Oncology 102:2, 230-235
CrossRef1048
Eduardo L. Franco, F. Xavier Bosch, Jack Cuzick, John T. Schiller, Geoffrey P. Garnett, André Meheus, Thomas C. Wright. (2006) Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer. Vaccine 24, S242-S249
CrossRef1049
Christine C. Roberts, Amha S. Tadesse, Jeffrey Sands, Tore Halvorsen, Timothy L. Schofield, Are Dalen, Finn Egil Skjeldestad, Kathrin U. Jansen. (2006) Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays. Journal of Clinical Virology 36:4, 277-282
CrossRef1050
Marc Arbyn, Peter Sasieni, Chris J.L.M. Meijer, Christine Clavel, George Koliopoulos, Joakim Dillner. (2006) Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses. Vaccine 24, S78-S89
CrossRef1051
Daniela Lombardi. (2006) Commentary: nm23, a metastasis suppressor gene with a tumor suppressor gene aptitude?. Journal of Bioenergetics and Biomembranes 38:3-4, 177-180
CrossRef1052
James E Kendrick, Warner K Huh, Ronald D Alvarez. (2006) Novel methods to treat and prevent human papillomavirus infection. Expert Review of Anti-infective Therapy 4:4, 593-600
CrossRef1053
Farin Kamangar, You-Lin Qiao, John T. Schiller, Sanford M. Dawsey, Thomas Fears, Xui-Di Sun, Christian C. Abnet, Ping Zhao, Philip R. Taylor, Steven D. Mark. (2006) Human papillomavirus serology and the risk of esophageal and gastric cancers: Results from a cohort in a high-risk region in China. International Journal of Cancer 119:3, 579-584
CrossRef1054
M DIDELOTROUSSEAU, V COURGNAUD, N NAGOT, A OUEDRAOGO, I KONATE, P MAYAUD, H WEISS, P VANDEPERRE, M SEGONDY. (2006) Comparison of INNO-LiPA HPV Genotyping v2 with PCR product subcloning and sequencing for identification of genital human papillomavirus genotypes in African women. Journal of Virological Methods 135:2, 181-185
CrossRef1055
Laura A. Koutsky, Diane M. Harper. (2006) Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine 24, S114-S121
CrossRef1056
X. Carcopino, M. Henry, D. Benmoura, A.S. Fallabregues, H. Richet, L. Boubli, C. Tamalet. (2006) Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy. Journal of Medical Virology 78:8, 1131-1140
CrossRef1057
Lisa E. Manhart, King K. Holmes, Laura A. Koutsky, Troy R. Wood, Donna L. Kenney, Qinghua Feng, Nancy B. Kiviat. (2006) Human Papillomavirus Infection Among Sexually Active Young Women in the United States: Implications for Developing a Vaccination Strategy. Sexually Transmitted Diseases 33:8, 502-508
CrossRef1058
Sonia R. Pagliusi, Joakim Dillner, Michael Pawlita, Wim G.V. Quint, Cosette M. Wheeler, M. Ferguson. (2006) Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays—an update. Vaccine 24, S193-S200
CrossRef1059
Thomas C. Wright, F. Xavier Bosch, Eduardo L. Franco, Jack Cuzick, John T. Schiller, Geoffrey P. Garnett, André Meheus. (2006) Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine 24, S251-S261
CrossRef1060
Anna Maria Mileo, Emanuela Piombino, Anna Severino, Alessandra Tritarelli, Marco G. Paggi, Daniela Lombardi. (2006) Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein. Journal of Bioenergetics and Biomembranes 38:3-4, 215-225
CrossRef1061
M. Branca, C. Giorgi, M. Ciotti, D. Santini, L. Di Bonito, S. Costa, A. Benedetto, D. Bonifacio, P. Di Bonito, P. Paba, L. Accardi, L. Mariani, M. Ruutu, S. Syrjänen, C. Favalli, K. Syrjänen, . (2006) Upregulation of nuclear factor-κB (NF-κB) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus or disease outcome in cervical cancer. Diagnostic Cytopathology 34:8, 555-563
CrossRef1062
Bjørn Inge Bertelsen, Kalaiarasy Kugarajh, Robert Skar, Ole Didrik Laerum. (2006) HPV subtypes in cervical cancer biopsies between 1930and 2004: detection using general primer pair PCR and sequencing. Virchows Archiv 449:2, 141-147
CrossRef1063
S Hibbitts, G C Rieck, K Hart, N G Powell, R Beukenholdt, N Dallimore, J McRea, A Hauke, A Tristram, A N Fiander. (2006) Human papillomavirus infection: an Anonymous Prevalence Study in South Wales, UK. British Journal of Cancer 95:2, 226-232
CrossRef1064
M Dai, Y P Bao, N Li, G M Clifford, S Vaccarella, P J F Snijders, R D Huang, L X Sun, C J L M Meijer, Y L Qiao, S Franceschi. (2006) Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. British Journal of Cancer 95:1, 96-101
CrossRef1065
Federico De Marco, Fatma Houissa-Kchouk, Ridha Khelifa, Maria Luisa Marcante. (2006) High-risk HPV types in Tunisia. A pilot study reveals an unexpectedly high prevalence of types 58 and 82 and lack of HPV 18 among female prostitutes. Journal of Medical Virology 78:7, 950-953
CrossRef1066
Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano, Ronaldo L.R. Costa, Carlos A. Petta, Rosires P. Andrade, Darron R. Brown, Alex Ferenczy, Diane M. Harper, Laura A. Koutsky, Robert J. Kurman, Matti Lehtinen, Christian Malm, Sven-Eric Olsson, Brigitte M. Ronnett, Finn Egil Skjeldestad, Margareta Steinwall, Mark H. Stoler, Cosette M. Wheeler, Frank J. Taddeo, Jimmy Yu, Lisa Lupinacci, Radha Railkar, Rocio Marchese, Mark T. Esser, Janine Bryan, Kathrin U. Jansen, Heather L. Sings, Gretchen M. Tamms, Alfred J. Saah, Eliav Barr. (2006) Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine 24:27-28, 5571-5583
CrossRef1067
Matthew P. Stevens, Suzanne M. Garland, Sepehr N. Tabrizi. (2006) Human papillomavirus genotyping using a modified linear array detection protocol. Journal of Virological Methods 135:1, 124-126
CrossRef1068
Naomi Peck, Mark J. Lucarelli, Michelle Yao, Denis Lee, Daniel Albert. (2006) Human Papillomavirus 6a Lesions of the Lower Eyelid and Genitalia. Ophthalmic Plastic & Reconstructive Surgery 22:4, 311-313
CrossRef1069
A. PEEDICAYIL, P. ABRAHAM, N. SATHISH, S. JOHN, K. SHAH, G. SRIDHARAN, P. GRAVITT. (2006) Human papillomavirus genotypes associated with cervical neoplasia in India. International Journal of Gynecological Cancer 16:4, 1591-1595
CrossRef1070
C. Dang, A. Koehler, T. Forschner, P. Sehr, K. Michael, M. Pawlita, E. Stockfleth, I. Nindl. (2006) E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. British Journal of Dermatology 155:1, 129-136
CrossRef1071
C KROUPIS, A MARKOU, N VOURLIDIS, A DIONYSSIOUASTERIOU, E LIANIDOU. (2006) Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clinical Biochemistry 39:7, 727-731
CrossRef1072
Winer, Rachel L., Hughes, James P., Feng, Qinghua, O'Reilly, Sandra, Kiviat, Nancy B., Holmes, King K., Koutsky, Laura A., . (2006) Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women. New England Journal of Medicine 354:25, 2645-2654
Full Text1073
B Y Zheng, X D Li, F Wiklund, S Chowdhry, T Ångstrom, G Hallmans, J Dillner, K L Wallin. (2006) Detection of adeno-associated virus type 2 genome in cervical carcinoma. British Journal of Cancer 94:12, 1913-1917
CrossRef1074
Yuping Wu, Yulong Chen, Longyu Li, Yicheng Cao, Zehuan Liu, Benrong Liu, Zhengping Du, Yanling Zhang, Shangwu Chen, Zhongqiu Lin, Anlong Xu. (2006) Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women. International Journal of Cancer 118:12, 3006-3011
CrossRef1075
J Thomas Cox. (2006) Human Papillomavirus Testing in Primary Cervical Screening and Abnormal Papanicolaou Management. Obstetrical & Gynecological Survey 61:Supplement 1, S15-S25
CrossRef1076
Katja Seme, Kristina Fujs, Boštjan J. Kocjan, Mario Poljak. (2006) Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping. Journal of Virological Methods 134:1-2, 252-256
CrossRef1077
Johan Bulten, Irene A.M. van der Avoort, Willem J.G. Melchers, Leon F.A.G. Massuger, Johanna M.M. Grefte, Antonius G.J.M. Hanselaar, Peter C.M. de Wilde. (2006) p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia. Gynecologic Oncology 101:3, 487-494
CrossRef1078
Kevin A. Ault. (2006) Vaccines for the Prevention of Human Papillomavirus and Associated Gynecologic Diseases: A Review. Obstetrical & Gynecological Survey 61:Supplement 1, S26-S31
CrossRef1079
Monika Hampl, Uwe Ramp, Hans G. Bender, Volkmar Kueppers. (2006) A case of a pT3, HPV 52-positive vulvar carcinoma in an 18-year-old woman. Gynecologic Oncology 101:3, 530-533
CrossRef1080
Kenneth E. Palmer, Ann Benko, Sarah A. Doucette, Terri I. Cameron, Tiffany Foster, Kathleen M. Hanley, Alison A. McCormick, Michael McCulloch, Gregory P. Pogue, Mark L. Smith, Neil D. Christensen. (2006) Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes. Vaccine 24:26, 5516-5525
CrossRef1081
Anna Gillio-Tos, Laura De Marco, Valeria Ghisetti, Peter J.F. Snijders, Nereo Segnan, Guglielmo Ronco, Franco Merletti. (2006) Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits. Journal of Clinical Virology 36:2, 126-132
CrossRef1082
ADAM C. ESSER, MARK R. PITTELKOW, HENRY W. RANDLE. (2006) Human Papillomavirus Isolated from Transplant-Associated Porokeratoses of Mibelli Responsive to Topical 5% Imiquimod Cream. Dermatologic Surgery 32:6, 858-861
CrossRef1083
J. Chacón, M.L. Mateos, I. Sanz, M.D. Rubio, F. Baquero. (2006) Genotipos de virus del papiloma humano más frecuentes en mujeres con citología cervicovaginal alterada utilizando técnicas de captura de híbridos y reacción en cadena de la polimerasa. Clínica e Investigación en Ginecología y Obstetricia 33:3, 97-101
CrossRef1084
B GHARIZADEH, B ZHENG, M AKHRAS, M GHADERI, O JEJELOWO, B STRANDER, P NYREN, K WALLIN, N POURMAND. (2006) Sentinel-base DNA genotyping using multiple sequencing primers for high-risk human papillomaviruses. Molecular and Cellular Probes 20:3-4, 230-238
CrossRef1085
Corinna McCarthy, Sarah J. Youde, Stephen Man. (2006) Definition of an HPV18/45 cross-reactive human T-cell epitope after DNA immunisation of HLA-A2/KB transgenic mice. International Journal of Cancer 118:10, 2514-2521
CrossRef1086
P. PINA-SANCHEZ, D.M. HERNANDEZ-HERNANDEZ, R. LOPEZ-ROMERO, G. VAZQUEZ-ORTIZ, C. PEREZ-PLASENCIA, M. LIZANO-SOBERON, J.L. GONZALEZ-SANCHEZ, F. CRUZ-TALONIA, M. SALCEDO. (2006) Human papillomavirus-specific viral types are common in Mexican women affected by cervical lesions. International Journal of Gynecological Cancer 16:3, 1041-1047
CrossRef1087
J. Sehouli, W. Lichtenegger. (2006) Aktuelles Management des Zervixkarzinoms. Der Gynäkologe 39:5, 379-394
CrossRef1088
Naoto HAMA, Tsutomu OHTSUKA, Soji YAMAZAKI. (2006) Detection of mucosal human papilloma virus DNA in bowenoid papulosis, Bowen's disease and squamous cell carcinoma of the skin. The Journal of Dermatology 33:5, 331-337
CrossRef1089
M.P. STEVENS, S.N. TABRIZI, M.A. QUINN, S.M. GARLAND. (2006) Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. International Journal of Gynecological Cancer 16:3, 1017-1024
CrossRef1090
M. INOUE, J. SAKAGUCHI, T. SASAGAWA, M. TANGO. (2006) The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population. International Journal of Gynecological Cancer 16:3, 1007-1013
CrossRef1091
Bjørn I. Bertelsen, Solrun J. Steine, Roar Sandvei, Anders Molven, Ole Didrik Laerum. (2006) Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: FrequentPIK3CA amplification and AKT phosphorylation. International Journal of Cancer 118:8, 1877-1883
CrossRef1092
J. J. M. De Carvalho, K. J. Syrjänen, M. Jacobino, N. T. Rosa, L. Z. M. Carvalho. (2006) Prevalence of genital human papillomavirus infections established using different diagnostic techniques among males attending a urological clinic. Scandinavian Journal of Urology and Nephrology 40:2, 138-143
CrossRef1093
Diane M Harper, Eduardo L Franco, Cosette M Wheeler, Anna-Barbara Moscicki, Barbara Romanowski, Cecilia M Roteli-Martins, David Jenkins, Anne Schuind, Sue Ann Costa Clemens, Gary Dubin. (2006) Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. The Lancet 367:9518, 1247-1255
CrossRef1094
Hao Lin, Yen-Ying Ma, Jau-Sung Moh, Yu-Che Ou, Shu-Yun Shen, Chan-Chao ChangChien. (2006) High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecologic Oncology 101:1, 40-45
CrossRef1095
R. E. Brown, J. G. Breugelmans, D. Theodoratou, S. Bénard. (2006) Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Current Medical Research and Opinion 22:4, 663-670
CrossRef1096
Guojun Li, Erich M. Sturgis. (2006) The role of human papillomavirus in squamous carcinoma of the head and neck. Current Oncology Reports 8:2, 130-139
CrossRef1097
Johannes Berkhof, Martine C. de Bruijne, Gilda D. Zielinski, Nicole W.J. Bulkmans, Lawrence Rozendaal, Peter J.F. Snijders, René H.M. Verheijen, Chris J.L.M. Meijer. (2006) Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis. International Journal of Cancer 118:7, 1759-1768
CrossRef1098
A BRINK, P SNIJDERS, C MEIJER, J BERKHOF, R VERHEIJEN. (2006) HPV testing in cervical screening. Best Practice & Research Clinical Obstetrics & Gynaecology 20:2, 253-266
CrossRef1099
R SANKARANARAYANAN, J FERLAY. (2006) Worldwide burden of gynaecological cancer: The size of the problem. Best Practice & Research Clinical Obstetrics & Gynaecology 20:2, 207-225
CrossRef1100
(2006) Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. International Journal of Cancer 118:6, 1481-1495
CrossRef1101
M. R. Karagas, H. H. Nelson, P. Sehr, T. Waterboer, T. A. Stukel, A. Andrew, A. C. Green, J. N. Bouwes Bavinck, A. Perry, S. Spencer, J. R. Rees, L. A. Mott, M. Pawlita. (2006) Human Papillomavirus Infection and Incidence of Squamous Cell and Basal Cell Carcinomas of the Skin. JNCI Journal of the National Cancer Institute 98:6, 389-395
CrossRef1102
Paul K.S. Chan, Jo L.K. Cheung, Tak-Hong Cheung, Che-kit Lin, Ann O.Y. Tam, Denise P.C. Chan, Daniel X. Zhou, Keith W.K. Lo, So-Fan Yim, Shing-Shun N. Siu. (2006) HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women. International Journal of Cancer 118:6, 1430-1435
CrossRef1103
Yuping Wu, Yulong Chen, Longyu Li, Guifang Yu, Yanling Zhang, Ying He. (2006) Associations of high-risk HPV types and viral load with cervical cancer in China. Journal of Clinical Virology 35:3, 264-269
CrossRef1104
J.J. TU, L. KUHN, L. DENNY, K.J. BEATTIE, A. LORINCZ, T.C. WRIGHT. (2006) Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa. International Journal of Gynecological Cancer 16:2, 736-742
CrossRef1105
A. Hildesheim, A. B. de Gonzalez. (2006) Etiology and Prevention of Cervical Adenocarcinomas. JNCI Journal of the National Cancer Institute 98:5, 292-293
CrossRef1106
Maria Benevolo, Marcella Mottolese, Ferdinando Marandino, Giuseppe Vocaturo, Roberto Sindico, Giulia Piperno, Luciano Mariani, Isabella Sperduti, Paola Canalini, Raffaele P Donnorso, Amina Vocaturo. (2006) Immunohistochemical expression of p16INK4a is predictive of HR-HPV infection in cervical low-grade lesions. Modern Pathology 19:3, 384-391
CrossRef1107
Luisa Lina Villa. (2006) Prophylactic HPV vaccines: Reducing the burden of HPV-related diseases. Vaccine 24, S23-S28
CrossRef1108
X. Castellsague, M. Diaz, S. de Sanjose, N. Munoz, R. Herrero, S. Franceschi, R. W. Peeling, R. Ashley, J. S. Smith, P. J. F. Snijders, C. J. L. M. Meijer, F. X. Bosch. (2006) Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention. JNCI Journal of the National Cancer Institute 98:5, 303-315
CrossRef1109
Helen Trottier, Eduardo L. Franco. (2006) The epidemiology of genital human papillomavirus infection. Vaccine 24, S4-S15
CrossRef1110
Mark F. Evans, Christine S.-C. Adamson, Jacalyn L. Papillo, Timothy L. St. John, Gladwyn Leiman, Kumarasen Cooper. (2006) Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 106:5, 1054-1064
CrossRef1111
Kerstin Dell, Robert Koesters, Michael Linnebacher, Corinna Klein, Lutz Gissmann. (2006) Intranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants elicits increased vaginal immunoglobulin levels. Vaccine 24:13, 2238-2247
CrossRef1112
Hans-Ulrich Bernard, Itzel E. Calleja-Macias, S. Terence Dunn. (2006) Genome variation of human papillomavirus types: Phylogenetic and medical implications. International Journal of Cancer 118:5, 1071-1076
CrossRef1113
Shaira Sahebali, Christophe E. Depuydt, Gaëlle A.V. Boulet, Marc Arbyn, Liliane M. Moeneclaey, Annie J. Vereecken, Eric A. Van Marck, Johannes J. Bogers. (2006) Immunocytochemistry in liquid-based cervical cytology: Analysis of clinical use following a cross-sectional study. International Journal of Cancer 118:5, 1254-1260
CrossRef1114
Philip Davies, Marc Arbyn, Joakim Dillner, Henry C. Kitchener, Chris J.L.M. Meijer, Guglielmo Ronco, Matti Hakama. (2006) A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. International Journal of Cancer 118:4, 791-796
CrossRef1115
Marij J.P. Welters, Pauline van der Logt, Susan J.F. van den Eeden, Kitty M.C. Kwappenberg, Jan Wouter Drijfhout, Gert Jan Fleuren, Gemma G. Kenter, Cornelis J.M. Melief, Sjoerd H. van der Burg, Rienk Offringa. (2006) Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease. International Journal of Cancer 118:4, 950-956
CrossRef1116
Ian H. Frazer, J Thomas Cox, Edward John Mayeaux, Eduardo L. Franco, Anna-Barbara Moscicki, Joel M. Palefsky, Daron G. Ferris, Alex S. Ferenczy, Luisa L. Villa. (2006) Advances in Prevention of Cervical Cancer and Other Human Papillomavirus-Related Diseases. The Pediatric Infectious Disease Journal 25:Supplement, S65-S81
CrossRef1117
Edward J Mayeaux. (2006) Harnessing the power of prevention: human papillomavirus vaccines. Current Opinion in Obstetrics and Gynecology 18:Suppl 1, s15-s21
CrossRef1118
Justin Stebbing, Gairin Dancey, Mark Bower. (2006) A tale of three Hs: HPV, HIV & HAART. Future Oncology 2:1, 1-9
CrossRef1119
J Thomas Cox. (2006) The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?. Current Opinion in Obstetrics and Gynecology 18:Suppl 1, s5-s13
CrossRef1120
Mariëtte I.E. van Poelgeest, Esther R. Nijhuis, Kitty M.C. Kwappenberg, Ineke E. Hamming, Jan Wouter Drijfhout, Gert Jan Fleuren, Ate G.J. van der Zee, Cornelis J.M. Melief, Gemma G. Kenter, Hans W. Nijman, Rienk Offringa, Sjoerd H. van der Burg. (2006) Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia. International Journal of Cancer 118:3, 675-683
CrossRef1121
J Thomas Cox. (2006) Introduction. Current Opinion in Obstetrics and Gynecology 18:Suppl 1, s3-s4
CrossRef1122
M. Hampl. (2006) Vermeidung und Therapie HPV-assoziierter Erkrankungen durch Vakzinationsprogramme. Der Gynäkologe 39:2, 122-133
CrossRef1123
S Bulk, J Berkhof, N W J Bulkmans, G D Zielinski, L Rozendaal, F J van Kemenade, P J F Snijders, C J L M Meijer. (2006) Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. British Journal of Cancer 94:1, 171-175
CrossRef1124
Kerstin Dell, Robert Koesters, Lutz Gissmann. (2006) Transcutaneous immunization in mice: Induction of T-helper and cytotoxic T lymphocyte responses and protection against human papillomavirus-induced tumors. International Journal of Cancer 118:2, 364-372
CrossRef1125
Ruanne V. Barnabas, Päivi Laukkanen, Pentti Koskela, Osmo Kontula, Matti Lehtinen, Geoff P. Garnett. (2006) Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses. PLoS Medicine 3:5, e138
CrossRef1126
Rana Domiati-Saad, Richard H. Scheuermann. (2006) Nucleic acid testing for viral burden and viral genotyping. Clinica Chimica Acta 363:1-2, 197-205
CrossRef1127
Paul K. S. Chan, Tak-Hong Cheung, Ann O. Y. Tam, Keith W. K. Lo, So-Fan Yim, May M. Y. Yu, Ka-Fai To, Yick-Fu Wong, Jo L. K. Cheung, Denise P. C. Chan, Mamie Hui, Margaret Ip. (2006) Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers. International Journal of Cancer 118:1, 243-245
CrossRef1128
David Soper. (2006) Reducing the Health Burden of HPV Infection Through Vaccination. Infectious Diseases in Obstetrics & Gynecology 2006, 1-6
CrossRef1129
I A. M van der Avoort, H Shirango, B M Hoevenaars, J M. M Grefte, J A de Hullu, P C. M de Wilde, J Bulten, W J. G Melchers, L F. A. G Massuger. (2006) Vulvar Squamous Cell Carcinoma is a Multifactorial Disease Following Two Separate and Independent Pathways. International Journal of Gynecological Pathology 25:1, 22-29
CrossRef1130
Peter JF Snijders, Renske DM Steenbergen, Daniëlle AM Heideman, Chris JLM Meijer. (2006) HPV-mediated cervical carcinogenesis: concepts and clinical implications. The Journal of Pathology 208:2, 152-164
CrossRef1131
Jeffrey M Partridge, Laura A Koutsky. (2006) Genital human papillomavirus infection in men. The Lancet Infectious Diseases 6:1, 21-31
CrossRef1132
P. Naud, J. Matos, L. Hammes, J. Stuckzynski, K. Brouwers, V. Magno, E. Dias, P. Crusius, A. d’Avila, C. Campos, M. Costa, M. Höblik, C. Marc, R. Marroni, K. Syrjänen. (2006) Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil. European Journal of Obstetrics & Gynecology and Reproductive Biology 124:1, 110-118
CrossRef1133
S. SRIAMPORN, P.J.F. SNIJDERS, C. PIENTONG, P. PISANI, T. EKALAKSANANAN, C.J.L.M. MEIJER, D.M. PARKIN. (2006) Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand. International Journal of Gynecological Cancer 16:1, 266-269
CrossRef1134
Ki Hyung Kim, Man Soo Yoon, Yong Jin Na, Chang Soo Park, Myung Ryurl Oh, Woo Chul Moon. (2006) Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip. Gynecologic Oncology 100:1, 38-43
CrossRef1135
Jose Jeronimo, L Rodney Long, Leif Neve, Bopf Michael, Sameer Antani, Mark Schiffman. (2006) Digital Tools for Collecting Data from Cervigrams for Research and Training in Colposcopy. Journal of Lower Genital Tract Disease 10:1, 16-25
CrossRef1136
T. Molden, I. Kraus, F. Karlsen, H. Skomedal, B. Hagmar. (2006) Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age. Gynecologic Oncology 100:1, 95-100
CrossRef1137
Philip E. Castle, Joan L. Walker, Mark Schiffman, Cosette M. Wheeler. (2005) Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. International Journal of Cancer 117:6, 1007-1012
CrossRef1138
Jessica A. Kahn. (2005) Vaccination as a prevention strategy for human papillomavirus-related diseases. Journal of Adolescent Health 37:6, S10-S16
CrossRef1139
Anna-Barbara Moscicki. (2005) Impact of HPV infection in adolescent populations. Journal of Adolescent Health 37:6, S3-S9
CrossRef1140
Schiffman, Mark, Castle, Philip E., . (2005) The Promise of Global Cervical-Cancer Prevention. New England Journal of Medicine 353:20, 2101-2104
Full Text1141
Nicole W.J. Bulkmans, Maaike C.G. Bleeker, Johannes Berkhof, Feja J. Voorhorst, Peter J.F. Snijders, Chris J.L.M. Meijer. (2005) Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. International Journal of Cancer 117:2, 177-181
CrossRef1142
Philip E. Castle, Raheela Ashfaq, Faryal Ansari, Carolyn Y. Muller. (2005) Immunohistochemical evaluation of heat shock proteins in normal and preinvasive lesions of the cervix. Cancer Letters 229:2, 245-252
CrossRef1143
Renwei Chen, Leena-Maija Aaltonen, Antti Vaheri. (2005) Human papillomavirus type 16 in head and neck carcinogenesis. Reviews in Medical Virology 15:6, 351-363
CrossRef1144
Guillaume S. Carpentier, Maxime J.J. Fleury, Antoine Touzé, Jean-Rémy Sadeyen, Sylvie Tourne, Pierre-Yves Sizaret, Pierre Coursaget. (2005) Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies. Journal of Medical Virology 77:4, 558-565
CrossRef1145
Santiago García-Vallvé, Ángel Alonso, Ignacio G. Bravo. (2005) Papillomaviruses: different genes have different histories. Trends in Microbiology 13:11, 514-521
CrossRef1146
Ali Si-Mohamed, Angélique Ndjoyi-Mbiguino, Kate Cuschieri, Isabelle Ndombi Onas, Isabelle Colombet, Francis Ozouaki, Jérôme Le Goff, Heather Cubie, Laurent Bélec. (2005) High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon. Journal of Medical Virology 77:3, 430-438
CrossRef1147
S R Wall, C F Scherf, L Morison, K W Hart, B West, G Ekpo, A N Fiander, S Man, C M Gelder, G Walraven, L K Borysiewicz. (2005) Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. British Journal of Cancer 93:9, 1068-1076
CrossRef1148
Rosemary E. Zuna, Sophia S. Wang, Dorothy L. Rosenthal, Jose Jeronimo, Mark Schiffman, Diane Solomon. (2005) Determinants of human papillomavirus-negative, low-grade squamous intraepithelial lesions in the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS). Cancer 105:5, 253-262
CrossRef1149
Andrea L. Fuessel Haws, Sabine Woeber, Miroslava Gomez, Noe Garza, Yvonne Gomez, Peter Rady, Qin He, Lifang Zhang, James J. Grady, Joseph B. McCormick, Susan P. Fisher-Hoch, Stephen K. Tyring. (2005) Human papillomavirus infection and P53 codon 72 genotypes in a hispanic population at high-risk for cervical cancer. Journal of Medical Virology 77:2, 265-272
CrossRef1150
Jessica A Kahn, David I Bernstein. (2005) Human papillomavirus vaccines and adolescents. Current Opinion in Obstetrics and Gynecology 17:5, 476-482
CrossRef1151
Martha Jacob, Janet Bradley, Mark A. Barone. (2005) Human Papillomavirus Vaccines: What Does the Future Hold for Preventing Cervical Cancer in Resource-Poor Settings Through Immunization Programs?. Sexually Transmitted Diseases 32:10, 635-640
CrossRef1152
Eric Van Der Snoek, Hubert Niesters, Gerard Van Doornum, Paul Mulder, Albert Osterhaus, Willem Van Der Meijden. (2005) Acquisition and Clearance of Perianal Human Papillomavirus Infection in Relation to HIV‐positivity in Men Who Have Sex with Men in the Netherlands. Acta Dermato-Venereologica 85:5, 437-443
CrossRef1153
GM Clifford, S Gallus, R Herrero, N Muñoz, PJF Snijders, S Vaccarella, PTH Anh, C Ferreccio, NT Hieu, E Matos, M Molano, R Rajkumar, G Ronco, S de Sanjosé, HR Shin, S Sukvirach, JO Thomas, S Tunsakul, CJLM Meijer, S Franceschi. (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. The Lancet 366:9490, 991-998
CrossRef1154
M.E. SCHEURER, G. TORTOLERO-LUNA, K. ADLER-STORTHZ. (2005) Human papillomavirus infection: biology, epidemiology, and prevention. International Journal of Gynecological Cancer 15:5, 727-746
CrossRef1155
Jorma Paavonen, Matti Lehtinen. (2005) First-generation vaccines against human papillomavirus. Women's Health 1:2, 223-229
CrossRef1156
M. C. G. Bleeker, C. J. A. Hogewoning, J. Berkhof, F. J. Voorhorst, A. T. Hesselink, P. M. van Diemen, A. J. C. van den Brule, P. J. F. Snijders, C. J. L. M. Meijer. (2005) Concordance of Specific Human Papillomavirus Types in Sex Partners Is More Prevalent than Would Be Expected by Chance and Is Associated with Increased Viral Loads. Clinical Infectious Diseases 41:5, 612-620
CrossRef1157
Yoo-Duk Choi, Woon-Won Jung, Jong-Hee Nam, Ho-Sun Choi, Chang-Soo Park. (2005) Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencing. Gynecologic Oncology 98:3, 369-375
CrossRef1158
Lynette Denny. (2005) REVIEW: The prevention of cervical cancer in developing countries. BJOG: An International Journal of Obstetrics & Gynaecology 112:9, 1204-1212
CrossRef1159
Ruth M. Pfeiffer, Philip E. Castle. (2005) With or Without a Gold Standard. Epidemiology 16:5, 595-597
CrossRef1160
P. Petignat, C. Hankins, S. Walmsley, D. Money, D. Provencher, K. Pourreaux, J. Kornegay, F. Rouah, , F. Coutlue. (2005) Self-Sampling Is Associated with Increased Detection of Human Papillomavirus DNA in the Genital Tract of HIV-Seropositive Women. Clinical Infectious Diseases 41:4, 527-534
CrossRef1161
E. Beerens, L. Van Renterghem, M. Praet, Y. Sturtewagen, S. Weyers, M. Temmerman, H. Depypere, P. Claeys, C. A. Cuvelier. (2005) Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes. Cytopathology 16:4, 199-205
CrossRef1162
Daniel Tena, Nuria Garrido, José Manuel Menéndez, Juan José Delgado, Juan Romanyk, María del Rosario González, Álvaro Zapico, María Beltrán. (2005) Utilidad de la detección del virus del papiloma humano de alto riesgo mediante Hybrid Capture II® en mujeres con citologías anormales del cuello uterino. Enfermedades Infecciosas y Microbiología Clínica 23:8, 474-478
CrossRef1163
Smita N. Joshi, V. Gopalkrishna, B. Kishore Kumar, Soma Dutta, Pratima Nyaynirgune, Madhuri Thakar, Srikanth Tripathy, Sanjay Mehendale, Ramesh Paranjape. (2005) Cervical squamous intra-epithelial changes and human papillomavirus infection in women infected with human immunodeficiency virus in Pune, India. Journal of Medical Virology 76:4, 470-475
CrossRef1164
W.A.A. Tjalma, T.R. Van Waes, L.E.M. Van den Eeden, J.J.P.M. Bogers. (2005) Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best Practice & Research Clinical Obstetrics & Gynaecology 19:4, 469-483
CrossRef1165
L.A. Denny, T.C. Wright. (2005) Human papillomavirus testing and screening. Best Practice & Research Clinical Obstetrics & Gynaecology 19:4, 501-515
CrossRef1166
H.S. Cronjé. (2005) Screening for cervical cancer in the developing world. Best Practice & Research Clinical Obstetrics & Gynaecology 19:4, 517-529
CrossRef1167
A.-L. Williamson, J.-A. Passmore, E.P. Rybicki. (2005) Strategies for the prevention of cervical cancer by human papillomavirus vaccination. Best Practice & Research Clinical Obstetrics & Gynaecology 19:4, 531-544
CrossRef1168
P. E. Castle, D. Solomon, M. Schiffman, C. M. Wheeler, . (2005) Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities. JNCI Journal of the National Cancer Institute 97:14, 1066-1071
CrossRef1169
M. J. Khan, P. E. Castle, A. T. Lorincz, S. Wacholder, M. Sherman, D. R. Scott, B. B. Rush, A. G. Glass, M. Schiffman. (2005) The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice. JNCI Journal of the National Cancer Institute 97:14, 1072-1079
CrossRef1170
M. J. Trunk, N. Wentzensen, M. von Knebel Doeberitz. (2005) Molekulare Pathogenese des Zervixkarzinoms und seiner Vorstufen. Der Pathologe 26:4, 283-290
CrossRef1171
Jason D. Wright, Jianduan Li, Daniela S. Gerhard, Zhengyan Zhang, Phyllis C. Huettner, Matthew A. Powell, Randall K. Gibb, Thomas J. Herzog, David G. Mutch, Kathryn M. Trinkaus, Janet S. Rader. (2005) Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma. Gynecologic Oncology 98:1, 84-91
CrossRef1172
Keun-Ho Lee, Eun-Kyoung Yim, Chan-Joo Kim, Sung-Eun Namkoong, Soo-Jong Um, Jong-Sup Park. (2005) Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecologic Oncology 98:1, 45-53
CrossRef1173
Fabiola Medeiros, Liping Yuan, Gillian Breslin, Joshua Brodsky, Ashraf Saleemuddin, Sarah Feldman, Lynda Rushing, Aida Cviko, Kenneth R Lee, Christopher P Crum. (2005) Type-Specific HPV Testing as a Predictor of High-Grade Squamous Intraepithelial Lesion Outcome after Cytologic Abnormalities. Journal of Lower Genital Tract Disease 9:3, 154-159
CrossRef1174
S Andersson, H Safari, M Mints, I Lewensohn- Fuchs, U Gyllensten, B Johansson. (2005) Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). British Journal of Cancer 92:12, 2195-2200
CrossRef1175
S. Franceschi, G. M. Clifford. (2005) Re: A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests. JNCI Journal of the National Cancer Institute 97:12, 938-939
CrossRef1176
P. V. Chin-Hong, E. Vittinghoff, R. D. Cranston, L. Browne, S. Buchbinder, G. Colfax, M. Da Costa, T. Darragh, D. J. Benet, F. Judson, B. Koblin, K. H. Mayer, J. M. Palefsky. (2005) Age-Related Prevalence of Anal Cancer Precursors in Homosexual Men: The EXPLORE Study. JNCI Journal of the National Cancer Institute 97:12, 896-905
CrossRef1177
Johannes Berkhof, Martine C de Bruijne, Gilda D Zielinski, Chris JLM Meijer. (2005) Natural history and screening model for high-risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands. International Journal of Cancer 115:2, 268-275
CrossRef1178
Guillem Sirera, Sebastián Videla, Eva Castellá, Lluís Cavallé, Núria Grané, Mariona Llatjos, Cristina Tural, Eugenia Negredo, Ángela Fernández, Celestino Rey-Joly, Bonaventura Clotet. (2005) Contribución de la captura de híbridos de segunda generación del virus del papiloma humano en el cribado de afección cervical en mujeres con infección por el virus de la inmunodeficiencia humana. Medicina Clínica 125:4, 127-131
CrossRef1179
Toshiyuki Sasagawa, Mayuko Tani, Walid Basha, Robert C. Rose, Hideki Tohda, Yuko Giga-Hama, Khadijeh K. Azar, Hideyo Yasuda, Akemi Sakai, Masaki Inoue. (2005) A human papillomavirus type 16 vaccine by oral delivery of L1 protein. Virus Research 110:1-2, 81-90
CrossRef1180
S. Zheng, A. Adachi, M. Shimizu, S-I. Shibata, S. Yasue, A. Sakakibara, M. Sugiura, T. Nagasaka, Y. Tomita. (2005) Human papillomaviruses of the mucosal type are present in some cases of extragenital Bowen's disease. British Journal of Dermatology 152:6, 1243-1247
CrossRef1181
A.K. Lie, B. Risberg, B. Borge, B. Sandstad, J. Delabie, R. Rimala, M. Onsrud, S. Thoresen. (2005) DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecologic Oncology 97:3, 908-915
CrossRef1182
Patti E. Gravitt, Roxanne Jamshidi. (2005) Diagnosis and Management of Oncogenic Cervical Human Papillomavirus Infection. Infectious Disease Clinics of North America 19:2, 439-458
CrossRef1183
Brian Brestovac, Gerald B. Harnett, David W. Smith, Felicity Frost, Geoffrey R. Shellam. (2005) Multiplex nested PCR (MNP) assay for the detection of 15 high risk genotypes of human papillomavirus. Journal of Clinical Virology 33:2, 116-122
CrossRef1184
Tor Molden, Jan F. Nyg
rd, Irene Kraus, Frank Karlsen, Mari Nyg
CrossRef1185
M J Grainge, R Seth, C Coupland, L Guo, T Rittman, P Vryenhoef, J Johnson, D Jenkins, K R Neal. (2005) Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case–control study in the UK. British Journal of Cancer 92:9, 1794-1799
CrossRef1186
Diane Solomon, Philip E. Castle. (2005) Findings From ALTS. Pathology Case Reviews 10:3, 128-137
CrossRef1187
Baback Gharizadeh, Maria Oggionni, Biying Zheng, Edit Akom, Nader Pourmand, Afshin Ahmadian, Keng-Ling Wallin, Pål Nyrén. (2005) Type-Specific Multiple Sequencing Primers. The Journal of Molecular Diagnostics 7:2, 198-205
CrossRef1188
Susie Baldwin, Carlos Santos, Elena Mendez Brown, Thomas Nuño, Anna Giuliano, John Davis, Francisco Garcia. (2005) Comparison of type-specific human papillomavirus data from self and clinician directed sampling. Gynecologic Oncology 97:2, 612-617
CrossRef1189
Brian Brestovac, Gerry B. Harnett, David W. Smith, Geoffrey R. Shellam, Felicity A. Frost. (2005) Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women. Journal of Medical Virology 76:1, 106-110
CrossRef1190
Mark H. Stoler. (2005) The Impact of Human Papillomavirus Biology on the Clinical Practice of Cervical Pathology. Pathology Case Reviews 10:3, 119-127
CrossRef1191
Sebastian Oerke, Hanni H
CrossRef1192
G. A. Poland, R. M. Jacobson, L. A. Koutsky, G. M. Tamms, R. Railkar, J. F. Smith, J. T. Bryan, P. F. Cavanaugh, K. U. Jansen, E. Barr. (2005) Immunogenicity and Reactogenicity of a Novel Vaccine for Human Papillomavirus 16: A 2-Year Randomized Controlled Clinical Trial. Mayo Clinic Proceedings 80:5, 601-610
CrossRef1193
M C G Bleeker, J Berkhof, C J A Hogewoning, F J Voorhorst, A J C van den Brule, T M Starink, P J F Snijders, C J L M Meijer. (2005) HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions. British Journal of Cancer 92:8, 1388-1392
CrossRef1194
Reinhard Bollmann, Gábor Méhes, Norbert Speich, Christoph Schmitt, Magdolna Bollmann. (2005) Aberrant, highly hyperdiploid cells in human papillomavirus-positive, abnormal cytologic samples are associated with progressive lesions of the uterine cervix. Cancer 105:2, 96-100
CrossRef1195
John Lynch, George Davey Smith. (2005) A LIFE COURSE APPROACH TO CHRONIC DISEASE EPIDEMIOLOGY. Annual Review of Public Health 26:1, 1-35
CrossRef1196
Sarah J. Youde, Corinna M. McCarthy, Karen J. Thomas, Kelly L. Smith, Stephen Man. (2005) Cross-typic specificity and immunotherapeutic potential of a human HPV16 E7-specific CTL line. International Journal of Cancer 114:4, 606-612
CrossRef1197
H. D. Strickler, R. D. Burk, M. Fazzari, K. Anastos, H. Minkoff, L. S. Massad, C. Hall, M. Bacon, A. M. Levine, D. H. Watts, M. J. Silverberg, X. Xue, N. F. Schlecht, S. Melnick, J. M. Palefsky. (2005) Natural History and Possible Reactivation of Human Papillomavirus in Human Immunodeficiency Virus-Positive Women. JNCI Journal of the National Cancer Institute 97:8, 577-586
CrossRef1198
Shin Nieh, Su-Feng Chen, Tang-Yuan Chu, Hung-Cheng Lai, Yaoh-Shiang Lin, Earl Fu, Ching-Hwa Gau. (2005) Is p16INK4A expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecologic Oncology 97:1, 35-40
CrossRef1199
Hee J An, Kyu R Kim, In S Kim, Dong W Kim, Moon H Park, In A Park, Kwang S Suh, Eun J Seo, Sun H Sung, Jin H Sohn, Hye K Yoon, Eun D Chang, Hyun I Cho, Ji Y Han, Sung R Hong, Geung H Ahn. (2005) Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Modern Pathology 18:4, 528-534
CrossRef1200
Gabriel Levi, Joseph Feldman, Susan Holman, Afshin Salarieh, Howard D. Strickler, Shira Alter, Howard Minkoff. (2005) Relationship between HIV viral load and Langerhans cells of the cervical epithelium. Journal of Obstetrics and Gynaecology Research 31:2, 178-184
CrossRef1201
Patti E. Gravitt, Keerti V. Shah. (2005) A virus-based vaccine may prevent cervical cancer. Current Infectious Disease Reports 7:2, 125-131
CrossRef1202
Hans-Ulrich Bernard. (2005) The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. Journal of Clinical Virology 32, 1-6
CrossRef1203
Alan G Waxman. (2005) Guidelines for Cervical Cancer Screening: History and Scientific Rationale. Clinical Obstetrics and Gynecology 48:1, 77-97
CrossRef1204
Janet G. Baseman, Laura A. Koutsky. (2005) The epidemiology of human papillomavirus infections. Journal of Clinical Virology 32, 16-24
CrossRef1205
Anco Molijn, Berhard Kleter, Wim Quint, Leen-Jan van Doorn. (2005) Molecular diagnosis of human papillomavirus (HPV) infections. Journal of Clinical Virology 32, 43-51
CrossRef1206
Renske D.M. Steenbergen, Jillian de Wilde, Saskia M. Wilting, Antoinette A.T.P. Brink, Peter J.F. Snijders, Chris J.L.M. Meijer. (2005) HPV-mediated transformation of the anogenital tract. Journal of Clinical Virology 32, 25-33
CrossRef1207
Mitchell S Wachtel, Mathilde E Boon, Hans Korporaal, Lambrecht P Kok. (2005) Human papillomavirus testing as a cytology gold standard: comparing Surinam with the Netherlands. Modern Pathology 18:3, 349-353
CrossRef1208
Kate S. Cuschieri, Heather A. Cubie. (2005) The role of human papillomavirus testing in cervical screening. Journal of Clinical Virology 32, 34-42
CrossRef1209
Lulin Hu, Ming Guo, Zhi He, Justin Thornton, Larry S McDaniel, Michael D Hughson. (2005) Human papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. Modern Pathology 18:2, 267-273
CrossRef1210
A. A. T. P. Brink, G. D. Zielinski, R. D. M. Steenbergen, P. J. F. Snijders, C. J. L. M. Meijer. (2005) Clinical relevance of human papillomavirus testing in cytopathology. Cytopathology 16:1, 7-12
CrossRef1211
M. Bollmann, A. Bankfalvi, A. Trosic, N. Speich, C. Schmitt, R. Bollmann. (2005) Can we detect cervical human papillomavirus (HPV) infection by cytomorphology alone? Diagnostic value of non-classic cytological signs of HPV effect in minimally abnormal Pap tests. Cytopathology 16:1, 13-21
CrossRef1212
Neil D Christensen. (2005) Emerging human papillomavirus vaccines. Expert Opinion on Emerging Drugs 10:1, 5-19
CrossRef1213
Jan Wallace, Bruce A. Woda, German Pihan. (2005) Facile, Comprehensive, High-Throughput Genotyping of Human Genital Papillomaviruses Using Spectrally Addressable Liquid Bead Microarrays. The Journal of Molecular Diagnostics 7:1, 72-80
CrossRef1214
Simon Gagnon, Catherine Hankins, C
CrossRef1215
S Franceschi, R Rajkumar, P J F Snijders, A Arslan, C Mahé, M Plummer, R Sankaranarayanan, J Cherian, C J L M Meijer, E Weiderpass. (2005) Papillomavirus infection in rural women in southern India. British Journal of Cancer
CrossRef1216
Doudja Hammouda, Nubia Mu
CrossRef1217
M. Schiffman, M. J. Khan, D. Solomon, R. Herrero, S. Wacholder, A. Hildesheim, A. C. Rodriguez, M. C. Bratti, C. M. Wheeler, R. D. Burk, . (2005) A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage Tests. JNCI Journal of the National Cancer Institute 97:2, 147-150
CrossRef1218
Anil K. Chaturvedi, Jeanne Dumestre, Ann M. Gaffga, Kristina M. Mire, Rebecca A. Clark, Patricia S. Braly, Kathleen Dunlap, Tracy E. Beckel, Ansley F. Hammons, Patricia J. Kissinger, Michael E. Hagensee. (2005) Prevalence of human papillomavirus genotypes in women from three clinical settings. Journal of Medical Virology 75:1, 105-113
CrossRef1219
Diane M Da Silva, W Martin Kast. (2005) Vaccination Against Cervical Cancer. American Journal of Cancer 4:4, 207-219
CrossRef1220
Peter V. Chin-Hong, Joel M. Palefsky. (2005) Human papillomavirus anogenital disease in HIV-infected individuals. Dermatologic Therapy 18:1, 67-76
CrossRef1221
James Maclean, Edward P Rybicki, Anna-Lise Williamson. (2005) Vaccination strategies for the prevention of cervical cancer. Expert Review of Anticancer Therapy 5:1, 97-107
CrossRef1222
Maja Cupic, Ivana Lazarevic, Nada Kuljic-Kapulica. (2005) Oncogenic viruses and their role in tumor formation. Srpski arhiv za celokupno lekarstvo 133:7-8, 384-387
CrossRef1223
Anja Gulliksen, Lars Anders Solli, Klaus Stefan Drese, Olaf S?rensen, Frank Karlsen, Henrik Rogne, Eivind Hovig, Reidun Sirev?g. (2005) Parallel nanoliter detection of cancer markers using polymer microchips. Lab on a Chip 5:4, 416
CrossRef1224
Elizabeth Webb, John Cox, Stirling Edwards. (2005) Cervical Cancer-causing Human Papillomaviruses have an Alternative Initiation Site for the L1 Protein. Virus Genes 30:1, 31-35
CrossRef1225
(2005) Guideline zum Vorgehen bei suspektem und positivem zytologischen Abstrich der Cervix uteri (überarbeitete Fassung, Version 2.4). Gyn?kologisch-geburtshilfliche Rundschau 45:1, 44-55
CrossRef1226
Paul A Fox, Mun-Yee Tung. (2005) Human Papillomavirus. American Journal of Clinical Dermatology 6:6, 365-381
CrossRef1227
Andrea R Spence, Eduardo L Franco, Alex Ferenczy. (2005) The Role of Human Papillomaviruses in Cancer. American Journal of Cancer 4:1, 49-64
CrossRef1228
T DOG. 2005. Cervical Dysplasia and Cancer. , 278-292.
CrossRef1229
W Alazawi, M Pett, S Strauss, R Moseley, J Gray, M Stanley, N Coleman. (2004) Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. British Journal of Cancer 91:12, 2063-2070
CrossRef1230
G Terry, L Ho, P Londesborough, P Cross, A Lopes, J Monaghan, J Cuzick. (2004) The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions. British Journal of Cancer 91:12, 2056-2062
CrossRef1231
Margherita Branca, Marco Ciotti, Donatella Santini, Luigi Di Bonito, Arrigo Benedetto, Colomba Giorgi, Pierpaolo Paba, Carterio Favalli, Silvano Costa, Alberto Agarossi, Mauro Alderisio, Kari Syrjänen, ISS Study Group. (2004) Activation of the ERK/MAP Kinase Pathway in Cervical Intraepithelial Neoplasia Is Related to Grade of the Lesion but not to High-Risk Human Papillomavirus, Virus Clearance, or Prognosis in Cervical Cancer. American Journal of Clinical Pathology 122:6, 902-911
CrossRef1232
A FUESSELHAWS, Q HE, P RADY, L ZHANG, J GRADY, T HUGHES, K STISSER, R KONIG, S TYRING. (2004) Nested PCR with the PGMY09/11 and GP5/6 primer sets improves detection of HPV DNA in cervical samples. Journal of Virological Methods 122:1, 87-93
CrossRef1233
Eduardo L. Franco, Pelayo Correa, Regina M. Santella, Xifeng Wu, Steven N. Goodman, Gloria M. Petersen. (2004) Role and limitations of epidemiology in establishing a causal association. Seminars in Cancer Biology 14:6, 413-426
CrossRef1234
Maura L. Gillison. (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Seminars in Oncology 31:6, 744-754
CrossRef1235
Sophie Françoise Mauricette Derchain, Silvia Helena Rabelo-Santos, Luis Otávio Sarian, Luiz Carlos Zeferino, Eliane Regina de Oliveira Zambeli, Maria Cristina do Amaral Westin, Liliana Aparecida Lucci de Ângelo Andrade, Kari Juhani Syrjänen. (2004) Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecologic Oncology 95:3, 618-623
CrossRef1236
Antoinette A. T. P. Brink, Chris J. L. M. Meijer, Adriaan J. C. van den Brule, Peter J. F. Snijders. 2004. HPV Typing Comparison of Different Molecular Assays. , 640-645.
CrossRef1237
Narayanan Sathish, Priya Abraham, Abraham Peedicayil, Gopalan Sridharan, R.V. Shaji, George Chandy. (2004) E2 sequence variations of HPV 16 among patients with cervical neoplasia seen in the Indian subcontinent. Gynecologic Oncology 95:2, 363-369
CrossRef1238
Matti Lehtinen, Jorma Paavonen. (2004) Vaccination against human papillomaviruses shows great promise. The Lancet 364:9447, 1731-1732
CrossRef1239
Rosemary E Zuna, Richard A Allen, William E Moore, Rubina Mattu, S Terence Dunn. (2004) Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence for differences in biologic potential of precursor lesions. Modern Pathology 17:11, 1314-1322
CrossRef1240
Diane M Harper, Eduardo L Franco, Cosette Wheeler, Daron G Ferris, David Jenkins, Anne Schuind, Toufik Zahaf, Bruce Innis, Paulo Naud, Newton S De Carvalho, Cecilia M Roteli-Martins, Julio Teixeira, Mark M Blatter, Abner P Korn, Wim Quint, Gary Dubin. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. The Lancet 364:9447, 1757-1765
CrossRef1241
Khadijeh K. Azar, Mayuko Tani, Hideyo Yasuda, Akemi Sakai, Masaki Inoue, Toshiyuki Sasagawa. (2004) Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Human Pathology 35:11, 1376-1384
CrossRef1242
Philip E. Castle, Mark Schiffman, Cosette M. Wheeler, for the ALTS Group. (2004) Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer. American Journal of Obstetrics and Gynecology 191:5, 1590-1597
CrossRef1243
S S Wang, M Schiffman, R Herrero, J Carreon, A Hildesheim, A C Rodriguez, M C Bratti, M E Sherman, J Morales, D Guillen, M Alfaro, B Clayman, R D Burk, R P Viscidi. (2004) Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. British Journal of Cancer 91:7, 1269-1274
CrossRef1244
Stephen J. Genuis, Shelagh K. Genuis. (2004) Managing the sexually transmitted disease pandemic: A time for reevaluation. American Journal of Obstetrics and Gynecology 191:4, 1103-1112
CrossRef1245
M Branca, M Ciotti, D Santini, L Di Bonito, C Giorgi, A Benedetto, P Paba, C Favalli, S Costa, A Agarossi, M Alderisio, K Syrjänen. (2004) p16INK4A Expression Is Related to Grade of CIN and High-risk Human Papillomavirus but Does not Predict Virus Clearance After Conization or Disease Outcome. International Journal of Gynecological Pathology 23:4, 354-365
CrossRef1246
W. A. A. Tjalma, M. Arbyn, J. Paavonen, T. R. Van Waes, J. J. Bogers. (2004) Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer. International Journal of Gynecological Cancer 14:5, 751-761
CrossRef1247
Nubia Mu
CrossRef1248
Richard B.S Roden, Morris Ling, T.-C Wu. (2004) Vaccination to prevent and treat cervical cancer. Human Pathology 35:8, 971-982
CrossRef1249
Kevin A Ault, Anna R Giuliano, Robert P Edwards, Gretchen Tamms, Lee-Lian Kim, Judith F Smith, Kathrin U Jansen, Maria Allende, Frank J Taddeo, DeeMarie Skulsky, Eliav Barr. (2004) A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine. Vaccine 22:23-24, 3004-3007
CrossRef1250
Susan Hayden Gray, Toni Beth Walzer. (2004) New strategies for cervical cancer screening in adolescents. Current Opinion in Pediatrics 16:4, 344-349
CrossRef1251
F GEMIGNANI. (2004) Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16. Journal of Virological Methods 119:2, 95-102
CrossRef1252
Marc F.D. Baay, Eyrun F. Kjetland, Patricia D. Ndhlovu, Vanessa Deschoolmeester, Takafira Mduluza, Exenevia Gomo, Henrik Friis, Nicholas Midzi, Lovemore Gwanzura, Peter R. Mason, Jan B. Vermorken, Svein G. Gundersen. (2004) Human papillomavirus in a rural community in Zimbabwe: The impact of HIV co-infection on HPV genotype distribution. Journal of Medical Virology 73:3, 481-485
CrossRef1253
Phuong Dai Vo, Tung T. Nguyen, Phuong Nguyen, Joan F. Hilton, Joel M. Palefsky, Yifei Ma, Stephen J. McPhee. (2004) Human Papillomavirus and Abnormal Pap Test Results in Vietnamese-American Women: A Pilot Case-Control Study. Journal of Lower Genital Tract Disease 8:3, 217-223
CrossRef1254
Philip E. Castle. (2004) Beyond Human Papillomavirus: The Cervix, Exogenous Secondary Factors, and the Development of Cervical Precancer and Cancer. Journal of Lower Genital Tract Disease 8:3, 224-230
CrossRef1255
Kenneth H Fife, Cosette M Wheeler, Laura A Koutsky, Eliav Barr, Darron R Brown, Melissa A Schiff, Nancy B Kiviat, Kathrin U Jansen, Harriet Barber, Judith F Smith, Amha Tadesse, Katherine Giacoletti, Paula R Smith, Gretchen Suhr, Daniel A Johnson. (2004) Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy women. Vaccine 22:21-22, 2943-2952
CrossRef1256
Latifa Bousarghin, Antoine Touz
CrossRef1257
K. Jyotsna Reddy, Babak Banapour, David E. Anderson, Sang H. Lee, Juan P. Marquez, Maria P. Carlos, Jose V. Torres. (2004) Induction of immune responses against human papillomaviruses by hypervariable epitope constructs. Immunology 112:2, 321-327
CrossRef1258
Barbara Tringler, Carol J Gup, Meenakshi Singh, Steve Groshong, A.Laurie Shroyer, David E Heinz, Kenneth R Shroyer. (2004) Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Human Pathology 35:6, 689-696
CrossRef1259
Jessica A. Kahn, Gail B. Slap, Bin Huang, Susan L. Rosenthal, Abbigail M. Wanchick, Linda M. Kollar, Paula A. Hillard, David Witte, Pam Groen, David I. Bernstein. (2004) Comparison of Adolescent and Young Adult Self-Collected and Clinician-Collected Samples for Human Papillomavirus. Obstetrics & Gynecology 103:5, Part 1, 952-959
CrossRef1260
Kate S. Cuschieri, M.J. Whitley, Heather A. Cubie. (2004) Human papillomavirus type specific DNA and RNA persistence?implications for cervical disease progression and monitoring. Journal of Medical Virology 73:1, 65-70
CrossRef1261
Tomomi Yoshida, Toshio Fukuda, Takaaki Sano, Tatsuya Kanuma, Nobuo Owada, Takashi Nakajima. (2004) Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing. Cancer 102:2, 100-108
CrossRef1262
S. J. Goldie, M. Kohli, D. Grima, M. C. Weinstein, T. C. Wright, F. X. Bosch, E. Franco. (2004) Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine. JNCI Journal of the National Cancer Institute 96:8, 604-615
CrossRef1263
Elke A Jarboe, L.Chesney Thompson, David Heinz, J.A McGregor, Kenneth R Shroyer. (2004) Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Human Pathology 35:4, 396-402
CrossRef1264
Sue J. Goldie, Jane J. Kim, Thomas C. Wright. (2004) Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More. Obstetrics & Gynecology 103:4, 619-631
CrossRef1265
Krisztina Szöke, Anita Szalmás, Györgyi Szládek, György Veress, Lajos Gergely, Ferenc D. Tóth, József Kónya. (2004) IL-10 Promoter nt - 1082A/G Polymorphism and Human Papillomavirus Infection in Cytologic Abnormalities of the Uterine Cervix. Journal of Interferon & Cytokine Research 24:4, 245-251
CrossRef1266
Diane R. Blake. (2004) Adolescent sexually transmitted diseases: Recent developments. Current Infectious Disease Reports 6:2, 141-148
CrossRef1267
Stefan Duensing, Karl M
CrossRef1268
Gernot Hudelist, Mahmood Manavi, Kerstin I.D Pischinger, Thomas Watkins-Riedel, Christian F Singer, E Kubista, Klaus F Czerwenka. (2004) Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecologic Oncology 92:3, 873-880
CrossRef1269
Shaira Sahebali, Christophe E. Depuydt, Kurt Segers, Liliane M. Moeneclaey, Annie J. Vereecken, Eric Van Marck, Johannes J. Bogers. (2004) P16INK4a as an adjunct marker in liquid-based cervical cytology. International Journal of Cancer 108:6, 871-876
CrossRef1270
C. Duttagupta, S. Sengupta, M. Roy, D. Sengupta, P. Bhattacharya, P. Laikangbam, S. Roy, S. Ghosh, R. Das. (2004) Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India. International Journal of Gynecological Cancer 14:2, 293-303
CrossRef1271
Annarosa Del Mistro, Roberta Bertorelle, Marzia Franzetti, Annamaria Cattelan, Angela Torrisi, Maria Teresa Giordani, Roberto Sposetti, Emanuela Bonoldi, Lolita Sasset, Laura Bonaldi, Daria Minucci, Luigi Chieco‐Bianchi. (2004) Antiretroviral Therapy and the Clinical Evolution of Human Papillomavirus–Associated Genital Lesions in HIV‐Positive Women. Clinical Infectious Diseases 38:5, 737-742
CrossRef1272
Albertus T. Hesselink, Adriaan J. C. van den Brule, Antoinette A. T. P. Brink, Johannes Berkhof, Folkert J. van Kemenade, René H. M. Verheijen, Peter J. F. Snijders. (2004) Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer 102:1, 11-18
CrossRef1273
R. D. M. Steenbergen, D. Kramer, B. J. M. Braakhuis, P. L. Stern, R. H. M. Verheijen, C. J. L. M. Meijer, P. J. F. Snijders. (2004) TSLC1 Gene Silencing in Cervical Cancer Cell Lines and Cervical Neoplasia. JNCI Journal of the National Cancer Institute 96:4, 294-305
CrossRef1274
ELIZABETH A. PLATZ, ANGELO M. De MARZO. (2004) Epidemiology of Inflammation and Prostate Cancer. The Journal of Urology 171:2, S36-S40
CrossRef1275
Kathrin U. Jansen, Alan R. Shaw. (2004) Human Papillomavirus Vaccines and Prevention of Cervical Cancer. Annual Review of Medicine 55:1, 319-331
CrossRef1276
Tae Chul Park, Chan Joo Kim, Young Me Koh, Keun Ho Lee, Joo Hee Yoon, Ji Hoon Kim, Sung Eun Namkoong, Jong Sup Park. (2004) Human Papillomavirus Genotyping by the DNA Chip in the Cervical Neoplasia. DNA and Cell Biology 23:2, 119-125
CrossRef1277
Joseph Monsonego, F. Xavier Bosch, Pierre Coursaget, John Thomas Cox, Eduardo Franco, Ian Frazer, Rengaswamy Sankaranarayanan, John Schiller, Albert Singer, Tom Wright, Walter Kinney, Chris Meijer, James Linder. (2004) Cervical cancer control, priorities and new directions. International Journal of Cancer 108:3, 329-333
CrossRef1278
Lee-Wen Huang, Shiouh-Lirng Chao, Jiann-Loung Hwang. (2004) Human papillomavirus-31-related types predict better survival in cervical carcinoma. Cancer 100:2, 327-334
CrossRef1279
Rachel L. Winer, Laura A. Koutsky. (2004) Delivering Reassurance to Parents: Perinatal Human Papillomavirus Transmission Is Rare. Sexually Transmitted Diseases 31:1, 63-64
CrossRef1280
Narayanan Sathish, Priya Abraham, Abraham Peedicayil, Gopalan Sridharan, Subhashini John, George Chandy. (2004) Human Papillomavirus 16 E6/E7 Transcript and E2 Gene Status in Patients with Cervical Neoplasia. Molecular Diagnosis 8:1, 57-64
CrossRef1281
A. Singh, H. Sharma, S. Salhan, S. Datta Gupta, N. Bhatla, S.K. Jain, N. Singh. (2004) Evaluation of Expression of Apoptosis-Related Proteins and Their Correlation with HPV, Telomerase Activity, and Apoptotic Index in Cervical Cancer. Pathobiology 71:6, 314-322
CrossRef1282
Georgette Damasus-Awatai, Theresa Freeman-Wang. (2003) Human papilloma virus and cervical screening. Current Opinion in Obstetrics and Gynecology 15:6, 473-477
CrossRef1283
G Denise Zielinski, Peter JF Snijders, Lawrence Rozendaal, Nathalie Fransen Daalmeijer, Elle KJ Risse, Feja J Voorhorst, N Medi Jiwa, Hans C van der Linden, Frits A de Schipper, Arnold P Runsink, Chris JLM Meijer. (2003) The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinomain situ and adenocarcinoma of the cervix. The Journal of Pathology 201:4, 535-543
CrossRef1284
Krisztina Sz?ke, Tam
CrossRef1285
Justin Stebbing, Simon Portsmouth, Paul Fox, Cathryn Brock, Mark Bower. (2003) Multiple human papillomavirus types appear to be a feature of anal not cervical intra-epithelial neoplasia. AIDS 17:16, 2401
CrossRef1286
Silvia Franceschi, Thangarajan Rajkumar, Salvatore Vaccarella, Vendhan Gajalakshmi, Ajit Sharmila, Peter J.F. Snijders, Nubia Mu
CrossRef1287
Cabot, Richard C.Harris, Nancy Lee, McNeely, William F., Shepard, Jo-Anne O., Ebeling, Sally H.Ellender, Stacey M.Peters, Christine C., Goodman, Annekathryn, Wilbur, David C., . (2003) Case 32-2003. New England Journal of Medicine 349:16, 1555-1564
Full Text1288
Silvia de Sanjose, Rosa Almirall, Belen Lloveras, Rebeca Font, Mireia Diaz, Nubia Muñoz, Isabel Català, Chris J. L. M. Meijer, Peter J. F. Snijders, Rolando Herrero, F. Xavier Bosch. (2003) Cervical Human Papillomavirus Infection in the Female Population in Barcelona, Spain. Sexually Transmitted Diseases 30:10, 788-793
CrossRef1289
Marcia Stickler, Regina Chin, Nargol Faravashi, Wendy Gebel, O.Jennifer Razo, Narapon Rochanayon, Scott Power, Ana M Valdes, Susan Holmes, Fiona A Harding. (2003) Human population-based identification of CD4+ T-cell peptide epitope determinants. Journal of Immunological Methods 281:1-2, 95-108
CrossRef1290
Lynette Denny, Louise Kuhn, Thomas C. Wright. (2003) Cervical cancer screening in non-industrialised countries. Papillomavirus Report 14:5, 209-215
CrossRef1291
Joel M. Palefsky. (2003) Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Current Opinion in Oncology 15:5, 382-388
CrossRef1292
Mark H. Stoler. (2003) The Virology of Cervical Neoplasia. The Cancer Journal 9:5, 360-367
CrossRef1293
Eduardo L. Franco, Nicolas F. Schlecht, Debbie Saslow. (2003) The Epidemiology of Cervical Cancer. The Cancer Journal 9:5, 348-359
CrossRef1294
Crum, Christopher P., . (2003) Type-Specific Testing for Human Papillomavirus. New England Journal of Medicine 349:6, 614-615
Full Text1295
P R Palan, M S Mikhail, D W Shaban, S L Romney. (2003) Plasma concentrations of coenzyme Q10 and tocopherols in cervical intraepithelial neoplasia and cervical cancer. European Journal of Cancer Prevention 12:4, 321-326
CrossRef1296
Dulce M Hernández-Hernández, Laura Ornelas-Bernal, Miriam Guido-Jiménez, Teresa Apresa-Garcia, Isabel Alvarado-Cabrero, Mauricio Salcedo-Vargas, Alejandro Mohar-Betancourt, Alejandro Garcia-Carranca. (2003) Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecologic Oncology 90:2, 310-317
CrossRef1297
G. Ada. (2003) Progress towards achieving new vaccine and vaccination goals. Internal Medicine Journal 33:7, 297-304
CrossRef1298
Marie-Claude Rousseau, Luisa L. Villa, Maria Cecilia Costa, Michal Abrahamowicz, Thomas E. Rohan, Eduardo Franco. (2003) Occurrence of Cervical Infection with Multiple Human Papillomavirus Types is Associated with Age and Cytologic Abnormalities. Sexually Transmitted Diseases 30:7, 581-587
CrossRef1299
Siegfried Kösel, Siegfried Burggraf, Jens Mommsen, Werner Engelhardt, Bernhard Olgemöller. (2003) Type-Specific Detection of Human Papillomaviruses in a Routine Laboratory Setting – Improved Sensitivity and Specificity of PCR and Sequence Analysis Compared to Direct Hybridisation. Clinical Chemistry and Laboratory Medicine 41:6, 787-791
CrossRef1300
S. Wacholder. (2003) Chapter 18: Statistical Issues in the Design and Analysis of Studies of Human Papillomavirus and Cervical Neoplasia. JNCI Monographs 2003:31, 125-130
CrossRef1301
F. X. Bosch, S. de Sanjose. (2003) Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality. JNCI Monographs 2003:31, 3-13
CrossRef1302
T. Iftner, L. L. Villa. (2003) Chapter 12: Human Papillomavirus Technologies. JNCI Monographs 2003:31, 80-88
CrossRef1303
(2003) Classification of Human Papillomavirus. New England Journal of Medicine 348:20, 2040-2041
Full Text1304
Elaine Bentley. (2003) Challenges for HPV Testing in Screening. Papillomavirus Report 14:3, 111-113
CrossRef1305
Wright, Thomas C. Jr., Schiffman, Mark, . (2003) Adding a Test for Human Papillomavirus DNA to Cervical-Cancer Screening. New England Journal of Medicine 348:6, 489-490
Full Text
- Letters
